10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended June 30, 2012

o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Transition Period From                       to                      .

Commission File Numbers:  001 – 34465 and 001 – 31441

SELECT MEDICAL HOLDINGS CORPORATION

SELECT MEDICAL CORPORATION

(Exact name of Registrants as specified in their charters)

Delaware Delaware
(State or other jurisdiction of
incorporation or organization) 20-1764048 23-2872718
(I.R.S. employer identification
number)

4714 Gettysburg Road, P.O. Box 2034, Mechanicsburg, Pennsylvania 17055

(Address of principal executive offices and zip code)

(717) 972-1100

(Registrants’ telephone number, including area code)

Indicate by check mark whether the Registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods as the Registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  YES  x  NO  o

Indicate by check mark whether the Registrants have submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrants were required to submit and post such files).  YES  x  NO  o

Indicate by check mark whether the Registrants are large accelerated filers, accelerated filers, non-accelerated filers, or smaller reporting companies.  See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  o	Accelerated filer  x
Non-accelerated filer  o	Smaller reporting company  o

Indicate by check mark whether the Registrants are shell companies (as defined in Rule 12b-2 of the Exchange Act).  YES  o  NO  x

As of July 31, 2012, Select Medical Holdings Corporation had outstanding 139,866,719 shares of common stock.

This Form 10-Q is a combined quarterly report being filed separately by two Registrants: Select Medical Holdings Corporation and Select Medical Corporation.  Unless the context indicates otherwise, any reference in this report to “Holdings” refers to Select Medical Holdings Corporation and any reference to “Select” refers to Select Medical Corporation, the wholly-owned operating subsidiary of Holdings.  References to the “Company,” “we,” “us,” and “our” refer collectively to Select Medical Holdings Corporation and Select Medical Corporation.

TABLE OF CONTENTS

PART I	FINANCIAL INFORMATION
ITEM 1.	CONSOLIDATED FINANCIAL STATEMENTS
	Consolidated balance sheets	3
	Consolidated statements of operations	4
	Consolidated statements of changes in stockholders’ equity and income	6
	Consolidated statements of cash flows	7
	Notes to consolidated financial statements	8
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	27
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	52
ITEM 4.	CONTROLS AND PROCEDURES	52
PART II	OTHER INFORMATION	52
ITEM 1.	LEGAL PROCEEDINGS	52
ITEM 1A.	RISK FACTORS	54
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	54
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	54
ITEM 4.	MINE SAFETY DISCLOSURES	54
ITEM 5.	OTHER INFORMATION	54
ITEM 6.	EXHIBITS	55
SIGNATURES

2

Consolidated Balance Sheets

(unaudited)

(in thousands, except share and per share amounts)

	Select Medical Holdings Corporation				Select Medical Corporation
	December 31,		June 30,		December 31,		June 30,
	2011		2012		2011		2012
ASSETS
Current Assets:
Cash and cash equivalents	$	12,043	$	21,520	$	12,043	$	21,520
Accounts receivable, net of allowance for doubtful accounts of $47,469 and $44,783 in 2011 and 2012, respectively	413,743		423,859		413,743		423,859
Current deferred tax asset	18,305		15,533		18,305		15,533
Prepaid income taxes	9,497		4,061		9,497		4,061
Other current assets	29,822		31,383		29,822		31,383
Total Current Assets	483,410		496,356		483,410		496,356
Property and equipment, net	510,028		492,781		510,028		492,781
Goodwill	1,631,716		1,631,461		1,631,716		1,631,461
Other identifiable intangibles	72,123		71,783		72,123		71,783
Assets held for sale	2,742		2,742		2,742		2,742
Other assets	72,128		84,514		70,719		83,291
Total Assets	$	2,772,147	$	2,779,637	$	2,770,738	$	2,778,414
LIABILITIES AND EQUITY
Current Liabilities:
Bank overdrafts	$	16,609	$	20,348	$	16,609	$	20,348
Current portion of long-term debt and notes payable	10,848		11,785		10,848		11,785
Accounts payable	95,618		90,132		95,618		90,132
Accrued payroll	82,888		73,712		82,888		73,712
Accrued vacation	51,250		56,208		51,250		56,208
Accrued interest	15,096		26,945		11,980		23,746
Accrued restructuring	5,027		3,038		5,027		3,038
Accrued other	101,076		99,583		106,316		104,823
Due to third party payors	5,526		7,264		5,526		7,264
Total Current Liabilities	383,938		389,015		386,062		391,056
Long-term debt, net of current portion	1,385,950		1,342,134		1,218,650		1,174,834
Non-current deferred tax liability	82,028		82,911		82,028		82,911
Other non-current liabilities	64,905		68,649		64,905		68,649
Total Liabilities	1,916,821		1,882,709		1,751,645		1,717,450
Stockholders’ Equity:
Common stock of Holdings, $0.001 par value, 700,000,000 shares authorized, 145,268,190 shares and 139,863,119 shares issued and outstanding in 2011 and 2012, respectively	145		140		—		—
Common stock of Select, $0.01 par value, 100 shares issued and outstanding	—		—		0		0
Capital in excess of par	493,828		469,410		848,844		853,506
Retained earnings	328,882		393,961		137,778		174,041
Total Select Medical Holdings Corporation and Select Medical Corporation Stockholders’ Equity	822,855		863,511		986,622		1,027,547
Non-controlling interest	32,471		33,417		32,471		33,417
Total Equity	855,326		896,928		1,019,093		1,060,964
Total Liabilities and Equity	$	2,772,147	$	2,779,637	$	2,770,738	$	2,778,414

The accompanying notes are an integral part of these consolidated financial statements.

3

Consolidated Statements of Operations

(unaudited)

(in thousands, except per share amounts)

	Select Medical Holdings Corporation						Select Medical Corporation
	For the Three Months Ended June 30,						For the Three Months Ended June 30,
	2011			2012			2011			2012
Net operating revenues	$	698,749		$	750,193		$	698,749		$	750,193
Costs and expenses:
Cost of services	569,666			612,669			569,666			612,669
General and administrative	16,115			18,554			16,115			18,554
Bad debt expense	13,943			10,029			13,943			10,029
Depreciation and amortization	17,999			15,428			17,999			15,428
Total costs and expenses	617,723			656,680			617,723			656,680
Income from operations	81,026			93,513			81,026			93,513
Other income and expense:
Loss on early retirement of debt	(31,018		)	—			(20,385		)	—
Equity in earnings (losses) of unconsolidated subsidiaries	(251		)	2,752			(251		)	2,752
Interest income	111			—			111			—
Interest expense	(25,296		)	(23,798		)	(19,694		)	(20,957		)
Income before income taxes	24,572			72,467			40,807			75,308
Income tax expense	10,915			27,651			16,597			28,646
Net income	13,657			44,816			24,210			46,662
Less: Net income attributable to non-controlling interests	1,938			1,644			1,938			1,644
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	$	11,719		$	43,172		$	22,272		$	45,018
Income per common share:
Basic	$	0.08		$	0.31
Diluted	$	0.08		$	0.31

The accompanying notes are an integral part of these consolidated financial statements.

4

Consolidated Statements of Operations

(unaudited)

(in thousands, except per share amounts)

	Select Medical Holdings Corporation						Select Medical Corporation
	For the Six Months Ended June 30,						For the Six Months Ended June 30,
	2011			2012			2011			2012
Net operating revenues	$	1,391,935		$	1,494,214		$	1,391,935		$	1,494,214
Costs and expenses:
Cost of services	1,127,082			1,224,288			1,127,082			1,224,288
General and administrative	32,681			32,778			32,681			32,778
Bad debt expense	28,293			20,404			28,293			20,404
Depreciation and amortization	35,221			31,627			35,221			31,627
Total costs and expenses	1,223,277			1,309,097			1,223,277			1,309,097
Income from operations	168,658			185,117			168,658			185,117
Other income and expense:
Loss on early retirement of debt	(31,018		)	—			(20,385		)	—
Equity in earnings (losses) of unconsolidated subsidiaries	(324		)	5,217			(324		)	5,217
Interest income	167			—			167			—
Interest expense	(50,960		)	(47,720		)	(38,356		)	(42,207		)
Income before income taxes	86,523			142,614			109,760			148,127
Income tax expense	37,479			55,226			45,611			57,156
Net income	49,044			87,388			64,149			90,971
Less: Net income attributable to non-controlling interests	3,653			2,674			3,653			2,674
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	$	45,391		$	84,714		$	60,496		$	88,297
Income per common share:
Basic	$	0.29		$	0.60
Diluted	$	0.29		$	0.59

The accompanying notes are an integral part of these consolidated financial statements.

5

Select Medical Holdings Corporation

Consolidated Statement of Changes in Equity and Income

(unaudited)

(in thousands)

				Select Medical Holdings Corporation Stockholders
	Total			Common Stock Issued		Common Stock Par Value			Capital in Excess of Par			Retained Earnings			Non-controlling Interests
Balance at December 31, 2011	$	855,326		145,268		$	145		$	493,828		$	328,882		$	32,471
Net income	87,388											84,714			2,674
Issuance and vesting of restricted stock	1,998			194		0			1,998
Exercise of stock options	547			127		0			547
Stock option expense	601								601
Repurchase of common shares	(46,790		)	(5,726	)	(5		)	(27,150		)	(19,635		)
Distributions to non-controlling interests	(1,681		)												(1,681		)
Other	(461		)						(414		)				(47		)
Balance at June 30, 2012	$	896,928		139,863		$	140		$	469,410		$	393,961		$	33,417

Select Medical Corporation

Consolidated Statement of Changes in Equity and Income

(unaudited)

(in thousands)

				Select Medical Corporation Stockholders
	Total			Common Stock Issued	Common Stock Par Value		Capital in Excess of Par			Retained Earnings			Non-controlling Interests
Balance at December 31, 2011	$	1,019,093		0	$	0	$	848,844		$	137,778		$	32,471
Net income	90,971									88,297			2,674
Federal tax benefit of losses contributed by Holdings	1,930						1,930
Additional investment by Holdings	547						547
Dividends declared and paid to Holdings	(52,034		)							(52,034		)
Distributions to non-controlling interests	(1,681		)										(1,681		)
Other	(461		)				(414		)				(47		)
Contribution related to restricted stock awards and stock option issuances by Holdings	2,599						2,599
Balance at June 30, 2012	$	1,060,964		0	$	0	$	853,506		$	174,041		$	33,417

The accompanying notes are an integral part of these consolidated financial statements.

6

Consolidated Statements of Cash Flows

(unaudited)

(in thousands)

	Select Medical Holdings Corporation						Select Medical Corporation
	For the Six Months Ended June 30,						For the Six Months Ended June 30,
	2011			2012			2011			2012
Operating activities
Net income	$	49,044		$	87,388		$	64,149		$	90,971
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	35,221			31,627			35,221			31,627
Provision for bad debts	28,293			20,404			28,293			20,404
Loss on early retirement of debt	31,018			—			20,385			—
Gain from disposal or sale of assets	(5,201		)	(3,604		)	(5,201		)	(3,604		)
Non-cash stock compensation expense	1,780			2,599			1,780			2,599
Amortization of debt discount	962			622			103			622
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Accounts receivable	(81,240		)	(30,520		)	(81,240		)	(30,520		)
Other current assets	(1,511		)	(1,612		)	(1,511		)	(1,612		)
Other assets	2,724			(653		)	2,469			(839		)
Accounts payable	8,107			(5,486		)	8,107			(5,486		)
Due to third-party payors	(464		)	1,738			(464		)	1,738
Accrued expenses	6,775			6,423			13,008			6,340
Income and deferred taxes	8,019			9,879			16,151			11,809
Net cash provided by operating activities	83,527			118,805			101,250			124,049
Investing activities
Purchases of property and equipment	(23,696		)	(27,934		)	(23,696		)	(27,934		)
Proceeds from sale of assets	7,879			16,511			7,879			16,511
Investment in business	(13,514		)	(10,014		)	(13,514		)	(10,014		)
Acquisition of businesses, net of cash acquired	1,921			(206		)	1,921			(206		)
Net cash used in investing activities	(27,410		)	(21,643		)	(27,410		)	(21,643		)
Financing activities
Borrowings on revolving credit facilities	435,000			340,000			435,000			340,000
Payments on revolving credit facilities	(395,000		)	(380,000		)	(395,000		)	(380,000		)
Borrowings on 2011 credit facility term loan, net of discount	841,500			—			841,500			—
Payments on 2011 credit facility term loan	—			(4,250		)	—			(4,250		)
Payments on 2005 credit facility term loans, net of call premium	(484,633		)	—			(484,633		)	—
Repurchase of 10% senior subordinated notes	(150,000		)	—			—			—
Repurchase of 7 5/8% senior subordinated notes, net of tender premium	(273,941		)	—			(273,941		)	—
Borrowings of other debt	5,496			5,835			5,496			5,835
Principal payments on other debt	(3,480		)	(5,085		)	(3,480		)	(5,085		)
Debt issuance costs	(18,556		)	—			(18,556		)	—
Dividends paid to Holdings	—			—			(171,008		)	(52,034		)
Repurchase of common stock	(3,285		)	(46,790		)	—			—
Proceeds from issuance of common stock	169			547			—			—
Equity investment by Holdings	—			—			169			547
Proceeds from bank overdrafts	2,102			3,739			2,102			3,739
Distributions to non-controlling interests	(2,270		)	(1,681		)	(2,270		)	(1,681		)
Net cash used in financing activities	(46,898		)	(87,685		)	(64,621		)	(92,929		)
Net increase in cash and cash equivalents	9,219			9,477			9,219			9,477
Cash and cash equivalents at beginning of period	4,365			12,043			4,365			12,043
Cash and cash equivalents at end of period	$	13,584		$	21,520		$	13,584		$	21,520
Supplemental Cash Flow Information
Cash paid for interest	$	59,289		$	32,378		$	41,572		$	27,136
Cash paid for taxes	$	29,435		$	45,344		$	29,435		$	45,344

The accompanying notes are an integral part of these consolidated financial statements.

7

SELECT MEDICAL HOLDINGS CORPORATION AND SELECT MEDICAL CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1.Basis of Presentation

Select Medical Corporation (“Select”) was formed in December 1996 and commenced operations during February 1997 upon the completion of its first acquisition. Select Medical Holdings Corporation (“Holdings”) was formed in October 2004 for the purpose of affecting a leveraged buyout of Select, which was a publicly traded entity.  On February 24, 2005, Select merged with a subsidiary of Holdings, which resulted in Select becoming a wholly-owned subsidiary of Holdings (the “Merger”). On September 30, 2009 Holdings completed its initial public offering of common stock.  Generally accepted accounting principles (“GAAP”) require that any amounts recorded or incurred (such as goodwill and compensation expense) by the parent as a result of the Merger or for the benefit of the subsidiary be “pushed down” and recorded in Select’s consolidated financial statements. Holdings and Select and their subsidiaries are collectively referred to as the “Company.” The consolidated financial statements of Holdings include the accounts of its wholly-owned subsidiary Select. Holdings conducts substantially all of its business through Select and its subsidiaries.

The unaudited condensed consolidated financial statements of the Company as of June 30, 2012 and for the three and six month periods ended June 30, 2011 and 2012 have been prepared in accordance with GAAP.  In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods.  All significant intercompany transactions and balances have been eliminated.  The results of operations for the three and six months ended June 30, 2012 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2012.

Certain information and disclosures normally included in the notes to consolidated financial statements have been condensed or omitted consistent with the rules and regulations of the Securities and Exchange Commission (the “SEC”), although the Company believes the disclosure is adequate to make the information presented not misleading.  The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2011 contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 2, 2012.

2.Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

8

Recent Accounting Pronouncements

In June 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2011-05, “Comprehensive Income (Topic 220) — Presentation of Comprehensive Income” (“Update 2011-05”) that improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income by eliminating the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. Update 2011-05 requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under either method, adjustments must be displayed for items that are reclassified from other comprehensive income (“OCI”) to net income, in both net income and OCI. Update 2011-05 does not change the current option for presenting components of OCI gross or net of the effect of income taxes, provided that such tax effects are presented in the statement in which OCI is presented or disclosed in the notes to the financial statements. Additionally, Update 2011-05 does not affect the calculation or reporting of earnings per share. Update 2011-05 was effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and is to be applied retrospectively. The Company adopted Update 2011-05 on January 1, 2012.  Update 2011-05 had no effect on the Company’s presentation of other comprehensive income for the three and six months ended June 30, 2011 and 2012 because the Company did not have any items of other comprehensive income during these periods.

3.  Intangible Assets

The Company’s intangible assets consist of the following:

	As of June 30, 2012
	Gross Carrying Amount		Accumulated Amortization
	(in thousands)
Amortized intangible assets:
Non-compete agreements	$	25,909	$	(25,909	)
Indefinite-lived intangible assets:
Goodwill	$	1,631,461
Trademarks	57,709
Certificates of need	11,914
Accreditations	2,160
Total	$	1,703,244

The Company’s accreditations and trademarks have renewal terms. The costs to renew these intangibles are expensed as incurred. At June 30, 2012, the accreditations and trademarks have a weighted average time until next renewal of approximately 1.5 years and 8.0 years, respectively.

9

Amortization expense for the Company’s intangible assets with finite lives follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2012		2011		2012
	(in thousands)				(in thousands)
Amortization expense	$	327	$	85	$	653	$	340

Amortization expense for the Company’s intangible assets primarily relates to the amortization of the value associated with the non-compete agreement entered into in connection with the acquisition of the outpatient rehabilitation division of HealthSouth Corporation. The useful life of the outpatient rehabilitation division of HealthSouth Corporation’s non-compete was five years.

The changes in the carrying amount of goodwill for the Company’s reportable segments for the six months ended June 30, 2012 are as follows:

	Specialty Hospitals			Outpatient Rehabilitation		Total
	(in thousands)
Balance as of December 31, 2011	$	1,333,553		$	298,163	$	1,631,716
Other	(333		)	—		(333		)
Goodwill acquired during the period	—			78		78
Balance as of June 30, 2012	$	1,333,220		$	298,241	$	1,631,461

4.  Restructuring Reserves

In connection with the acquisition of substantially all of the outpatient rehabilitation division of HealthSouth Corporation, the Company recorded an estimated liability of $18.7 million in 2007 for business restructuring which was accounted for as additional purchase price. This reserve primarily included costs associated with workforce reductions and lease termination costs in accordance with the Company’s restructuring plan.

In connection with the acquisition of all the issued and outstanding equity securities of Regency Hospital Company, L.L.C. (“Regency”), an operator of long term acute care hospitals, the Company recorded an estimated liability of $4.3 million in 2010 for business restructuring related to lease termination costs.

The following summarizes the Company’s restructuring activity:

	Lease Termination Costs
	(in thousands)
Balance as of December 31, 2011	$	5,027
Amounts paid in 2012	(845		)
Accretion expense	157
Revision of estimate	(1,301		)
Balance as of June 30, 2012	$	3,038

10

The Company expects to pay out the remaining lease termination costs through 2014 for the acquisition of the outpatient rehabilitation division of HealthSouth Corporation and through 2015 for the Regency acquisition.

5.  Fair Value

Financial instruments include cash and cash equivalents, notes payable and long-term debt.  The carrying amount of cash and cash equivalents approximates fair value because of the short-term maturity of these instruments.

The carrying value of Select’s senior secured credit facility was $878.0 million and $834.3 million at December 31, 2011 and June 30, 2012, respectively.  The fair value of Select’s senior secured credit facility was $823.3 million and $815.6 million at December 31, 2011 and June 30, 2012, respectively.  The fair value of Select’s senior secured credit facility was based on quoted market prices for this debt in the syndicated loan market.

The carrying value of Select’s 7 5/8% senior subordinated notes was $345.0 million at both December 31, 2011 and June 30, 2012.  The fair value of Select’s 7 5/8% senior subordinated notes was $326.4 million and $346.3 million at December 31, 2011 and June 30, 2012, respectively.  The fair value of this registered debt was based on quoted market prices.

The carrying value of Holdings’ senior floating rate notes was $167.3 million at both December 31, 2011 and June 30, 2012.  The fair value of Holdings’ senior floating rate notes was $143.9 million and $160.6 million at December 31, 2011 and June 30, 2012, respectively.  The fair value of this registered debt was based on quoted market prices.

The Company considers the inputs in the valuation process of its debt instruments to be Level 2 in the fair value hierarchy.  Level 2 in the fair value hierarchy is defined as inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly.  These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

11

6.  Segment Information

The Company’s reportable segments consist of (i) specialty hospitals and (ii) outpatient rehabilitation. All other represents amounts associated with corporate activities and non-healthcare related services. The outpatient rehabilitation reportable segment has two operating segments: outpatient rehabilitation clinics and contract therapy. These operating segments are aggregated for reporting purposes as they have common economic characteristics and provide a similar service to a similar patient base. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. The Company evaluates performance of the segments based on Adjusted EBITDA. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, equity in earnings (losses) of unconsolidated subsidiaries and other income (expense).

The following tables summarize selected financial data for the Company’s reportable segments for the three and six months ended June 30, 2011 and 2012.  The segment results of Holdings are identical to those of Select with the exception of total assets:

	Three Months Ended June 30, 2011
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	520,261	$	178,473	$	15		$	698,749
Adjusted EBITDA	91,081		24,467		(15,623		)	99,925
Total assets:
Select Medical Corporation	2,202,994		471,175		112,264			2,786,433
Select Medical Holdings Corporation	2,202,994		471,175		113,853			2,788,022
Capital expenditures	6,130		2,801		1,845			10,776
	Three Months Ended June 30, 2012
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	557,130	$	193,050	$	13		$	750,193
Adjusted EBITDA	102,166		25,837		(17,724		)	110,279
Total assets:
Select Medical Corporation	2,184,743		437,591		156,080			2,778,414
Select Medical Holdings Corporation	2,184,743		437,591		157,303			2,779,637
Capital expenditures	12,631		2,922		630			16,183

12

	Six Months Ended June 30, 2011
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	1,040,185	$	351,664	$	86		$	1,391,935
Adjusted EBITDA	191,434		45,873		(31,648		)	205,659
Total assets:
Select Medical Corporation	2,202,994		471,175		112,264			2,786,433
Select Medical Holdings Corporation	2,202,994		471,175		113,853			2,788,022
Capital expenditures	16,617		4,982		2,097			23,696

	Six Months Ended June 30, 2012
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	1,110,168	$	383,949	$	97		$	1,494,214
Adjusted EBITDA	202,120		48,315		(31,092		)	219,343
Total assets:
Select Medical Corporation	2,184,743		437,591		156,080			2,778,414
Select Medical Holdings Corporation	2,184,743		437,591		157,303			2,779,637
Capital expenditures	19,682		6,713		1,539			27,934

A reconciliation of Adjusted EBITDA to income before income taxes is as follows:

	Three Months Ended June 30, 2011
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	91,081			$	24,467			$		(15,623	)
Depreciation and amortization	(13,047			)	(4,227			)	(725			)
Stock compensation expense	—				—				(900			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		78,034		$		20,240		$	(17,248		)	$	81,026		$	81,026
Loss on early retirement of debt													(31,018		)	(20,385		)
Equity in losses of unconsolidated subsidiaries													(251		)	(251		)
Interest expense, net													(25,185		)	(19,583		)
Income before income taxes													$	24,572		$	40,807

13

	Three Months Ended June 30, 2012
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	102,166			$	25,837			$		(17,724	)
Depreciation and amortization	(11,479			)	(3,232			)	(717			)
Stock compensation expense	—				—				(1,338			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		90,687		$		22,605		$	(19,779		)	$	93,513		$	93,513
Equity in earnings of unconsolidated subsidiaries													2,752			2,752
Interest expense, net													(23,798		)	(20,957		)
Income before income taxes													$	72,467		$	75,308

	Six Months Ended June 30, 2011
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	191,434			$	45,873			$		(31,648	)
Depreciation and amortization	(25,093			)	(8,686			)	(1,442			)
Stock compensation expense	—				—				(1,780			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		166,341		$		37,187		$	(34,870		)	$	168,658		$	168,658
Loss on early retirement of debt													(31,018		)	(20,385		)
Equity in losses of unconsolidated subsidiaries													(324		)	(324		)
Interest expense, net													(50,793		)	(38,189		)
Income before income taxes													$	86,523		$	109,760

14

	Six Months Ended June 30, 2012
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	202,120			$	48,315			$		(31,092	)
Depreciation and amortization	(23,322			)	(6,882			)	(1,423			)
Stock compensation expense	—				—				(2,599			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		178,798		$		41,433		$	(35,114		)	$	185,117		$	185,117
Equity in earnings of unconsolidated subsidiaries													5,217			5,217
Interest expense, net													(47,720		)	(42,207		)
Income before income taxes													$	142,614		$	148,127

7.  Income per Common Share

The Company applies the two-class method for calculating and presenting income per common share. The two-class method is an earnings allocation formula that determines earnings per share for each class of stock participation rights in undistributed earnings. Effective January 1, 2009 the Financial Accounting Standards Board (“FASB”) clarified that share based payment awards that have not yet vested meet the definition of a participating security provided the right to receive the dividend is non-forfeitable and non-contingent. Participating securities are defined as securities that participate in dividends with common stock according to a predetermined formula. These participating securities should be included in the computation of basic earnings per share under the two class method. Based upon the clarification made by FASB, the Company concluded that its non-vested restricted stock awards meet the definition of a participating security and should be included in the Company’s computation of basic earnings per share.

15

The following table sets forth for the periods indicated the calculation of net income per share in the Company’s consolidated statement of operations and the differences between basic weighted average shares outstanding and diluted weighted average shares outstanding used to compute basic and diluted earnings per share, respectively:

	For the Three Months				For the Six Months
	Ended June 30,				Ended June, 30
	2011		2012		2011		2012
	(in thousands, except per share data)
Numerator:
Net income attributable to Select Medical Holdings Corporation	$	11,719	$	43,172	$	45,391	$	84,714
Less: Earnings allocated to unvested restricted stockholders	125		707		486		1,338
Net income available to common stockholders	$	11,594	$	42,465	$	44,905	$	83,376
Denominator:
Weighted average shares – basic	152,603		138,456		152,720		139,941
Effect of dilutive securities:
Stock options	278		229		231		221
Weighted average shares – diluted	152,881		138,685		152,951		140,162
Basic income per common share	$	0.08	$	0.31	$	0.29	$	0.60
Diluted income per common share	$	0.08	$	0.31	$	0.29	$	0.59

The following share amounts are shown here for informational and comparative purposes only since their inclusion would be anti-dilutive:

	For the Three Months Ended June 30,		For the Six Months Ended June 30,
	2011	2012	2011	2012
	(in thousands)
Stock options	1,691	1,684	2,400	1,699

8. Commitments and Contingencies

Litigation

The Company is a party to various legal actions, proceedings and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of its business. The Company cannot predict the ultimate outcome of pending litigation, proceedings and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines and other penalties. The Department of Justice, Centers for Medicare & Medicaid Services (“CMS”) or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company’s businesses in the future that may, either individually or in the

16

aggregate, have a material adverse effect on the Company’s business, financial position, results of operations and liquidity.

To address claims arising out of the operations of the Company’s specialty hospitals and outpatient rehabilitation facilities, the Company maintains professional malpractice liability insurance and general liability insurance, subject to self-insured retention of $2.0 million per medical incident for professional liability claims and $2.0 million per occurrence for general liability claims. The Company also maintains umbrella liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the Company’s other insurance policies. These insurance policies also do not generally cover punitive damages and are subject to various deductibles and policy limits. Significant legal actions, as well as the cost and possible lack of available insurance, could subject the Company to substantial uninsured liabilities. In the Company’s opinion, the outcome of these actions, individually or in the aggregate, will not have a material adverse effect on its financial position, results of operations, or cash flows.

Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act. Qui tam lawsuits typically remain under seal (hence, usually unknown to the defendant) for some time while the government decides whether or not to intervene on behalf of a private qui tam plaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the suits. The Company has been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.

During April 2012, the Company’s long term acute care hospital in Evansville, Indiana (“SSH - Evansville”) received two subpoenas from the Office of Attorney General for the State of Indiana. One subpoena demanded certain patient medical records of SSH - Evansville. The second subpoena demanded reports and documents related to SSH - Evansville for various periods beginning in 2006, including certain financial, statistical, billing and quality reports; certain policies and procedures, joint venture board meeting minutes, and documents related to certain complaints and internal investigations. SSH — Evansville subsequently received a Request for Information or Assistance from the Office of Inspector General of the U.S. Department of Health and Human Services (Indianapolis, Indiana Field Office) covering the period beginning in 2007 seeking substantially the same records demanded by the Indiana Attorney General’s Office, additional patient medical records of SSH - Evansville and additional documents and information of SSH - Evansville, including documents concerning SSH - Evansville’s relationships with its joint venture partner and seven other identified persons and entities. During May 2012, the Evansville (Indiana) Police Department executed a search warrant at SSH - Evansville purporting to seek evidence pertaining to the crime of theft. At the Company’s request, the Vanderburgh (Indiana) Superior Court ordered the release of the probable cause affidavit supporting that search warrant. According to the affidavit, confidential informants, some of whom are purportedly current or former employees of SSH-Evansville, alleged, among other things, that a physician on the medical staff at SSH-Evansville improperly manipulated patient diagnoses to raise the diagnosis related group (DRG) and lengths-of-stay to enhance reimbursement and, on one occasion, discontinued treatments to a patient based on financial motivation and without regard to the patient’s end of life instructions resulting in the patient’s death, and that a second physician on the medical staff at SSH-Evansville performed bronchoscopes that were medically unnecessary and resulted in at least two patient deaths. The affidavit also makes allegations that imply that the Company may not have provided complete or accurate documents called for in the Indiana Attorney General’s Office subpoenas which were received during April 2012. In August 2012, the Company received a subpoena from the Office of Inspector General of the U.S. Department of Health and Human Services (Chicago Regional Office) demanding additional documents covering the period beginning in March 2007 relating to the Company and SSH - Evansville, including contracts with SSH - Evansville’s joint venture partner, contracts and other documents relating to financial relationships with physicians practicing at SSH - Evansville, records of payments to and hours worked by physicians practicing at SSH - Evansville, documents relating to actual or expected physician referrals and admissions to SSH - Evansville, documents relating to billing for services furnished by the Company’s long term acute care hospitals (“LTCHs”), such as government program guidance and staff training materials, information relating to case manager duties and responsibilities at the Company’s LTCHs, reports on patient admissions, discharges, DRG, length-of-stay and transfers at SSH - Evansville, and documents relating to criteria used by the Company or SSH - Evansville for patient admissions, discharges and eligibility for service.  The Company has produced and will continue to produce documents in response to, and intends to fully cooperate with, these governmental investigations. At this time, the Company is unable to predict the timing and outcome of this matter.

17

Construction Commitments

At June 30, 2012, the Company had outstanding commitments under construction contracts related to new construction, improvements and renovations at the Company’s long term acute care properties and inpatient rehabilitation facilities totaling approximately $9.3 million.

9.Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select’s 7 5/8% Senior Subordinated Notes

Select’s 7 5/8% senior subordinated notes are fully and unconditionally guaranteed, except for customary limitations, on a senior subordinated basis by all of Select’s wholly-owned subsidiaries (the “Subsidiary Guarantors”). Certain of Select’s subsidiaries did not guarantee the 7 5/8% senior subordinated notes (the “Non-Guarantor Subsidiaries”).

Select conducts a significant portion of its business through its subsidiaries. Presented below is condensed consolidating financial information for Select, the Subsidiary Guarantors and the Non-Guarantor Subsidiaries at December 31, 2011 and June 30, 2012 and for the three and six months ended June 30, 2011 and 2012.

The equity method has been used by Select with respect to investments in subsidiaries. The equity method has been used by Subsidiary Guarantors with respect to investments in Non-Guarantor Subsidiaries. Separate financial statements for Subsidiary Guarantors are not presented.

18

	Select Medical Corporation
	Condensed Consolidating Balance Sheet
	June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Assets
Current Assets:
Cash and cash equivalents	$	18,100		$	2,798		$	622		$	—		$	21,520
Accounts receivable, net	—			367,585			56,274			—			423,859
Current deferred tax asset	8,774			3,262			3,497			—			15,533
Prepaid income taxes	4,061			—			—			—			4,061
Other current assets	7,654			20,339			3,390			—			31,383
Total Current Assets	38,589			393,984			63,783			—			496,356
Property and equipment, net	14,754			422,031			55,996			—			492,781
Investment in affiliates	2,861,419			78,736			—			(2,940,155		)(a)(b)	—
Goodwill	—			1,631,461			—			—			1,631,461
Other identifiable intangibles	—			71,783			—			—			71,783
Assets held for sale	2,742			—			—			—			2,742
Other assets	24,335			58,224			732			—			83,291
Total Assets	$	2,941,839		$	2,656,219		$	120,511		$	(2,940,155	)	$	2,778,414
Liabilities and Equity
Current Liabilities:
Bank overdrafts	$	20,348		$	—		$	—		$	—		$	20,348
Current portion of long-term debt and notes payable	10,236			370			1,179			—			11,785
Accounts payable	6,679			72,709			10,744			—			90,132
Intercompany accounts	1,036,057			(944,178		)	(91,879		)	—			—
Accrued payroll	13			73,528			171			—			73,712
Accrued vacation	4,319			44,964			6,925			—			56,208
Accrued interest	22,920			826			—			—			23,746
Accrued restructuring	—			3,038			—			—			3,038
Accrued other	45,069			52,856			6,898			—			104,823
Due to third party payors	—			4,106			3,158			—			7,264
Total Current Liabilities	1,145,641			(691,781		)	(62,804		)	—			391,056
Long-term debt, net of current portion	723,251			392,423			59,160			—			1,174,834
Non-current deferred tax liability	(3,960		)	78,164			8,707			—			82,911
Other non-current liabilities	49,360			18,909			380			—			68,649
Total Liabilities	1,914,292			(202,285		)	5,443			—			1,717,450
Stockholder’s Equity:
Common stock	0			—			—			—			0
Capital in excess of par	853,506			—			—			—			853,506
Retained earnings	174,041			724,340			22,366			(746,706		)(b)	174,041
Subsidiary investment	—			2,134,164			59,285			(2,193,449		)(a)	—
Total Select Medical Corporation Stockholder’s Equity	1,027,547			2,858,504			81,651			(2,940,155		)	1,027,547
Non-controlling interest	—			—			33,417			—			33,417
Total Equity	1,027,547			2,858,504			115,068			(2,940,155		)	1,060,964
Total Liabilities and Equity	$	2,941,839		$	2,656,219		$	120,511		$	(2,940,155	)	$	2,778,414

(a)  Elimination of investments in consolidated subsidiaries.

(b)  Elimination of investments in consolidated subsidiaries’ earnings.

19

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Three Months Ended June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	13		$	649,628		$	100,552		$	—		$	750,193
Costs and expenses:
Cost of services	521			527,479			84,669			—			612,669
General and administrative	19,345			(791		)	—			—			18,554
Bad debt expense	—			8,832			1,197			—			10,029
Depreciation and amortization	718			12,410			2,300			—			15,428
Total costs and expenses	20,584			547,930			88,166			—			656,680
Income (loss) from operations	(20,571		)	101,698			12,386			—			93,513
Other income and expense:
Intercompany interest and royalty fees	(763		)	754			9			—			—
Intercompany management fees	27,755			(23,159		)	(4,596		)	—			—
Equity in earnings of unconsolidated subsidiaries	—			2,739			13			—			2,752
Interest expense	(13,173		)	(6,712		)	(1,072		)	—			(20,957		)
Income (loss) from operations before income taxes	(6,752		)	75,320			6,740			—			75,308
Income tax expense	2,211			26,377			58			—			28,646
Equity in earnings of subsidiaries	53,981			5,612			—			(59,593		)(a)	—
Net income	45,018			54,555			6,682			(59,593		)	46,662
Less: Net income attributable to non-controlling interests	—			—			1,644			—			1,644
Net income attributable to Select Medical Corporation	$	45,018		$	54,555		$	5,038		$	(59,593	)	$	45,018

(a) Elimination of equity in earnings of subsidiaries.

20

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Six Months Ended June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	97		$	1,293,953		$	200,164		$	—		$	1,494,214
Costs and expenses:
Cost of services	1,010			1,052,944			170,334			—			1,224,288
General and administrative	33,455			(677		)	—			—			32,778
Bad debt expense	—			17,674			2,730			—			20,404
Depreciation and amortization	1,423			25,580			4,624			—			31,627
Total costs and expenses	35,888			1,095,521			177,688			—			1,309,097
Income (loss) from operations	(35,791		)	198,432			22,476			—			185,117
Other income and expense:
Intercompany interest and royalty fees	(1,556		)	1,539			17			—			—
Intercompany management fees	57,129			(48,242		)	(8,887		)	—			—
Equity in earnings of unconsolidated subsidiaries	—			5,194			23			—			5,217
Interest expense	(26,147		)	(13,910		)	(2,150		)	—			(42,207		)
Income (loss) from operations before income taxes	(6,365		)	143,013			11,479			—			148,127
Income tax expense	1,976			54,904			276			—			57,156
Equity in earnings of subsidiaries	96,638			9,111			—			(105,749		)(a)	—
Net income	88,297			97,220			11,203			(105,749		)	90,971
Less: Net income attributable to non-controlling interests	—			—			2,674			—			2,674
Net income attributable to Select Medical Corporation	$	88,297		$	97,220		$	8,529		$	(105,749	)	$	88,297

(a) Elimination of equity in earnings of subsidiaries.

21

	Select Medical Corporation
	Condensed Consolidating Statement of Cash Flows
	For the Six Months Ended June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Operating activities
Net income	$	88,297		$	97,220		$	11,203		$	(105,749	)(a)	$	90,971
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,423			25,580			4,624			—			31,627
Provision for bad debts	—			17,674			2,730			—			20,404
Loss (gain) from disposal of assets	—			(3,606		)	2			—			(3,604		)
Non-cash stock compensation expense	2,599			—			—			—			2,599
Amortization of debt discount	622			—			—			—			622
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries	(96,638		)	(9,111		)	—			105,749		(a)	—
Intercompany	46,380			(40,086		)	(6,294		)	—			—
Accounts receivable	—			(15,938		)	(14,582		)	—			(30,520		)
Other current assets	(1,314		)	(983		)	685			—			(1,612		)
Other assets	4,051			(5,011		)	121			—			(839		)
Accounts payable	(674		)	(3,498		)	(1,314		)	—			(5,486		)
Due to third-party payors	—			(9,527		)	11,265			—			1,738
Accrued expenses	8,717			(2,587		)	210			—			6,340
Income and deferred taxes	11,809			—			—			—			11,809
Net cash provided by operating activities	65,272			50,127			8,650			—			124,049
Investing activities
Purchases of property and equipment	(1,536		)	(20,684		)	(5,714		)	—			(27,934		)
Proceeds from sale of assets	—			16,511			—			—			16,511
Investment in businesses	—			(10,014		)	—			—			(10,014		)
Acquisition of businesses, net of cash acquired	—			(206		)	—			—			(206		)
Net cash used in investing activities	(1,536		)	(14,393		)	(5,714		)	—			(21,643		)
Financing activities
Borrowings on revolving credit facility	340,000			—			—			—			340,000
Payments on revolving credit facility	(380,000		)	—			—			—			(380,000		)
Payments on 2011 credit facility term loan	(4,250		)	—			—			—			(4,250		)
Borrowings of other debt	5,557			—			278			—			5,835
Principal payments on other debt	(4,179		)	(220		)	(686		)	—			(5,085		)
Dividends paid to Holdings	(52,034		)	—			—			—			(52,034		)
Equity investment by Holdings	547			—			—			—			547
Proceeds from bank overdrafts	3,739			—			—			—			3,739
Intercompany debt reallocation	33,557			(32,716		)	(841		)	—			—
Distributions to non-controlling interests	—			—			(1,681		)	—			(1,681		)
Net cash used in financing activities	(57,063		)	(32,936		)	(2,930		)	—			(92,929		)
Net increase in cash and cash equivalents	6,673			2,798			6			—			9,477
Cash and cash equivalents at beginning of period	11,427			—			616			—			12,043
Cash and cash equivalents at end of period	$	18,100		$	2,798		$	622		$	—		$	21,520

(a)  Elimination of equity in earnings of consolidated subsidiaries.

22

	Select Medical Corporation
	Condensed Consolidating Balance Sheet
	December 31, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Assets
Current Assets:
Cash and cash equivalents	$	11,427		$	—		$	616		$	—		$	12,043
Accounts receivable, net	—			369,321			44,422			—			413,743
Current deferred tax asset	11,415			3,221			3,669			—			18,305
Prepaid income taxes	9,497			—			—			—			9,497
Other current assets	6,340			19,407			4,075			—			29,822
Total Current Assets	38,679			391,949			52,782			—			483,410
Property and equipment, net	14,641			440,736			54,651			—			510,028
Investment in affiliates	2,751,776			83,772			—			(2,835,548		)(a)(b)	—
Goodwill	—			1,631,716			—			—			1,631,716
Other identifiable intangibles	—			72,123			—			—			72,123
Assets held for sale	2,742			—			—			—			2,742
Other assets	28,386			41,480			853			—			70,719
Total Assets	$	2,836,224		$	2,661,776		$	108,286		$	(2,835,548	)	$	2,770,738
Liabilities and Equity
Current Liabilities:
Bank overdrafts	$	16,609		$	—		$	—		$	—		$	16,609
Current portion of long-term debt and notes payable	8,853			390			1,605			—			10,848
Accounts payable	7,353			76,207			12,058			—			95,618
Intercompany accounts	975,809			(880,537		)	(95,272		)	—			—
Accrued payroll	229			82,518			141			—			82,888
Accrued vacation	3,703			41,305			6,242			—			51,250
Accrued interest	11,843			137			—			—			11,980
Accrued restructuring	—			5,027			—			—			5,027
Accrued other	47,829			51,086			7,401			—			106,316
Due to third party payors	—			13,633			(8,107		)	—			5,526
Total Current Liabilities	1,072,228			(610,234		)	(75,932		)	—			386,062
Long-term debt, net of current portion	733,328			425,315			60,007			—			1,218,650
Non-current deferred tax liability	(2,509		)	75,750			8,787			—			82,028
Other non-current liabilities	46,555			17,970			380			—			64,905
Total Liabilities	1,849,602			(91,199		)	(6,758		)	—			1,751,645
Stockholder’s Equity:
Common stock	0			—			—			—			0
Capital in excess of par	848,844			—			—			—			848,844
Retained earnings	137,778			627,120			23,154			(650,274		)(b)	137,778
Subsidiary investment	—			2,125,855			59,419			(2,185,274		)(a)	—
Total Select Medical Corporation Stockholder’s Equity	986,622			2,752,975			82,573			(2,835,548		)	986,622
Non-controlling interest	—			—			32,471			—			32,471
Total Equity	986,622			2,752,975			115,044			(2,835,548		)	1,019,093
Total Liabilities and Equity	$	2,836,224		$	2,661,776		$	108,286		$	(2,835,548	)	$	2,770,738

(a)  Elimination of investments in consolidated subsidiaries.

(b)  Elimination of investments in consolidated subsidiaries’ earnings.

23

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Three Months Ended June 30, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	15		$	605,562		$	93,172		$	—		$	698,749
Costs and expenses:
Cost of services	194			493,059			76,413			—			569,666
General and administrative	16,039			76			—			—			16,115
Bad debt expense	—			11,908			2,035			—			13,943
Depreciation and amortization	654			15,099			2,246			—			17,999
Total costs and expenses	16,887			520,142			80,694			—			617,723
Income (loss) from operations	(16,872		)	85,420			12,478			—			81,026
Other income and expense:
Intercompany interest and royalty fees	(1,000		)	994			6			—			—
Intercompany management fees	44,391			(39,901		)	(4,490		)	—			—
Loss on early retirement of debt	(20,385		)	—			—			—			(20,385		)
Equity in earnings (losses) of unconsolidated subsidiaries	—			(260		)	9			—			(251		)
Interest income	34			77			—			—			111
Interest expense	(9,011		)	(9,370		)	(1,313		)	—			(19,694		)
Income (loss) from operations before income taxes	(2,843		)	36,960			6,690			—			40,807
Income tax expense	362			16,224			11			—			16,597
Equity in earnings of subsidiaries	25,477			4,784			—			(30,261		)(a)	—
Net income	22,272			25,520			6,679			(30,261		)	24,210
Less: Net income attributable to non-controlling interests	—			—			1,938			—			1,938
Net income attributable to Select Medical Corporation	$	22,272		$	25,520		$	4,741		$	(30,261	)	$	22,272

(a) Elimination of equity in earnings of subsidiaries.

24

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Six Months Ended June 30, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	86		$	1,205,815		$	186,034		$	—		$	1,391,935
Costs and expenses:
Cost of services	832			974,281			151,969			—			1,127,082
General and administrative	32,494			187			—			—			32,681
Bad debt expense	—			24,909			3,384			—			28,293
Depreciation and amortization	1,300			29,455			4,466			—			35,221
Total costs and expenses	34,626			1,028,832			159,819			—			1,223,277
Income (loss) from operations	(34,540		)	176,983			26,215			—			168,658
Other income and expense:
Intercompany interest and royalty fees	(1,995		)	1,980			15			—			—
Intercompany management fees	67,863			(59,131		)	(8,732		)	—			—
Loss on early retirement of debt	(20,385		)	—			—			—			(20,385		)
Equity in earnings (losses) of unconsolidated subsidiaries	—			(348		)	24			—			(324		)
Interest income	65			101			1			—			167
Interest expense	(16,376		)	(19,319		)	(2,661		)	—			(38,356		)
Income (loss) from operations before income taxes	(5,368		)	100,266			14,862			—			109,760
Income tax expense	1,288			44,044			279			—			45,611
Equity in earnings of subsidiaries	67,152			10,581			—			(77,733		)(a)	—
Net income	60,496			66,803			14,583			(77,733		)	64,149
Less: Net income attributable to non-controlling interests	—			—			3,653			—			3,653
Net income attributable to Select Medical Corporation	$	60,496		$	66,803		$	10,930		$	(77,733	)	$	60,496

(a) Elimination of equity in earnings of subsidiaries.

25

	Select Medical Corporation
	Condensed Consolidating Statement of Cash Flows
	For the Six Months Ended June 30, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Operating activities
Net income	$	60,496		$	66,803		$	14,583		$	(77,733	)(a)	$	64,149
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,300			29,455			4,466			—			35,221
Provision for bad debts	—			24,909			3,384			—			28,293
Loss on early retirement of debt	20,385			—			—			—			20,385
Loss (gain) from disposal of assets	10			(5,225		)	14			—			(5,201		)
Non-cash stock compensation expense	1,780			—			—			—			1,780
Amortization of debt discount	103			—			—			—			103
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries	(67,152		)	(10,581		)	—			77,733		(a)	—
Intercompany	53,735			(46,683		)	(7,052		)	—			—
Accounts receivable	—			(73,715		)	(7,525		)	—			(81,240		)
Other current assets	(2,096		)	245			340			—			(1,511		)
Other assets	(4,203		)	6,564			108			—			2,469
Accounts payable	2,758			4,531			818			—			8,107
Due to third-party payors	—			6,599			(7,063		)	—			(464		)
Accrued expenses	9,410			4,606			(1,008		)	—			13,008
Income and deferred taxes	16,151			—			—			—			16,151
Net cash provided by operating activities	92,677			7,508			1,065			—			101,250
Investing activities
Purchases of property and equipment	(1,178		)	(18,898		)	(3,620		)	—			(23,696		)
Investment in business	—			(13,514		)	—			—			(13,514		)
Acquisition of businesses, net of cash acquired	—			1,921			—			—			1,921
Proceeds from sale of assets	—			7,879			—			—			7,879
Net cash used in investing activities	(1,178		)	(22,612		)	(3,620		)	—			(27,410		)
Financing activities
Borrowings on revolving credit facilities	435,000			—			—			—			435,000
Payments on revolving credit facilities	(395,000		)	—			—			—			(395,000		)
Borrowings on 2011 credit facility term loan, net of discount	841,500			—			—			—			841,500
Payments on 2005 credit facility term loans, net of call premium	(484,633		)	—			—			—			(484,633		)
Repurchase of 7 5/8% senior subordinated notes, net of tender premium	(273,941		)	—			—			—			(273,941		)
Borrowings of other debt	5,496			—			—			—			5,496
Principal payments on other debt	(2,581		)	(899		)	—			—			(3,480		)
Debt issuance costs	(18,556		)	—			—			—			(18,556		)
Proceeds from bank overdrafts	2,102			—			—			—			2,102
Equity investment by Holdings	169			—			—			—			169
Dividends paid to Holdings	(171,008		)	—			—			—			(171,008		)
Intercompany debt reallocation	(20,061		)	15,372			4,689			—			—
Distributions to non-controlling interests	—			—			(2,270		)	—			(2,270		)
Net cash provided by (used in) financing activities	(81,513		)	14,473			2,419			—			(64,621		)
Net increase (decrease) in cash and cash equivalents	9,986			(631		)	(136		)	—			9,219
Cash and cash equivalents at beginning of period	149			3,567			649			—			4,365
Cash and cash equivalents at end of period	$	10,135		$	2,936		$	513		$	—		$	13,584

(a)  Elimination of equity in earnings of consolidated subsidiaries.

26

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read this discussion together with our unaudited consolidated financial statements and accompanying notes.

Forward-Looking Statements

This report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws.  Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements.  Forward-looking statements include statements preceded by, followed by or that include the words “may,” “could,” “would,” “should,” “believe,” “expect,” “anticipate,” “plan,” “target,” “estimate,” “project,” “intend” and similar expressions.  These statements include, among others, statements regarding our expected business outlook, anticipated financial and operating results, our business strategy and means to implement our strategy, our objectives, the amount and timing of capital expenditures, the likelihood of our success in expanding our business, financing plans, budgets, working capital needs and sources of liquidity.

Forward-looking statements are only predictions and are not guarantees of performance.  These statements are based on our management’s beliefs and assumptions, which in turn are based on currently available information. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding our services, the expansion of our services, competitive conditions and general economic conditions. These assumptions could prove inaccurate. Forward-looking statements also involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. Many of these factors are beyond our ability to control or predict. Such factors include, but are not limited to, the following:

·additional changes in government reimbursement for our services, including changes that will result from the expiration of the moratorium for long term acute care hospitals established by the Medicare, Medicaid, and SCHIP Extension Act of 2007, the American Recovery and Reinvestment Act, and the Patient Protection and Affordable Care Act may result in a reduction in net operating revenues, an increase in costs and a reduction in profitability;

·the failure of our specialty hospitals to maintain their Medicare certifications may cause our net operating revenues and profitability to decline;

·the failure of our facilities operated as “hospitals within hospitals” to qualify as hospitals separate from their host hospitals may cause our net operating revenues and profitability to decline;

·a government investigation or assertion that we have violated applicable regulations may result in sanctions or reputational harm and increased costs;

·acquisitions or joint ventures may prove difficult or unsuccessful, use significant resources or expose us to unforeseen liabilities;

·private third-party payors for our services may undertake future cost containment initiatives that limit our future net operating revenues and profitability;

27

·the failure to maintain established relationships with the physicians in the areas we serve could reduce our net operating revenues and profitability;

·shortages in qualified nurses or therapists could increase our operating costs significantly;

·competition may limit our ability to grow and result in a decrease in our net operating revenues and profitability;

·the loss of key members of our management team could significantly disrupt our operations;

·the effect of claims asserted against us could subject us to substantial uninsured liabilities; and

·other factors discussed from time to time in our filings with the Securities and Exchange Commission (the “SEC”), including factors discussed under the heading “Risk Factors” for the year ended December 31, 2011 contained in our annual report on Form 10-K filed with the SEC on March 2, 2012.

Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we are under no obligation to publicly update or revise any forward-looking statements, whether as a result of any new information, future events or otherwise.  You should not place undue reliance on our forward-looking statements.  Although we believe that the expectations reflected in forward-looking statements are reasonable, we cannot guarantee future results or performance.

Investors should also be aware that while we do, from time to time, communicate with securities analysts, it is against our policy to disclose to securities analysts any material non-public information or other confidential commercial information.  Accordingly, stockholders should not assume that we agree with any statement or report issued by any securities analyst irrespective of the content of the statement or report.  Thus, to the extent that reports issued by securities analysts contain any projections, forecasts or opinions, such reports are not the responsibility of the Company.

Overview

We believe that we are one of the largest operators of both specialty hospitals and outpatient rehabilitation clinics in the United States based on number of facilities.  As of June 30, 2012, we operated 111 long term acute care hospitals and 12 acute medical rehabilitation hospitals in 28 states, and 956 outpatient rehabilitation clinics in 32 states and the District of Columbia. We also provide medical rehabilitation services on a contracted basis to nursing homes, hospitals, assisted living and senior care centers, schools and work sites.  We began operations in 1997 under the leadership of our current management team.  As of June 30, 2012 we had operations in 44 states and the District of Columbia.

We manage our Company through two business segments, our specialty hospital segment and our outpatient rehabilitation segment.  We had net operating revenues of $1,494.2 million for the six months ended June 30, 2012.  Of this total, we earned approximately 74% of our net operating revenues from our specialty hospitals and approximately 26% from our outpatient rehabilitation business.  Our specialty hospital segment consists of hospitals designed to serve the needs of long term stay acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.  Patients are typically admitted to our specialty hospitals from general acute care hospitals.  These patients have specialized needs, and serious and often complex medical conditions such as respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes,

28

non-healing wounds, cardiac disorders, renal disorders and cancer.  Our outpatient rehabilitation segment consists of clinics and contract services that provide physical, occupational and speech rehabilitation services.  Our outpatient rehabilitation patients are typically diagnosed with musculoskeletal impairments that restrict their ability to perform normal activities of daily living.

Significant 2012 Events

Stock Repurchase Program

On February 22, 2012, the Company’s board of directors authorized an increase of $100.0 million in the capacity of its common stock repurchase program from $150.0 million to $250.0 million.  The program will remain in effect until March 31, 2013, unless extended by the board of directors.  Stock repurchases under this program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as the Company deems appropriate.  The timing of purchases of stock will be based upon market conditions and other factors.  The Company is funding this program with cash on hand or borrowings under its revolving credit facility.  The Company repurchased 2,522,090 shares at a cost of $21.1 million and 5,725,782 shares at a cost of $46.8 million, which includes transaction costs, during the three months ended June 30, 2012 and the six months ended June 30, 2012, respectively.  Since the inception of the program through June 30, 2012, the Company has repurchased 22,490,389 shares at a cost of $163.6 million, or $7.28 per share, which includes transaction costs.

Summary Financial Results

Second Quarter Ended June 30, 2012

For the three months ended June 30, 2012, our net operating revenues increased $51.4 million or 7.4% to $750.2 million compared to $698.7 million for the three months ended June 30, 2011.  Our specialty hospital revenues increased $36.9 million or 7.1% and our outpatient rehabilitation revenues increased $14.6 million or 8.2%.  We had income from operations for the three months ended June 30, 2012 of $93.5 million compared to $81.0 million for the three months ended June 30, 2011.  We had net income attributable to Holdings’ for the three months ended June 30, 2012 of $43.2 million compared to $11.7 million for the three months ended June 30, 2011.  Our Adjusted EBITDA for the three months ended June 30, 2012 was $110.3 million compared to $99.9 million for the three months ended June 30, 2011.  See the section entitled “Results of Operations” for a reconciliation of net income to Adjusted EBITDA.  The increase in our income from operations and Adjusted EBITDA is principally due to increases in operating performance in our specialty hospital segment. We were able to increase our specialty hospital income from operations $12.7 million or 16.2% and our specialty hospital Adjusted EBITDA $11.1 million or 12.2% for the three months ended June 30, 2012 from the same period prior year.  These increases principally occurred in our Regency hospitals that were acquired in 2010.

Net income attributable to Holdings’ increased $31.5 million to $43.2 million for the three months ended June 30, 2012 compared to $11.7 million for the three months ended June 30, 2011.  The increase resulted primarily from an increase in our income from operations described above, increases in our equity in earnings of unconsolidated subsidiaries principally related to our investment in our joint venture with the Baylor Health Care System that was formed on April 1, 2011 (“Baylor JV”) and a reduction in our interest expense.  We also incurred a loss on early retirement of debt related to the refinancing completed June 1, 2011 that reduced our net income in the three months ended June 30, 2011.

For the six months ended June 30, 2012, our net operating revenues increased 7.3% to $1,494.2 million compared to $1,391.9 million for the six months ended June 30, 2011.  Our specialty hospital revenues

29

increased $70.0 million or 6.7% and our outpatient rehabilitation revenues increased $32.3 million or 9.2%.  We had income from operations for the six months ended June 30, 2012 of $185.1 million compared to $168.7 million for the six months ended June 30, 2011.  We had net income attributable to Holdings’ for the six months ended June 30, 2012 of $84.7 million compared to $45.4 million for the six months ended June 30, 2011.  Our Adjusted EBITDA for the six months ended June 30, 2012 was $219.3 million compared to $205.7 million for the six months ended June 30, 2011.  See the section entitled “Results of Operations” for a reconciliation of net income to Adjusted EBITDA.  The increases in our income from operations and Adjusted EBITDA is principally due to increases in our operating performance of our specialty hospital segment. We were able to increase our specialty hospital income from operations $12.5 million or 7.5% and our specialty hospital Adjusted EBITDA $10.7 million or 5.6% for the six months ended June 30, 2012 as compared to the six months ended June 30, 2011.  These increases principally occurred in our Regency hospitals that were acquired in 2010.

Net income attributable to Holdings’ increased $39.3 million to $84.7 million for the six months ended June 30, 2012 compared to $45.4 million for the six months ended June 30, 2011. The increase resulted primarily from an increase in our income from operations described above, increases in our equity in earnings of unconsolidated subsidiaries principally related to our Baylor JV, and a reduction of interest expense.  We also incurred a loss on early retirement of debt related to the refinancing completed June 1, 2011 that reduced our net income in the six months ended June 30, 2011.

Cash flow from operations provided $118.8 million of cash for the six months ended June 30, 2012 for Holdings and $124.0 million of cash for the six months ended June 30, 2012 for Select.  The difference in cash flow from operations between Holdings and Select primarily relates to interest payments on Holdings’ senior floating rate notes.

Regulatory Changes

In the past few years, there have been significant regulatory changes that have affected our net operating revenues and, in some cases, caused us to change our operating models and strategies.  The following is a discussion of recent regulatory changes that are affecting our results of operations in 2012 or may have an affect on our future results of operations.  Our Annual Report on Form 10-K for the year ended December 31, 2011 filed with the Securities and Exchange Commission (“SEC”) on March 2, 2012 contains a more detailed discussion of the regulations that affect our business in Part I — Business — Government Regulations, and the information below should be read in connection with that more detailed discussion.

Healthcare Reform Legislation

Federal agencies, including the Centers for Medicare & Medicaid Services (“CMS”), continue to implement provisions of the Patient Protection and Affordable Care Act (“PPACA”).  The PPACA expands access to health insurance through subsidies, coverage mandates and other insurance market reforms.  In addition, PPACA makes dramatic changes to the Medicare and Medicaid programs by adopting numerous initiatives addressing, among other things, reductions in healthcare spending, patient safety incentives and protections against fraud and abuse of federal healthcare programs.  The PPACA adopts significant changes to the Medicare program that are particularly relevant to long term acute care hospitals (“LTCHs”), inpatient rehabilitation facilities (“IRFs”) and outpatient rehabilitation services.  As part of healthcare reform legislation, President Obama also signed the “Health Care and Education Affordability Reconciliation Act of 2010,” which made some limited but important changes to the PPACA.

A number of states attorneys general and other parties filed legal challenges to the PPACA seeking to block its implementation on constitutional grounds.  On June 28, 2012 the U.S. Supreme Court upheld the PPACA finding that the individual health insurance mandate does not violate the Constitution because it may be viewed

30

as a permissible tax on individuals who do not obtain health insurance.  The only provision of the law that the Court invalidated is a Medicaid provision that threatened states with the loss of existing Medicaid funding if they decline to comply with the PPACA’s Medicaid coverage extension.  Federal and state agencies are expected to continue to implement provisions of the PPACA following the Court’s decision.

We have included in our Annual Report on Form 10-K for the year ended December 31, 2011 a discussion of the PPACA provisions that affect our business, as well as regulatory initiatives adopted by CMS in response to particular provisions of the PPACA.

Budget Control Act of 2011

Beginning in January 2013, the Budget Control Act of 2011 will automatically reduce federal spending by approximately $1.2 trillion split evenly between domestic and defense spending.  Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap.  Unless further legislation is enacted, we believe this will generally result in a 2% reduction to Medicare payments, beginning in January 2013.

Medicare Payment of Long Term Acute Care Hospitals during Fiscal Year 2012

On August 18, 2011, CMS published the policies and payment rates for LTCH-PPS for fiscal year 2012 (affecting discharges and cost reporting periods beginning on or after October 1, 2011 through September 30, 2012).  The standard federal rate for fiscal year 2012 is $40,222, an increase from the fiscal year 2011 standard federal rate of $39,600.  The final rule establishes a fixed-loss amount for high cost outlier cases for fiscal year 2012 of $17,931, which is a decrease from the fixed-loss amount in the 2011 fiscal year of $18,785.

The labor-related share of the LTCH-PPS standard federal rate is adjusted annually to account for geographic differences in area wage levels by applying the applicable LTCH-PPS wage index.  CMS adopted a decrease in the labor-related share from 75.271% to 70.199% under the LTCH-PPS for fiscal year 2012.

In addition, CMS applied an area wage level budget neutrality factor to the standard federal rate to make annual changes to the area wage level adjustment budget neutral.  Previously, there was no statutory or regulatory requirement that these adjustments to the area wage level be made in a budget neutral manner.  The final rule creates a regulatory requirement that any adjustments or updates to the area wage level adjustment be made in a budget neutral manner such that estimated aggregate LTCH-PPS payments are not affected.

An LTCH must have an average inpatient length of stay for Medicare patients (including both Medicare covered and non-covered days) of greater than 25 days.  In the preamble to the final rule for fiscal year 2012, CMS clarified its policy on the calculation of the average length of stay by specifying that all data on all Medicare inpatient days, including Medicare Advantage days, must be included in the average length of stay calculation effective for cost reporting periods beginning on or after January 1, 2012.

Medicare Payment of Long Term Acute Care Hospitals during Fiscal Year 2013

On August 1, 2012, CMS published the final rule updating the policies and payment rates for LTCH-PPS for fiscal year 2013 (affecting discharges and cost reporting periods beginning on or after October 1, 2012 through September 30, 2013).  Two different standard federal rates apply during fiscal year 2013.  The standard federal rate for discharges on or after October 1, 2012 and before December 29, 2012 is set at $40,916, an increase from $40,222 applicable during fiscal year 2012. The standard federal rate for discharges on or after December 29, 2012 and the remainder of fiscal year 2013 is set at $40,398. The increase through December 28, 2012

31

is based on a market basket increase of 2.6% less a productivity adjustment of 0.7% and less an additional reduction of 0.1% mandated by the PPACA. The market basket increase for the period of December 29, 2012 through the remainder of fiscal 2013 is further reduced by a portion of the one-time budget neutrality adjustment, as discussed below.  The fixed loss amount for high cost outlier cases is set at $15,408, a decrease from the fixed loss amount in the 2012 fiscal year of $17,931.

Very Short Stay Outlier Policy

CMS established a different payment methodology for Medicare patients with a length of stay less than or equal to five-sixths of the geometric average length of stay for that particular MS-LTC-DRG, referred to as a short stay outlier, or “SSO.” The SSO rule was further revised adding a category referred to as a “very short stay outlier” for discharges occurring after July 1, 2007. For cases with a length of stay that is equal to or less than one standard deviation from the geometric average length of stay for the same MS-DRG under IPPS, referred to as the so-called “IPPS comparable threshold,” the rule lowers the LTCH payment to a rate based on the general acute care hospital IPPS per diem. SSO cases with covered lengths of stay that exceed the IPPS comparable threshold would continue to be paid under the SSO payment policy. The SCHIP Extension Act, as amended by the PPACA, prevented CMS from applying the very short-stay outlier policy before December 29, 2012. Under existing regulations Medicare payments for very short-stay cases will be generally lowered to a rate based on the general acute care hospital IPPS per diem beginning with discharges on or after December 29, 2012.

25 Percent Rule

The 25 Percent Rule is a downward payment adjustment that applies to Medicare patients discharged from LTCHs who were admitted from a co-located hospital or a non-co-located hospital and caused the LTCH to exceed the applicable percentage thresholds of discharged Medicare patients. The SCHIP Extension Act as amended by the American Recovery and Reinvestment Act, or “ARRA,” and the PPACA limited the full application of the Medicare percentage threshold and, in some cases, postponed application of the percentage threshold until cost reporting periods beginning on or after July 1, 2012 or October 1, 2012.

In the update to the Medicare policies and payment rates for fiscal year 2013, CMS adopted through regulations a one-year extension of relief granted by the SCHIP Extension Act from the full application of Medicare admission thresholds. As a result, full implementation of the Medicare admission thresholds will not go into effect until cost reporting periods beginning on or after October 1, 2013, except for certain LTCHs with cost reporting periods that begin between July 1, 2012 and September 30, 2012. Specifically, those freestanding facilities, grandfathered HIHs and grandfathered satellites with cost reporting periods beginning on or after July 1, 2012 and before October 1, 2012 are subject to a modified 25 Percent Rule for discharges occurring in a three month period between July 1,2012 and September 30, 2012.

In the preamble to the proposed update to the Medicare policies and payment rates for fiscal year 2013, CMS indicates that “within the near future” it may recommend revisions to the payment policies addressing MedPAC’s recommendations for the development of patient-level and facility-level criteria.  CMS also indicates that these recommendations may render unnecessary the existing payment reductions for Medicare patients admitted from a general acute care hospital in excess of the applicable admission thresholds.

One-Time Budget Neutrality Adjustment

Congress required that the LTCH-PPS payment rates maintain budget neutrality during the first year of the prospective payment system with total expenditures that would have been made under the previous reasonable cost-based payment system. The LTCH-PPS regulations give CMS the ability to make a one-time adjustment to

32

the standard federal rate to correct any “significant difference between actual payments and estimated payments for the first year” of LTCH-PPS. The SCHIP Extension Act, as amended by the PPACA, precluded CMS from implementing the one-time prospective adjustment to the LTCH standard federal rate before December 29, 2012.

In the update to the Medicare policies and payment rates for fiscal year 2013, CMS adopted a one-time budget neutrality adjustment that results in a permanent negative adjustment of 3.75% to the LTCH base rate.  CMS is implementing the adjustment over a three-year period by applying a factor of 0.98734 to the standard federal rate in fiscal years 2013, 2014 and 2015, except that the adjustment would not apply to payments for discharges occurring on or after October 1, 2012 through December 28, 2012.

Medicare Market Basket Adjustments for Long Term Acute Care Hospitals

In the update to the Medicare policies and payment rates for fiscal year 2013, CMS adopted for the first time an LTCH-specific market basket based entirely on Medicare cost report data from LTCHs.  The LTCH-specific market basket replaces the rehabilitation, psychiatric and long-term care hospital market basket previously used to determine the annual update to the LTCH-PPS.  For fiscal year 2013 CMS adopted an LTCH-specific market basket update of 1.8% based on an estimate of the LTCH-specific market basket update of 2.6% less a productivity adjustment of 0.7% and less an additional reduction of 0.1% mandated by the PPACA and as further adjusted by the one-time budget neutrality adjustment described above.

The PPACA institutes a market basket payment adjustment for LTCHs.  For fiscal years 2012 and 2013, the reduction is 0.1%.  For fiscal year 2014, the reduction is 0.3%.  For fiscal years 2015 and 2016, the reduction is 0.2%.  For fiscal years 2017 through fiscal year 2019, the reduction is 0.75%.

Medicare Payment of Inpatient Rehabilitation Facilities during Fiscal Year 2012

On August 5, 2011, CMS published the policies and payment rates for IRF-PPS for fiscal year 2012 (affecting discharges and cost reporting periods beginning on or after October 1, 2011 through September 30, 2012). The standard payment conversion factor for discharges for fiscal year 2012 is $14,076, an increase from the fiscal year 2011 standard payment conversion factor of $13,860.  CMS initially decreased the outlier threshold amount for fiscal year 2012 to $10,660 from $11,410 for fiscal year 2011.  In a notice published September 26, 2011, CMS corrected its calculation of the outlier threshold amount for fiscal year 2012 to $10,713.

Medicare Payment of Inpatient Rehabilitation Facilities during Fiscal Year 2013

On July 30, 2012, CMS published the policies and payment rates for IRF-PPS for fiscal year 2013 (affecting discharges and cost reporting periods beginning on or after October 1, 2012 through September 30, 2013).  The standard payment conversion factor for discharges for fiscal year 2013 is $14,343, an increase from the fiscal year 2012 standard payment conversion factor of $14,076.  The standard payment conversion factor for fiscal year 2013 includes a market basket payment reduction adjustment for IRFs as mandated by the PPACA.  The outlier

33

threshold amount for fiscal year 2013 is set at $10,466, a decrease from the outlier threshold amount in the 2012 fiscal year of $10,713.

Medicare Market Basket Adjustments for Inpatient Rehabilitation Facilities

The PPACA instituted a market basket payment reduction adjustment for IRFs.  For fiscal years 2012 and 2013, the reduction is 0.1%.  For fiscal year 2014, the reduction is 0.3%.  For fiscal years 2015 and 2016, the reduction is 0.2%.  For fiscal years 2017 - 2019, the reduction is 0.75%.

Medicare Payment of Outpatient Rehabilitation Services

Medicare Physician Fee Schedule Sustainable Growth Rate Update

The Medicare program reimburses outpatient rehabilitation providers based on the Medicare physician fee schedule.  The Medicare physician fee schedule rates are automatically updated annually based on the sustainable growth rate (“SGR”) formula contained in legislation.  The SGR formula has resulted in automatic reductions in rates in every year since 2002; however, for each year through 2012 CMS or Congress has taken action to prevent the SGR formula reductions.  The Middle Class Tax Relief and Job Creation Act of 2012 froze Medicare physician fee schedule rates at 2011 levels through December 31, 2012, temporarily averting a scheduled 27.4% cut as a result of the SGR formula that would have taken effect on March 1, 2012.  In the proposed 2013 Medicare physician fee schedule rule, CMS has estimated a 27.0% reduction in the Medicare physician fee schedule payment rates beginning on January 1, 2013, unless Congress again takes legislative action to prevent the SGR formula reductions from going into effect.  This reduction would be in addition to any sequestration being enacted which would cut all of Medicare by 2%.  If the 27.0% SGR and 2% sequestration cuts are averted by Congress, the projected impact of other changes in the proposed 2013 Medicare physician fee schedule rule on outpatient physical therapy services in aggregate would be a 3% increase in 2013.  This positive change is primarily due to the phase in of the final year of the 4-year transition to the new practice expense relative value units based on data from the Physician Practice Information Survey.

On October 6, 2011, MedPAC recommended that Congress repeal and replace the statutory SGR formula.  The MedPAC proposal, which would require Congressional approval, would freeze current Medicare physician fee schedule rates for primary care services for 10 years, while other services would be subject to annual payment reductions of 5.9% for 3 years, followed by a freeze on payments for the next seven years. MedPAC offered a list of options for Congress to consider if it decides to offset SGR repeal costs (estimated at about $200 billion over 10 years) within the Medicare program.

In addition to the SGR proposal, MedPAC recommended that Congress direct CMS to collect data on provider service volume and work time to establish more accurate relative value unit payment rates and to identify and reduce overpriced fee schedule services.  Similarly, the PPACA requires CMS to identify and review potentially misvalued codes and make appropriate adjustments to the relative values of those services identified as being misvalued.  In the final update to the Medicare physician fee schedule for calendar year 2012, CMS identified several CPT codes used by physical therapists as codes they will review.

Therapy Caps

Beginning on January 1, 1999, the Balanced Budget Act of 1997 subjected certain outpatient therapy providers reimbursed under the Medicare physician fee schedule to annual limits for therapy expenses.  Effective January 1, 2012, the annual limit on outpatient therapy services is $1,880 for combined physical and speech language pathology services and $1,880 for occupational therapy services.  The per beneficiary caps were $1,870 for calendar year 2011.  The annual limits for therapy expenses do not apply to services furnished and billed by outpatient hospital departments.  However, beginning no later than October 1, 2012 and expiring on December 31, 2012, the Middle Class Tax Relief and Job Creation Act of 2012 will apply the annual limits on therapy expenses to hospital outpatient department settings.  The application of annual limits to hospital outpatient department settings will sunset at the end of 2012 unless extended by Congress. We operated 956

34

outpatient rehabilitation clinics at June 30, 2012, of which 135 are provider-based outpatient rehabilitation clinics operated as departments of the inpatient rehabilitation hospitals.

In the Deficit Reduction Act of 2005, Congress implemented an exceptions process to the annual limit for therapy expenses.  Under this process, a Medicare enrollee (or person acting on behalf of the Medicare enrollee) is able to request an exception from the therapy caps if the provision of therapy services was deemed to be medically necessary.  Therapy cap exceptions have been available automatically for certain conditions and on a case-by-case basis upon submission of documentation of medical necessity.  The Middle Class Tax Relief and Job Creation Act of 2012 extended the exceptions process for outpatient therapy caps through December 31, 2012.  Unless Congress extends the exceptions process, the therapy caps will apply to all outpatient therapy services beginning January 1, 2013, except those services furnished and billed by outpatient hospital departments.

The Middle Class Tax Relief and Job Creation Act of 2012 made several changes to the exceptions process to the annual limit for therapy expenses.  For any claim above the annual limit, the claim must contain a modifier, such as the KX modifier, indicating that the services are medically necessary and justified by appropriate documentation in the medical record.  Effective October 1, 2012, all claims exceeding $3,700 will be subject to a manual medical review process.  The $3,700 threshold will be applied separately to the combined physical therapy/speech therapy cap and the occupational therapy cap.  Effective October 1, 2012, all therapy claims, whether above or below the annual limit, must include the national provider identifier (NPI) of the physician responsible for certifying and periodically reviewing the plan of care.

In the proposed 2013 Medicare physician fee schedule rule, CMS will implement a claims-based data collection process to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes.  All practice settings that provide outpatient therapy services must include this data on the claim form.  Beginning on January 1, 2013,  therapists will be required to report new codes and modifiers on the claim form that reflect a patient’s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge.  For claims submitted after July 1, 2013, CMS proposes to return claims as unpaid if the required data is not included in the claim.

Several government agencies are expected to release reports on aspects of the Medicare payment system for therapy services.  In the final 2011 Medicare physician fee schedule rule, CMS indicated the agency is evaluating alternative payment methodologies that would provide appropriate payment for medically necessary and effective therapy services furnished to Medicare beneficiaries based on patient needs rather than the current therapy caps.  The Middle Class Tax Relief and Job Creation Act of 2012 directs the MedPAC to submit a report to Congress by June 15, 2013 making recommendations on how to reform the payment system to better reflect acuity, condition, and the therapy needs of the patient.  The MedPAC report is to include an examination of private sector initiatives related to therapy benefits.  In addition, the GAO is directed to issue a report no later than May 1, 2013 regarding implementation of the manual medical review process instituted by the Middle Class Tax Relief and Job Creation Act of 2012.  The report must detail the number of beneficiaries subject to the process, the number of reviews conducted, and the outcome of the reviews.

Multiple Procedure Payment Reduction

CMS adopted a multiple procedure payment reduction for therapy services in the final update to the Medicare physician fee schedule for calendar year 2011.  Under the policy, the Medicare program pays 100% of the practice expense component of the therapy procedure or unit of service with the highest relative value unit and then reduces the payment for the practice expense component by 20% in office and other non-institutional

35

settings and 25% in institutional settings for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions.  This multiple procedure payment reduction policy became effective January 1, 2011 and applies to all outpatient therapy services paid under Medicare Part B.  Furthermore, the multiple procedure payment reduction policy applies across all therapy disciplines — occupational therapy, physical therapy and speech language pathology.  Our outpatient rehabilitation therapy services are primarily offered in institutional settings and, as such, are subject to the applicable 25% payment reduction in the practice expense component for the second and subsequent therapy services furnished by us to the same patient on the same day.  In the 2012 Medicare physician fee schedule rule, CMS indicated that over the next year it will continue to review whether specific CPT codes billed under the fee schedule are overvalued or undervalued, including certain specific CPT codes used by physical therapists.

Medicare Quality Reporting Program for LTCHs and IRFs

The PPACA requires that CMS establish new quality data reporting programs for LTCHs and IRFs by fiscal year 2014.  CMS has adopted a quality data reporting program requiring LTCHs to submit data from three quality measures in order to receive the full payment update in fiscal year 2014, including measures related to (1) catheter-associated urinary tract infections, (2) central line catheter-associated blood stream infection, and (3) pressure ulcers that are new or have worsened.  In addition to the foregoing measures, CMS has adopted the following quality measures for LTCH reporting beginning in fiscal year 2016: (1) percent of nursing home residents who were assessed and appropriately given the seasonal influenza vaccine, and (2) influenza vaccination coverage among healthcare personnel.  CMS adopted a quality data reporting program requiring IRFs to submit data from two quality measures in order to receive the full payment update in fiscal year 2014, including measures related to (1) catheter-associated urinary tract infections and (2) pressure ulcers that are new or have worsened.  Under the PPACA and CMS regulations, if an LTCH or IRF fails to report on the selected quality measures, its reimbursement will be reduced by 2.0% of the annual market basket update.  The reduction can result in payment rates less than the prior year.  However, the reduction will not carry over into the subsequent fiscal years.

36

Operating Statistics

The following tables set forth operating statistics for our specialty hospitals and our outpatient rehabilitation clinics for each of the periods presented. The data in the tables reflect the changes in the number of specialty hospitals and outpatient rehabilitation clinics we operate that resulted from acquisitions, start-up activities, closures and sales. The operating statistics reflect data for the period of time these operations were managed by us.

	Three Months Ended  June 30,						Six Months Ended  June 30,
	2011			2012			2011			2012
Specialty hospital data(1):
Number of hospitals owned - start of period	116			117			116			115
Number of hospitals acquired	—			—			1			1
Number of hospital start-ups	—			—			—			1
Number of hospitals closed/sold	(1		)	—			(2		)	—
Number of hospitals owned - end of period	115			117			115			117
Number of hospitals managed - end of period	4			6			4			6
Total number of hospitals (all) - end of period	119			123			119			123
Long term acute care hospitals	110			111			110			111
Rehabilitation hospitals	9			12			9			12
Available licensed beds (2)	5,135			5,205			5,135			5,205
Admissions (2)	13,556			13,872			27,366			27,927
Patient days (2)	327,001			336,016			660,857			679,037
Average length of stay (days) (2)	24			24			24			24
Net revenue per patient day (2)(3)	$	1,505		$	1,554		$	1,510		$	1,539
Occupancy rate (2)	70		%	71		%	71		%	72		%
Percent patient days - Medicare (2)	64		%	64		%	64		%	65		%
Outpatient rehabilitation data:
Number of clinics owned - start of period	874			848			875			850
Number of clinic start-ups	7			10			15			18
Number of clinics closed/sold	(32		)	(6		)	(41		)	(16		)
Number of clinics owned - end of period	849			852			849			852
Number of clinics managed - end of period	103			104			103			104
Total number of clinics (all) - end of period	952			956			952			956
Number of visits (2)	1,143,854			1,166,550			2,282,554			2,318,759
Net revenue per visit (2)(4)	$	102		$	102		$	102		$	103

(1)  Specialty hospitals consist of long term acute care hospitals and inpatient rehabilitation facilities.

(2)  Data excludes specialty hospitals and outpatient clinics managed by the Company.

(3)  Net revenue per patient day is calculated by dividing specialty hospital direct patient service revenues by the total number of patient days.

(4)  Net revenue per visit is calculated by dividing outpatient rehabilitation clinic revenue by the total number of visits. For purposes of this computation, outpatient rehabilitation clinic revenue does not include contract services revenue.

37

Results of Operations

The following table outlines, for the periods indicated, selected operating data as a percentage of net operating revenues:

	Select Medical Holdings  Corporation				Select Medical Corporation
	Three MonthsEnded June 30,				Three MonthsEnded June 30,
	2011		2012		2011		2012
Net operating revenues	100.0	%	100.0	%	100.0	%	100.0	%
Cost of services(1)	81.5		81.7		81.5		81.7
General and administrative	2.3		2.5		2.3		2.5
Bad debt expense	2.0		1.3		2.0		1.3
Depreciation and amortization	2.6		2.0		2.6		2.0
Income from operations	11.6		12.5		11.6		12.5
Loss on early retirement of debt	(4.4	)	—		(2.9	)	—
Equity in earnings (losses) of unconsolidated subsidiaries	(0.0	)	0.3		(0.0	)	0.3
Interest expense, net	(3.6	)	(3.1	)	(2.8	)	(2.8	)
Income before income taxes	3.6		9.7		5.9		10.0
Income tax expense	1.6		3.7		2.4		3.8
Net income	2.0		6.0		3.5		6.2
Net income attributable to non-controlling interest	0.3		0.2		0.3		0.2
Net income attributable to Holdings and Select	1.7	%	5.8	%	3.2	%	6.0	%

	Select Medical Holdings Corporation				Select Medical Corporation
	Six MonthsEnded June 30,				Six MonthsEnded June 30,
	2011		2012		2011		2012
Net operating revenues	100.0	%	100.0	%	100.0	%	100.0	%
Cost of services(1)	81.0		81.9		81.0		81.9
General and administrative	2.4		2.2		2.4		2.2
Bad debt expense	2.0		1.4		2.0		1.4
Depreciation and amortization	2.5		2.1		2.5		2.1
Income from operations	12.1		12.4		12.1		12.4
Loss on early retirement of debt	(2.2	)	—		(1.5	)	—
Equity in earnings (losses) of unconsolidated subsidiaries	(0.0	)	0.3		(0.0	)	0.3
Interest expense, net	(3.7	)	(3.2	)	(2.7	)	(2.8	)
Income before income taxes	6.2		9.5		7.9		9.9
Income tax expense	2.7		3.7		3.3		3.8
Net income	3.5		5.8		4.6		6.1
Net income attributable to non-controlling interest	0.3		0.2		0.3		0.2
Net income attributable to Holdings and Select	3.2	%	5.6	%	4.3	%	5.9	%

38

The following tables summarize selected financial data by business segment, for the periods indicated:

	Select Medical Holdings Corporation								Select Medical Corporation
	Three Months Ended June 30,								Three Months Ended June 30,
	2011			2012			%  Change		2011			2012			% Change
	(in thousands)								(in thousands)
Net operating revenues:
Specialty hospitals	$	520,261		$	557,130		7.1	%	$	520,261		$	557,130		7.1	%
Outpatient rehabilitation	178,473			193,050			8.2		178,473			193,050			8.2
Other(2)	15			13			(13.3	)	15			13			(13.3	)
Total company	$	698,749		$	750,193		7.4	%	$	698,749		$	750,193		7.4	%
Income (loss) from operations:
Specialty hospitals	$	78,034		$	90,687		16.2	%	$	78,034		$	90,687		16.2	%
Outpatient rehabilitation	20,240			22,605			11.7		20,240			22,605			11.7
Other(2)	(17,248		)	(19,779		)	(14.7	)	(17,248		)	(19,779		)	(14.7	)
Total company	$	81,026		$	93,513		15.4	%	$	81,026		$	93,513		15.4	%
Adjusted EBITDA:(3)
Specialty hospitals	$	91,081		$	102,166		12.2	%	$	91,081		$	102,166		12.2	%
Outpatient rehabilitation	24,467			25,837			5.6		24,467			25,837			5.6
Other(2)	(15,623		)	(17,724		)	(13.4	)	(15,623		)	(17,724		)	(13.4	)
Total company	$	99,925		$	110,279		10.4	%	$	99,925		$	110,279		10.4	%
Adjusted EBITDA margins:(3)
Specialty hospitals	17.5		%	18.3		%			17.5		%	18.3		%
Outpatient rehabilitation	13.7			13.4					13.7			13.4
Other(2)	N/M			N/M					N/M			N/M
Total company	14.3		%	14.7		%			14.3		%	14.7		%
Total assets:
Specialty hospitals	$	2,202,994		$	2,184,743				$	2,202,994		$	2,184,743
Outpatient rehabilitation	471,175			437,591					471,175			437,591
Other(2)	113,853			157,303					112,264			156,080
Total company	$	2,788,022		$	2,779,637				$	2,786,433		$	2,778,414
Purchases of property and equipment:
Specialty hospitals	$	6,130		$	12,631				$	6,130		$	12,631
Outpatient rehabilitation	2,801			2,922					2,801			2,922
Other(2)	1,845			630					1,845			630
Total company	$	10,776		$	16,183				$	10,776		$	16,183

39

	Select Medical Holdings Corporation								Select Medical Corporation
	Six Months Ended June 30,								Six Months Ended June 30,
	2011			2012			%  Change		2011			2012			% Change
	(in thousands)								(in thousands)
Net operating revenues:
Specialty hospitals	$	1,040,185		$	1,110,168		6.7	%	$	1,040,185		$	1,110,168		6.7	%
Outpatient rehabilitation	351,664			383,949			9.2		351,664			383,949			9.2
Other(2)	86			97			12.8		86			97			12.8
Total company	$	1,391,935		$	1,494,214		7.3	%	$	1,391,935		$	1,494,214		7.3	%
Income (loss) from operations:
Specialty hospitals	$	166,341		$	178,798		7.5	%	$	166,341		$	178,798		7.5	%
Outpatient rehabilitation	37,187			41,433			11.4		37,187			41,433			11.4
Other(2)	(34,870		)	(35,114		)	(0.7	)	(34,870		)	(35,114		)	(0.7	)
Total company	$	168,658		$	185,117		9.8	%	$	168,658		$	185,117		9.8	%
Adjusted EBITDA:(3)
Specialty hospitals	$	191,434		$	202,120		5.6	%	$	191,434		$	202,120		5.6	%
Outpatient rehabilitation	45,873			48,315			5.3		45,873			48,315			5.3
Other(2)	(31,648		)	(31,092		)	1.8		(31,648		)	(31,092		)	1.8
Total company	$	205,659		$	219,343		6.7	%	$	205,659		$	219,343		6.7	%
Adjusted EBITDA margins:(3)
Specialty hospitals	18.4		%	18.2		%			18.4		%	18.2		%
Outpatient rehabilitation	13.0			12.6					13.0			12.6
Other(2)	N/M			N/M					N/M			N/M
Total company	14.8		%	14.7		%			14.8		%	14.7		%
Total assets:
Specialty hospitals	$	2,202,994		$	2,184,743				$	2,202,994		$	2,184,743
Outpatient rehabilitation	471,175			437,591					471,175			437,591
Other(2)	113,853			157,303					112,264			156,080
Total company	$	2,788,022		$	2,779,637				$	2,786,433		$	2,778,414
Purchases of property and equipment:
Specialty hospitals	$	16,617		$	19,682				$	16,617		$	19,682
Outpatient rehabilitation	4,982			6,713					4,982			6,713
Other(2)	2,097			1,539					2,097			1,539
Total company	$	23,696		$	27,934				$	23,696		$	27,934

40

N/M — Not Meaningful.

(1)Cost of services includes salaries, wages and benefits, operating supplies, lease and rent expense and other operating costs.

(2)Other includes our general and administrative services and non-healthcare services.

(3)We define Adjusted EBITDA as net income before interest, income taxes, depreciation and amortization, stock compensation expense, equity in earnings (losses) of unconsolidated subsidiaries, gain (loss) on early retirement of debt and other income (expense). We believe that the presentation of Adjusted EBITDA is important to investors because Adjusted EBITDA is commonly used as an analytical indicator of performance by investors within the healthcare industry. Adjusted EBITDA is used by management to evaluate financial performance and determine resource allocation for each of our operating units. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles. Items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies.

Following is a reconciliation of net income to Adjusted EBITDA as utilized by us in reporting our segment performance:

	Select Medical Holdings  Corporation					Select Medical Corporation
	Three Months Ended June 30,					Three Months Ended June 30,
	2011		2012			2011		2012
	(in thousands)					(in thousands)
Net income	$	13,657	$	44,816		$	24,210	$	46,662
Income tax expense	10,915		27,651			16,597		28,646
Interest expense, net of interest income	25,185		23,798			19,583		20,957
Loss on early retirement of debt	31,018		—			20,385		—
Equity in (earnings) losses of unconsolidated subsidiaries	251		(2,752		)	251		(2,752		)
Stock compensation expense:
Included in general and administrative	478		817			478		817
Included in cost of services	422		521			422		521
Depreciation and amortization	17,999		15,428			17,999		15,428
Adjusted EBITDA	$	99,925	$	110,279		$	99,925	$	110,279

	Select Medical Holdings  Corporation					Select Medical Corporation
	Six Months Ended June 30,					Six Months Ended June 30,
	2011		2012			2011		2012
	(in thousands)					(in thousands)
Net income	$	49,044	$	87,388		$	64,149	$	90,971
Income tax expense	37,479		55,226			45,611		57,156
Interest expense, net of interest income	50,793		47,720			38,189		42,207
Loss on early retirement of debt	31,018		—			20,385		—
Equity in (earnings) losses of unconsolidated subsidiaries	324		(5,217		)	324		(5,217		)
Stock compensation expense:
Included in general and administrative	948		1,589			948		1,589
Included in cost of services	832		1,010			832		1,010
Depreciation and amortization	35,221		31,627			35,221		31,627
Adjusted EBITDA	$	205,659	$	219,343		$	205,659	$	219,343

41

Three Months Ended June 30, 2012 Compared to Three Months Ended June 30, 2011

In the following discussion, we address the results of operations of Select and Holdings.  With the exception of loss on early retirement of debt, interest expense and income taxes, the results of operations of Holdings are identical to those of Select.  Therefore, the discussion related to net operating revenues, operating expenses, Adjusted EBITDA, income from operations, equity in earnings (losses) of unconsolidated subsidiaries and non-controlling interest is identical for Holdings and Select.

Net Operating Revenues

Our net operating revenues increased by 7.4% to $750.2 million for the three months ended June 30, 2012 compared to $698.7 million for the three months ended June 30, 2011.

Specialty Hospitals.  Our specialty hospital net operating revenues increased 7.1% to $557.1 million for the three months ended June 30, 2012 compared to $520.3 million for the three months ended June 30, 2011.  The growth in net operating revenue primarily resulted from increases in patient volumes, increases in non-Medicare rates and revenues that are generated from contracted labor services provided to the Baylor JV.  Our patient days increased 2.8% to 336,016 days for the three months ended June 30, 2012 compared to the three months ended June 30, 2011 resulting from equal increases in both Medicare and non-Medicare patient days.  Our specialty hospital occupancy increased to 71% for the three months ended June 30, 2012 compared to 70% for the three months ended June 30, 2011.  Our average net revenue per patient day was $1,554 for the three months ended June 30, 2012 compared to $1,505 for the three months ended June 30, 2011.  The increase in our net revenue per patient day was principally due to increases in our average non-Medicare net revenue per patient day, resulting principally from Medicaid bonus payments we received during the quarter.

Outpatient Rehabilitation.  Our outpatient rehabilitation net operating revenues increased 8.2% to $193.1 million for the three months ended June 30, 2012 compared to $178.5 million for the three months ended June 30, 2011.  The net operating revenues generated by our outpatient rehabilitation clinics for the three months ended June 30, 2012 increased 2.9% to $142.8 million for the three months ended June 30, 2012 compared to $138.7 million for the three months ended June 30, 2011.  The increase was related to volume growth in our owned outpatient clinics and revenues we generated from contracted labor services provided to the Baylor JV.  The number of patient visits in our owned outpatient rehabilitation clinics increased 2.0% for the three months ended June 30, 2012 to 1,166,550 visits compared to 1,143,854 visits for the three months ended June 30, 2011.  Net revenue per visit in our clinics was $102 for both the three months ended June 30, 2012 and 2011.  Our contract services business increased net operating revenues by 26.6% to $50.3 million for the three months ended June 30, 2012 compared to $39.8 million for the three months ended June 30, 2011, which primarily resulted from the addition of new contracts in the fourth quarter of 2011.

Operating Expenses

Our operating expenses include our cost of services, general and administrative expense and bad debt expense.  Our operating expenses increased 6.9% to $641.3 million for the three months ended June 30, 2012 compared to $599.7 million for the three months ended June 30, 2011.  As a percentage of our net operating revenues, our operating expenses were 85.5% for the three months ended June 30, 2012 compared to 85.8% for the three months ended June 30, 2011.  Our cost of services, a major component of which is labor expense, were $612.7 million or 81.7% of net operating revenue for the three months ended June 30, 2012 compared to $569.7 million or 81.5% of net operating revenue for the three months ended June 30, 2011.  The increase in cost of

42

services as a percentage of net operating revenue resulted primarily from increased relative labor costs in our outpatient rehabilitation segment.  This increase in relative labor costs for the three months ended June 30, 2012 resulted from increased labor costs associated with the Baylor JV services agreement,  increased staffing in our rehabilitation clinics, and lower productivity in our contract services business.  Facility rent expense, which is a component of cost of services, was $31.3 million for three months ended June 30, 2012 compared to $29.6 million for the three months ended June 30, 2011.  General and administrative expenses were 2.5% of net operating revenue or $18.6 million for the three months ended June 30, 2012 compared to 2.3% of net operating revenue or $16.1 million for the three months ended June 30, 2011.  The increase in our general and administrative expenses resulted from increased administrative costs principally related to executive compensation and the write-off of costs related to a withdrawn financing transaction.  Our bad debt expense was $10.0 million or 1.3% of net operating revenues for the three months ended June 30, 2012 compared to $13.9 million or 2.0% of net operating revenues for the three months ended June 30, 2011.  The decline in our bad debt expense was attributed to our favorable collections experience of accounts receivable in both our operating segments for the three months ended June 30, 2012 as compared to the three months ended June 30, 2011.

Adjusted EBITDA

Specialty Hospitals.  Our Adjusted EBITDA for our specialty hospitals increased 12.2% to $102.2 million for the three months ended June 30, 2012 compared to $91.1 million for the three months ended June 30, 2011.  Our Adjusted EBITDA margins for the segment increased to 18.3% for the three months ended June 30, 2012 from 17.5% for the three months ended June 30, 2011.  The increase in the Adjusted EBITDA for our specialty hospitals was primarily the result of operating improvements in the Regency hospitals we acquired in 2010, lower bad debt expense and the Medicaid bonus payments we received during the quarter.

Outpatient Rehabilitation.  Our Adjusted EBITDA for our outpatient rehabilitation segment increased 5.6% to $25.8 million for the three months ended June 30, 2012 compared to $24.5 million for the three months ended June 30, 2011.  Our Adjusted EBITDA margins for the segment decreased to 13.4% for the three months ended June 30, 2012 from 13.7% for the three months ended June 30, 2011.  The Adjusted EBITDA in our outpatient rehabilitation clinics increased by $0.8 million to $21.6 million and our Adjusted EBITDA margins increased to 15.1% from 15.0% for the three months ended June 30, 2012 compared to the three months ended June 30, 2011.  The increase in our Adjusted EBITDA in our rehabilitation clinics was principally due to increased volumes and a reduction of bad debt expense, offset in part by increases in labor costs. The Adjusted EBITDA in our contract services business increased by $0.6 million to $4.3 million and the Adjusted EBITDA margins declined to 8.5% from 9.2% for the three months ended June 30, 2012 compared to the three months ended June 30, 2011.  The decline in Adjusted EBITDA margins in our contract services business was principally due to increased relative labor costs associated with lower productivity related to new business.

Other.  The Adjusted EBITDA loss was $17.7 million for the three months ended June 30, 2012 compared to an Adjusted EBITDA loss of $15.6 million for the three months ended June 30, 2011 and is primarily related to higher general and administrative expenses, as described under “Operating Expenses.”

Income from Operations

For the three months ended June 30, 2012 we had income from operations of $93.5 million compared to $81.0 million for the three months ended June 30, 2011.  The increase in our income from operations resulted principally from increases in our operating performance of our specialty hospital segment, a reduction in bad debt expense and a reduction in depreciation and amortization expense, offset in part by an increase in general and administrative expenses.

43

Loss on Early Retirement of Debt

Select Medical Corporation.  On June 1, 2011 we refinanced our senior secured credit facility which now consists of an $850.0 million term loan facility and a $300.0 million revolving facility.  A portion of the proceeds from this transaction were used to repay $266.5 million of Select’s 7 5/8% senior subordinated notes.  We recognized a loss on early retirement of debt of $20.4 million for the three months ended June 30, 2011 which included the write-off of unamortized deferred financing costs and tender premiums.

Select Medical Holdings Corporation.  On June 1, 2011 we refinanced our senior secured credit facility which now consists of an $850.0 million term loan facility and a $300.0 million revolving facility.  A portion of the proceeds from this transaction were used to repurchase and retire $266.5 million of Select’s 7 5/8% senior subordinated notes and $150.0 million to repurchase and retire our 10% senior subordinated notes.  As a result of this debt repayment, we recognized a loss on early retirement of debt of $31.0 million for the three months ended June 30, 2011, which included the write-off of unamortized deferred financing costs, tender premiums and original issue discount.

Equity in Earnings (Losses) of Unconsolidated Subsidiaries

For the three months ended June 30, 2012 we had equity in earnings of unconsolidated subsidiaries of $2.8 million compared to equity in losses of unconsolidated subsidiaries of $0.3 million for the three months ended June 30, 2011.  The increase in our equity in earnings of unconsolidated subsidiaries resulted principally from an increase in the contribution from the Baylor JV.

Interest Expense

Select Medical Corporation.  Interest expense was $21.0 million for the three months ended June 30, 2012 compared to $19.7 million for the three months ended June 30, 2011.  The increase in interest expense resulted primarily from the refinancing of $150.0 million of Holdings’ debt, for which Select was not previously obligated, through indebtedness incurred by Select under the new senior secured credit facility on June 1, 2011.

Select Medical Holdings Corporation.  Interest expense was $23.8 million for the three months ended June 30, 2012 compared to $25.3 million for the three months ended June 30, 2011.  The decrease in interest expense resulted primarily from the lower interest rates on the portions of the debt that were refinanced on June 1, 2011 and reduced borrowings for the three months ended June 30, 2012 compared to the three months ended June 30, 2011.

Income Taxes

Select Medical Corporation. We recorded income tax expense of $28.6 million for the three months ended June 30, 2012. The expense represented an effective tax rate of 38.0%.  We recorded income tax expense of $16.6 million for the three months ended June 30, 2011. The expense represented an effective tax rate of 40.7%.  Select Medical Corporation is part of the consolidated federal tax return for Select Medical Holdings Corporation.  We allocate income taxes between Select and Holdings for purposes of financial statement presentation.  Because Holdings is a passive investment company incorporated in Delaware, it does not incur any state income tax expense or benefit on its specific income or loss and, as such, receives a tax allocation equal to the federal statutory rate of 35% on its specific income or loss.  Based upon the relative size of Holdings’ income or loss, this can cause the effective tax rate for Select to differ from the effective tax rate for the consolidated company.

44

Select Medical Holdings Corporation.  We recorded income tax expense of $27.7 million for the three months ended June 30, 2012. The expense represented an effective tax rate of 38.2%.  We recorded income tax expense of $10.9 million for the three months ended June 30, 2011. The expense represented an effective tax rate of 44.4%.  The decline in our effective tax rate is primarily a consequence of the 2011 rate having been impacted by a tax gain associated with a hospital exchange that occurred in 2011, a reduction in the provision for uncertain tax positions and a lower effective state tax rate.

Non-Controlling Interests

Non-controlling interests in consolidated earnings were $1.6 million for the three months ended June 30, 2012 and $1.9 million for the three months ended June 30, 2011.

Six Months Ended June 30, 2012 Compared to Six Months Ended June 30, 2011

In the following discussion, we address the results of operations of Select and Holdings.  With the exception of loss on early retirement of debt, interest expense, and income taxes, the results of operations of Holdings are identical to those of Select.  Therefore, the discussion related to net operating revenues, operating expenses, Adjusted EBITDA, income from operations, equity in earnings (losses) of unconsolidated subsidiaries and non-controlling interest is identical for Holdings and Select.

Net Operating Revenues

Our net operating revenues increased by 7.3% to $1,494.2 million for the six months ended June 30, 2012 compared to $1,391.9 million for the six months ended June 30, 2011.

Specialty Hospitals.  Our specialty hospital net operating revenues increased by 6.7% to $1,110.2 million for the six months ended June 30, 2012 compared to $1,040.2 million for the six months ended June 30, 2011.  The growth in net operating revenue primarily resulted from increases in Medicare patient volumes, increases in non-Medicare rates and revenues that are generated from contracted labor services provided to the Baylor JV.  Our patient days increased 2.8% to 679,037 days for the six months ended June 30, 2012 primarily as a result of an increase in Medicare patient days.  Our specialty hospital occupancy increased to 72% for the six months ended June 30, 2012 compared to 71% for the six months ended June 30, 2011.  Our average net revenue per patient day was $1,539 for the six months ended June 30, 2012 compared to $1,510 for the six months ended June 30, 2011.  The increase in our net revenue per patient day was principally due to increases in our average non-Medicare net revenue per patient day, resulting principally from Medicaid bonus payments we received during the six months ended June 30, 2012.

Outpatient Rehabilitation.  Our outpatient rehabilitation net operating revenues increased 9.2% to $383.9 million for the six months ended June 30, 2012 compared to $351.7 million for the six months ended June 30, 2011.  The net operating revenues generated by our outpatient rehabilitation clinics for the six months ended June 30, 2012 increased 4.0% to $283.6 million compared to $272.7 million for the six months ended June 30, 2011.  The increase was primarily related to revenues we generated from contracted labor services provided to the Baylor JV and volume growth in our owned outpatient clinics.  The number of patient visits in our owned outpatient rehabilitation clinics increased 1.6% for the six months ended June 30, 2012 to 2,318,759 visits compared to 2,282,554 visits for the six months ended June 30, 2011.  Net revenue per visit in our clinics was $103 for the six months ended June 30, 2012 compared to $102 for the six months ended June 30, 2011.  Our contract services business increased net operating revenues 27.1% to $100.4 million compared to $79.0 million for the six months ended June 30, 2011, which primarily resulted from the addition of new contracts in the fourth quarter of 2011.

45

Operating Expenses

Our operating expenses include our cost of services, general and administrative expense and bad debt expense.  Our operating expenses increased by 7.5% to $1,277.5 million for the six months ended June 30, 2012 compared to $1,188.1 million for the six months ended June 30, 2011.  As a percentage of our net operating revenues, our operating expenses were 85.5% for the six months ended June 30, 2012 compared to 85.4% for the six months ended June 30, 2011.  Our cost of services, a major component of which is labor expense, were $1,224.3 million or 81.9% of net operating revenue for the six months ended June 30, 2012 compared to $1,127.1 million or 81.0% of net operating revenue for the six months ended June 30, 2011.  The increase in cost of services as a percentage of net operating revenue resulted primarily from increased relative labor costs in both our specialty hospital and our outpatient rehabilitation segments.  Our specialty hospitals experienced an increase in relative labor costs due to the labor costs associated with the Baylor JV services agreement and increased staffing costs during six months ended June 30, 2012 compared to the six months ended June 30, 2011.  Our outpatient rehabilitation segment experienced an increase in relative labor costs associated with the Baylor JV services agreement and lower productivity in our contract services business.  Facility rent expense, which is a component of cost of services, was $61.7 million for the six months ended June 30, 2012 compared to $59.6 million for the six months ended June 30, 2011.  General and administrative expenses were 2.2% of net operating revenue or $32.8 million for the six months ended June 30, 2012 compared to 2.4% of net operating revenue or $32.7 million for the six months ended June 30, 2011.  This small increase in general and administrative expense resulted from the increases we experienced in the second quarter of 2012 and discussed above under “Three Months Ended June 30, 2012 compared to Three Months Ended June 30, 2012 — Operating Expenses” offset by the gain on the sale of a building that occurred during our first quarter ended March 31, 2012.  Our bad debt expense was $20.4 million or 1.4% of net operating revenues for the six months ended June 30, 2012 compared to $28.3 million or 2.0% for the six months ended June 30, 2011.  The decline in our bad debt expense was attributed to our favorable collections experience of accounts receivable in both our operating segments for the six months ended June 30, 2012 as compared to the six months ended June 30, 2011.

Adjusted EBITDA

Specialty Hospitals.   Our Adjusted EBITDA for our specialty hospitals increased by 5.6% to $202.1 million for the six months ended June 30, 2012 compared to $191.4 million for the six months ended June 30, 2011.  Our Adjusted EBITDA margins for the segment decreased to 18.2% for the six months ended June 30, 2012 from 18.4% for the six months ended June 30, 2011.  The increase in the Adjusted EBITDA for our specialty hospitals was primarily the result of increases in our net operating revenues discussed above under “Net Operating Revenues” and a reduction in bad debt expense discussed above under “Operating Expenses.”  The decrease in the Adjusted EBITDA margin is due to negative margin effect of the Baylor JV services agreement and higher relative labor costs in our hospitals.

Outpatient Rehabilitation.   Our Adjusted EBITDA for our outpatient rehabilitation segment increased 5.3% to $48.3 million for the six months ended June 30, 2012 compared to $45.9 million for the six months ended June 30, 2011.  Our Adjusted EBITDA margins decreased to 12.6% for the six months ended June 30, 2012 from 13.0% for the six months ended June 30, 2011.  The Adjusted EBITDA in our outpatient rehabilitation clinics increased by $1.4 million to $40.3 million for the six months ended June 30, 2012 compared to $38.9 million for the six months ended June 30, 2011.  Our Adjusted EBITDA margins for our outpatient rehabilitation clinics decreased to 14.2% for the six months ended June 30, 2012 from 14.3% for the six months ended June 30, 2011.  The decline in our Adjusted EBITDA margin in our rehabilitation clinics was principally due to increased relative labor costs associated with the Baylor JV services agreement.  The Adjusted EBITDA

46

in our contract services business increased by $1.0 million to $8.0 million for the six months ended June 30, 2012 compared to $7.0 million for the six months ended June 30, 2011.  The Adjusted EBITDA margins for our contract services business declined to 8.0% for the six months ended June 30, 2012 compared to 8.9% for the six months ended June 30, 2011.  The decline in Adjusted EBITDA margins was principally due to increased labor costs associated with new business and lower productivity resulting from regulatory changes that became effective on October 1, 2011.

Other.  The Adjusted EBITDA loss was $31.1 million for the six months ended June 30, 2012 compared to an Adjusted EBITDA loss of $31.6 million for the six months ended June 30, 2011.  The reduction in loss is primarily related to the recognition of a gain on the sale of a building that occurred during our first quarter ended March 31, 2012, offset by higher general and administrative costs in the six months ended June 30, 2012 compared to the six months ended June 30, 2011.

Income from Operations

For the six months ended June 30, 2012 we had income from operations of $185.1 million compared to $168.7 million for the six months ended June 30, 2011.  The increase in our income from operations resulted principally from increases in our operating performance of our specialty hospital segment, reductions in bad debt expense and a reduction of our depreciation and amortization expenses.

Loss on Early Retirement of Debt

Select Medical Corporation.  On June 1, 2011, we refinanced our senior secured credit facility which now consists of an $850.0 million term loan facility and a $300.0 million revolving facility.  A portion of the proceeds from this transaction were used to repay $266.5 million of Select’s 7 5/8% senior subordinated notes.  We recognized a loss on early retirement of debt of $20.4 million for the six months ended June 30, 2011 which included the write-off of unamortized deferred financing costs and tender premiums.

Select Medical Holdings Corporation.  On June 1, 2011, we refinanced our senior secured credit facility which now consists of an $850.0 million term loan facility and a $300.0 million revolving facility.  A portion of the proceeds from this transaction were used to repurchase and retire $266.5 million of Select’s 7 5/8% senior subordinated notes and $150.0 million to repurchase and retire our 10% senior subordinated notes.  As a result of this debt repayment, we recognized a loss on early retirement of debt of $31.0 million for the six months ended June 30, 2011, which included the write-off of unamortized deferred financing costs, tender premiums and original issue discount.

Equity in Earnings (Losses) of Unconsolidated Subsidiaries

For the six months ended June 30, 2012, we had equity in earnings of unconsolidated subsidiaries of $5.2 million compared to equity in losses of unconsolidated subsidiaries of $0.3 million for the six months ended June 30, 2011.  The increase in our equity in earnings of unconsolidated subsidiaries resulted principally from an increase in the contribution from the Baylor JV.

Interest Expense

Select Medical Corporation.  Interest expense was $42.2 million for the six months ended June 30, 2012 compared to $38.4 million for the six months ended June 30, 2011.  The increase in interest expense resulted primarily from the refinancing of $150.0 million of Holdings’ debt, for which Select was not previously obligated, through indebtedness incurred by Select under the new senior secured credit facility on June 1, 2011.

47

Select Medical Holdings Corporation.  Interest expense was $47.7 million for the six months ended June 30, 2012 compared to $51.0 million for the six months ended June 30, 2011.  The decrease in interest expense resulted primarily from the lower interest rates on the portions of the debt that were refinanced on June 1, 2011 and reduced borrowings for the six months ended June 30, 2012 compared to the six months ended June 30, 2011.

Income Taxes

Select Medical Corporation.  We recorded income tax expense of $57.2 million for the six months ended June 30, 2012. The expense represented an effective tax rate of 38.6%.  We recorded income tax expense of $45.6 million for the six months ended June 30, 2011. The expense represented an effective tax rate of 41.6%.  Select Medical Corporation is part of the consolidated federal tax return for Select Medical Holdings Corporation.  We allocate income taxes between Select and Holdings for purposes of financial statement presentation.  Because Holdings is a passive investment company incorporated in Delaware, it does not incur any state income tax expense or benefit on its specific income or loss and, as such, receives a tax allocation equal to the federal statutory rate of 35% on its specific income or loss.  Based upon the relative size of Holdings’ income or loss, this can cause the effective tax rate for Select to differ from the effective tax rate for the consolidated company.

Select Medical Holdings Corporation.  We recorded income tax expense of $55.2 million for the six months ended June 30, 2012. The expense represented an effective tax rate of 38.7%.  We recorded income tax expense of $37.5 million for the six months ended June 30, 2011. The expense represented an effective tax rate of 43.3%.  The decline in our effective tax rate is primarily a consequence of the 2011 rate having been impacted by a tax gain associated with a hospital exchange that occurred in 2011, a reduction in the provision for uncertain tax positions and a lower effective state tax rate.

Non-Controlling Interests

Non-controlling interests in consolidated earnings were $2.7 million for the six months ended June 30, 2012 and $3.7 million for the six months ended June 30, 2011.

48

Liquidity and Capital Resources

Cash Flows for the Six Months Ended June 30, 2012 and Six Months Ended June 30, 2011

	Select Medical Holdings Corporation						Select Medical Corporation
	Six Months Ended June 30,						Six MonthsEnded June 30,
	2011			2012			2011			2012
	(in thousands)						(in thousands)
Cash flows provided by operating activities	$	83,527		$	118,805		$	101,250		$	124,049
Cash flows used in investing activities	(27,410		)	(21,643		)	(27,410		)	(21,643		)
Cash flows used in financing activities	(46,898		)	(87,685		)	(64,621		)	(92,929		)
Net increase in cash and cash equivalents	9,219			9,477			9,219			9,477
Cash and cash equivalents at beginning of period	4,365			12,043			4,365			12,043
Cash and cash equivalents at end of period	$	13,584		$	21,520		$	13,584		$	21,520

Operating activities for Holdings provided $118.8 million and for Select provided $124.0 million of cash flows for the six months ended June 30, 2012; and for Holdings provided $83.5 million and for Select provided $101.3 million of cash flows for the six months ended June 30, 2011. The operating cash flows of Select exceeded the operating cash flows of Holdings by $5.2 million for the six months ended June 30, 2012 and by $17.7 million for the six months ended June 30, 2011.  The difference relates to interest payments on Holdings’ indebtedness.

Our days sales outstanding were 51 days at June 30, 2012 compared to 53 days at June 30, 2011 and 53 days at December 31, 2011.  The decrease in days sales outstanding between December 31, 2011 and June 30, 2012 is primarily related to the timing of the periodic interim payments we receive from Medicare for the services provided at our specialty hospitals.

Investing activities used $21.6 million of cash flow for the six months ended June 30, 2012.  The principal use of cash included $27.9 million related to the purchase of property and equipment and $10.0 million related primarily to an additional investment in the Baylor JV.  This use of cash was offset by $16.5 million in proceeds related to the sale of a building.  Investing activities used $27.4 million of cash flow for the six months ended June 30, 2011.  The principal use of cash included $23.7 million related to the purchase of property and equipment and $13.5 million related to the purchase of the Baylor JV partnership units and working capital advances, offset by proceeds from the sale of assets of $7.9 million which was primarily related to the sale of a building we acquired in connection with the acquisition of Regency and $2.0 million from acquisition activities that includes the resolution of the  Regency net working capital settlement with the seller.

Financing activities for Select used $92.9 million of cash flow for the six months ended June 30, 2012.  The primary uses of cash related to net payments under our senior secured credit facility of $44.3 million, dividends paid to Holdings to fund interest payments and stock repurchases of $52.0 million and distributions to non-controlling interests of $1.7 million.  These uses were offset by net borrowings of other debt of $0.8 million, proceeds of $0.5 million from the issuance of common stock and proceeds from bank overdrafts of $3.7 million.  Financing activities for Select used $64.6 million of cash flow for the six months ended June 30, 2011.  The primary use of cash related to dividends paid to Holdings of $171.0 million to fund interest payments and the repurchase of all $150.0 million principal amount of Holdings 10% senior subordinated notes, $18.6 million of

49

debt issuance costs and $2.3 million in distributions to non-controlling interests offset by net borrowings of debt of $124.9 million and $2.1 million in proceeds from bank overdrafts.

The difference in cash flows provided by financing activities of Holdings compared to Select of $5.2 million for the six months ended June 30, 2012 and $17.7 million for the six months ended June 30, 2011 related to dividends paid by Select to Holdings to service Holdings’ interest obligations related to indebtedness.

Capital Resources

Select Medical Corporation.  Select had net working capital of $105.3 million at June 30, 2012 compared to a net working capital of $97.3 million at December 31, 2011.

Select Medical Holdings Corporation.  Holdings had net working capital of $107.3 million at June 30, 2012 compared to a net working capital of $99.5 million at December 31, 2011.

At June 30, 2012, we had outstanding borrowings of $834.3 million (net of unamortized original issue discount of $7.2 million) under the term loan and no outstanding borrowings under the revolving loan portions of our senior secured credit facilities. Also, as of June 30, 2012, we had $265.8 million of availability under our revolving loan facility (after giving effect to $34.2 million of outstanding letters of credit).

The applicable margin percentage for borrowings under our term loan is (1) 2.75% for alternate base rate loans and (2) 3.75% for adjusted LIBO rate loans. The adjusted LIBO rate at no time shall be less than 1.75% when used in reference to borrowings under our term loan. The applicable margin percentage for borrowings under our revolving loan is subject to change based upon the ratio of Select’s leverage ratio (as defined in the credit agreement). The applicable margin percentage for revolving loans is currently (1) 2.50% for alternate base rate loans and (2) 3.50% for adjusted LIBO rate loans. The applicable margin percentage for revolving loans will decrease to (1) 2.25% for alternate base rate loans and (2) 3.25% for adjusted LIBO rate loans upon the delivery of our Form 10-Q to JP Morgan Chase Bank, N.A., as administrative agent to our senior secured credit facility.

Our senior secured credit facility requires Select to maintain certain leverage ratios (as defined in our senior secured credit facility). For the four consecutive fiscal quarters ended June 30, 2012, Select was required to maintain its leverage ratio (its ratio of total indebtedness to consolidated EBITDA) at less than 5.25 to 1.00. Select’s leverage ratio was 2.97 to 1.00 as of June 30, 2012.

Holdings has authorized a program to repurchase up to $250.0 million worth of shares of our common stock.  The program will remain in effect until March 31, 2013, unless extended by the board of directors. During the six months ended June 30, 2012, Holdings has repurchased 5,725,782 shares at a cost of $46.8 million and since the inception of the program has repurchased 22,490,389 shares under the program at a cost of $163.6 million, which includes related transaction costs. We anticipate funding this program through available operating cash flow and borrowings under our senior secured credit facility.

We may from time to time seek to retire or purchase our outstanding debt through cash purchases and/or exchanges for equity securities, in open market purchases, privately negotiated transactions, tender offers or otherwise.  Such repurchases or exchanges, if any, may be funded from operating cash flows or other sources and will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.  The amounts involved may be material.

50

We believe our internally generated cash flows and borrowing capacity under our senior secured credit facility will be sufficient to finance operations over the next twelve months.

As a result of the SCHIP Extension Act as amended by PPACA, which prohibits the establishment and classification of new LTCHs or satellites during the five calendar years commencing on December 29, 2007, we have stopped all new LTCH development.  However, we continue to evaluate opportunities to develop new joint venture relationships with significant health systems, and from time to time we may also develop new inpatient rehabilitation hospitals. We also intend to open new outpatient rehabilitation clinics in local areas that we currently serve where we can benefit from existing referral relationships and brand awareness to produce incremental growth.  In addition to our development activities, we may grow our network of specialty hospitals through opportunistic acquisitions.

Recent Accounting Pronouncements

In June 2011, the FASB issued ASU 2011-05, “Comprehensive Income (Topic 220) — Presentation of Comprehensive Income” (“Update 2011-05”) that improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income by eliminating the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. Update 2011-05 requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under either method, adjustments must be displayed for items that are reclassified from other comprehensive income (“OCI”) to net income, in both net income and OCI. Update 2011-05 does not change the current option for presenting components of OCI gross or net of the effect of income taxes, provided that such tax effects are presented in the statement in which OCI is presented or disclosed in the notes to the financial statements. Additionally, Update 2011-05 does not affect the calculation or reporting of earnings per share. Update 2011-05 was effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and is to be applied retrospectively. We adopted Update 2011-05 on January 1, 2012.  Update 2011-05 had no effect on our presentation of other comprehensive income for the three months ended June 30, 2011 and 2012 because we did not have any items of other comprehensive income during these periods.

51

ITEM 3.        QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Quantitative and Qualitative Disclosures About Market Risk

We are subject to interest rate risk in connection with our long-term indebtedness.  Our principal interest rate exposure relates to the loans outstanding under Select’s senior secured credit facility and Holdings’ senior floating rate notes. As of June 30, 2012, we had $841.5 million (excluding unamortized original issue discount) in term loans outstanding under our senior secured credit facility and $167.3 million in senior floating rate notes outstanding, which bear interest at variable rates. Each eighth point change in interest rates on the variable rate portion of our long-term indebtedness would result in a $1.3 million annual change in interest expense on our term loans.  However, because the variable interest rate for our $841.5 million in term loans is subject to an Adjusted LIBO Rate floor of 1.75% until the Adjusted LIBO Rate exceeds 1.75%, our interest rate on this indebtedness is effectively fixed at 5.50%.

ITEM 4.        CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered in this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures, including the accumulation and communication of disclosure to our principal executive officer and principal financial officer as appropriate to allow timely decisions regarding disclosure, are effective as of June 30, 2012 to provide reasonable assurance that material information required to be included in our periodic SEC reports is recorded, processed, summarized and reported within the time periods specified in the relevant SEC rules and forms.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) identified in connection with the evaluation required by Rule 13a-15(d) of the Securities Exchange Act of 1934 that occurred during the second quarter ended June 30, 2012 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system will be met.  In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events.  Because of these and other inherent limitations of control systems, there is only reasonable assurance that our controls will succeed in achieving their goals under all potential future conditions.

PART II         OTHER INFORMATION

ITEM 1.          LEGAL PROCEEDINGS

The Company is a party to various legal actions, proceedings and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of its business. The

52

Company cannot predict the ultimate outcome of pending litigation, proceedings and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines and other penalties. The Department of Justice, CMS or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company’s businesses in the future that may, either individually or in the aggregate, have a material adverse effect on the Company’s business, financial position, results of operations and liquidity.

To cover claims arising out of the operations of the Company’s specialty hospitals and outpatient rehabilitation facilities, the Company maintains professional malpractice liability insurance and general liability insurance, subject to self-insured retention of $2.0 million per medical incident for professional liability claims and $2.0 million per occurrence for general liability claims. The Company also maintains umbrella liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the Company’s other insurance policies. These insurance policies also do not generally cover punitive damages and are subject to various deductibles and policy limits. Significant legal actions, as well as the cost and possible lack of available insurance, could subject the Company to substantial uninsured liabilities. In the Company’s opinion, the outcome of these actions, individually or in the aggregate, will not have a material adverse effect on its financial position, results of operations, or cash flows.

Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act. Qui tam lawsuits typically remain under seal (hence, usually unknown to the defendant) for some time while the government decides whether or not to intervene on behalf of a private qui tam plaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the suits. The Company has been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.

During April 2012, the Company’s long term acute care hospital in Evansville, Indiana (“SSH - Evansville”) received two subpoenas from the Office of Attorney General for the State of Indiana. One subpoena demanded certain patient medical records of SSH - Evansville. The second subpoena demanded reports and documents related to SSH - Evansville for various periods beginning in 2006, including certain financial, statistical, billing and quality reports; certain policies and procedures, joint venture board meeting minutes, and documents related to certain complaints and internal investigations. SSH - Evansville subsequently received a Request for Information or Assistance from the Office of Inspector General of the U.S. Department of Health and Human Services (Indianapolis, Indiana Field Office) covering the period beginning in 2007 seeking substantially the same records demanded by the Indiana Attorney General’s Office, additional patient medical records of SSH - Evansville and additional documents and information of SSH - Evansville, including documents concerning SSH - Evansville’s relationships with its joint venture partner and seven other identified persons and entities. During May 2012, the Evansville (Indiana) Police Department executed a search warrant at SSH - Evansville purporting to seek evidence pertaining to the crime of theft. At the Company’s request, the Vanderburgh (Indiana) Superior Court ordered the release of the probable cause affidavit supporting that search warrant. According to the affidavit, confidential informants, some of whom are purportedly current or former employees of SSH-Evansville, alleged, among other things, that a physician on the medical staff at SSH-Evansville improperly manipulated patient diagnoses to raise the diagnosis related group (DRG) and lengths-of-stay to enhance reimbursement and, on one occasion, discontinued treatments to a patient based on financial motivation and without regard to the patient’s end of life instructions resulting in the patient’s death, and that a second physician on the medical staff at SSH-Evansville  performed bronchoscopes that were medically unnecessary and resulted in at least two patient deaths. The affidavit also makes allegations that imply that the Company may not have provided complete or accurate documents called for in the Indiana Attorney General’s Office subpoenas which were received during April 2012. In August 2012, the Company received a subpoena from the Office of Inspector General of the U.S. Department of Health and Human Services (Chicago Regional Office) demanding additional documents covering the period beginning in March 2007 relating to the Company and SSH - Evansville, including contracts with SSH - Evansville’s joint venture partner, contracts and other documents relating to financial relationships with physicians practicing at SSH - Evansville, records of payments to and hours worked by physicians practicing at SSH - Evansville, documents relating to actual or expected physician referrals and admissions to SSH - Evansville, documents relating to billing for services furnished by the Company’s LTCHs, such as government program guidance and staff training materials, information relating to case manager duties and responsibilities at the Company’s LTCHs, reports on patient admissions, discharges, DRG, length-of-stay and transfers at SSH - Evansville, and documents relating to criteria used by the Company or SSH - Evansville for patient admissions, discharges and eligibility for service. The Company has produced and will continue to

53

produce documents in response to, and intends to fully cooperate with, these governmental investigations. At this time, the Company is unable to predict the timing and outcome of this matter.

ITEM 1A.RISK FACTORS.

There have been no material changes from our risk factors as previously reported in our Annual Report on Form 10-K for the year ended December 31, 2011.

ITEM 2.          UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Purchases of Equity Securities by the Issuer

In November 2010, our board of directors authorized a stock repurchase program pursuant to which we may purchase up to $100.0 million worth of our common stock.  On August 3, 2011, our board of directors authorized an increase of $50.0 million in the capacity of our common stock repurchase program, from $100.0 million to $150.0 million and on February 22, 2012 increased the capacity by an additional $100.0 million to $250.0 million.  The other terms of the plan remain unchanged.  Stock repurchases under this program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as the Company deems appropriate.  The program will remain in effect until March 31, 2013, unless extended by our board of directors.  During the three months ended June 30, 2012, we purchased a total of 2,522,090 shares of our common stock at an average purchase price of $8.33.

The following table sets forth the monthly purchases made under this program during the three months ended June 30, 2012:

Period	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
April 1, 2012 to April 30, 2012	1,101,471	$	7.59	1,101,471	$	99,029,913
May 1, 2012 to May 31, 2012	961,631	$	8.76	961,631	$	90,582,480
June 1, 2012 to June 30, 2012	458,988	$	9.19	458,988	$	86,354,165
Second Quarter 2012	2,522,090	$	8.33	2,522,090	$	86,354,165

ITEM 3.          DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4.          MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.          OTHER INFORMATION

None.

54

ITEM 6.          EXHIBITS

The exhibits to this report are listed in the Exhibit Index appearing on page 56 hereof.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SELECT MEDICAL CORPORATION
	By:	/s/  Martin F. Jackson
		Martin F. Jackson
		Executive Vice President and Chief Financial Officer
		(Duly Authorized Officer)
	By:	/s/  Scott A. Romberger
		Scott A. Romberger
		Senior Vice President, Chief Accounting Officer and Controller
		(Principal Accounting Officer)
Dated: August 7, 2012
	SELECT MEDICAL HOLDINGS CORPORATION
	By:	/s/  Martin F. Jackson
		Martin F. Jackson
		Executive Vice President and Chief Financial Officer
		(Duly Authorized Officer)
	By:	/s/  Scott A. Romberger
		Scott A. Romberger
		Senior Vice President, Chief Accounting Officer and Controller
		(Principal Accounting Officer)
Dated: August 7, 2012

55

EXHIBIT INDEX

Exhibit	Description
31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Executive Vice President and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer, and Executive Vice President and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	The following financial information from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012 formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Statements of Operations for the three and six months ended June 30, 2012 and 2011, (ii) Consolidated Balance Sheets as of June 30, 2012 and December 31, 2011, (iii) Consolidated Statements of Cash Flows for the six months ended June 30, 2012 and 2011, (iv) Consolidated Statements of Changes in Equity and Income for the six months ended June 30, 2012 and (v) Notes to Consolidated Financial Statements.*

*  XBRL information is furnished and not filed herewith, is not part of a registration statement or prospectus for purposes of section 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

56

EX-31.1

EXHIBIT 31.1

SELECT MEDICAL HOLDINGS CORPORATION AND

SELECT MEDICAL CORPORATION

CERTIFICATIONS PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION

I, Robert A. Ortenzio, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Select Medical Holdings Corporation and Select Medical Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the

registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 7, 2012	/s/ Robert A. Ortenzio
	Robert A. Ortenzio
	Chief Executive Officer

EX-31.2

EXHIBIT 31.2

SELECT MEDICAL HOLDINGS CORPORATION AND

SELECT MEDICAL CORPORATION

CERTIFICATIONS PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION

I, Martin F. Jackson, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Select Medical Holdings Corporation and Select Medical Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the

registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 7, 2012	/s/ Martin F. Jackson
	Martin F. Jackson
	Executive Vice President and Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Select Medical Holdings Corporation and Select Medical Corporation (the “Company”) for the period ended June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Robert A. Ortenzio and Martin F. Jackson, Chief Executive Officer and Chief Financial Officer, respectively, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to our knowledge:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

August 7, 2012

/s/ Robert A. Ortenzio

Robert A. Ortenzio

Chief Executive Officer

/s/ Martin F. Jackson

Martin F. Jackson

Executive Vice President and Chief Financial Officer

XML

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 7 5/8% Senior Subordinated Notes (Details 3) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Condensed Consolidating Statement of Operations
Net operating revenues	$ 750,193	$ 698,749	$ 1,494,214	$ 1,391,935
Costs and expenses:
Cost of services	612,669	569,666	1,224,288	1,127,082
General and administrative	18,554	16,115	32,778	32,681
Bad debt expense	10,029	13,943	20,404	28,293
Depreciation and amortization	15,428	17,999	31,627	35,221
Total costs and expenses	656,680	617,723	1,309,097	1,223,277
Income from operations	93,513	81,026	185,117	168,658
Other income and expense:
Loss on early retirement of debt		(31,018)		(31,018)
Equity in earnings (losses) of unconsolidated subsidiaries	2,752	(251)	5,217	(324)
Interest income		111		167
Interest expense	(23,798)	(25,296)	(47,720)	(50,960)
Income before income taxes	72,467	24,572	142,614	86,523
Income tax expense (benefit)	27,651	10,915	55,226	37,479
Net income	44,816	13,657	87,388	49,044
Less: Net income attributable to non-controlling interests	1,644	1,938	2,674	3,653
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	43,172	11,719	84,714	45,391
Select Medical Corporation
Condensed Consolidating Statement of Operations
Net operating revenues	750,193	698,749	1,494,214	1,391,935
Costs and expenses:
Cost of services	612,669	569,666	1,224,288	1,127,082
General and administrative	18,554	16,115	32,778	32,681
Bad debt expense	10,029	13,943	20,404	28,293
Depreciation and amortization	15,428	17,999	31,627	35,221
Total costs and expenses	656,680	617,723	1,309,097	1,223,277
Income from operations	93,513	81,026	185,117	168,658
Other income and expense:
Loss on early retirement of debt		(20,385)		(20,385)
Equity in earnings (losses) of unconsolidated subsidiaries	2,752	(251)	5,217	(324)
Interest income		111		167
Interest expense	(20,957)	(19,694)	(42,207)	(38,356)
Income before income taxes	75,308	40,807	148,127	109,760
Income tax expense (benefit)	28,646	16,597	57,156	45,611
Net income	46,662	24,210	90,971	64,149
Less: Net income attributable to non-controlling interests	1,644	1,938	2,674	3,653
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	45,018	22,272	88,297	60,496
Select Medical Corporation | Select Medical Corporation (Parent Company Only)
Condensed Consolidating Statement of Operations
Net operating revenues	13	15	97	86
Costs and expenses:
Cost of services	521	194	1,010	832
General and administrative	19,345	16,039	33,455	32,494
Depreciation and amortization	718	654	1,423	1,300
Total costs and expenses	20,584	16,887	35,888	34,626
Income from operations	(20,571)	(16,872)	(35,791)	(34,540)
Other income and expense:
Intercompany interest and royalty fees	(763)	(1,000)	(1,556)	(1,995)
Intercompany management fees	27,755	44,391	57,129	67,863
Loss on early retirement of debt		(20,385)		(20,385)
Interest income		34		65
Interest expense	(13,173)	(9,011)	(26,147)	(16,376)
Income before income taxes	(6,752)	(2,843)	(6,365)	(5,368)
Income tax expense (benefit)	2,211	362	1,976	1,288
Equity in earnings of subsidiaries	53,981	25,477	96,638	67,152
Net income	45,018	22,272	88,297	60,496
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	45,018	22,272	88,297	60,496
Select Medical Corporation | Subsidiary Guarantors
Condensed Consolidating Statement of Operations
Net operating revenues	649,628	605,562	1,293,953	1,205,815
Costs and expenses:
Cost of services	527,479	493,059	1,052,944	974,281
General and administrative	(791)	76	(677)	187
Bad debt expense	8,832	11,908	17,674	24,909
Depreciation and amortization	12,410	15,099	25,580	29,455
Total costs and expenses	547,930	520,142	1,095,521	1,028,832
Income from operations	101,698	85,420	198,432	176,983
Other income and expense:
Intercompany interest and royalty fees	754	994	1,539	1,980
Intercompany management fees	(23,159)	(39,901)	(48,242)	(59,131)
Equity in earnings (losses) of unconsolidated subsidiaries	2,739	(260)	5,194	(348)
Interest income		77		101
Interest expense	(6,712)	(9,370)	(13,910)	(19,319)
Income before income taxes	75,320	36,960	143,013	100,266
Income tax expense (benefit)	26,377	16,224	54,904	44,044
Equity in earnings of subsidiaries	5,612	4,784	9,111	10,581
Net income	54,555	25,520	97,220	66,803
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	54,555	25,520	97,220	66,803
Select Medical Corporation | Non-Guarantor Subsidiaries
Condensed Consolidating Statement of Operations
Net operating revenues	100,552	93,172	200,164	186,034
Costs and expenses:
Cost of services	84,669	76,413	170,334	151,969
Bad debt expense	1,197	2,035	2,730	3,384
Depreciation and amortization	2,300	2,246	4,624	4,466
Total costs and expenses	88,166	80,694	177,688	159,819
Income from operations	12,386	12,478	22,476	26,215
Other income and expense:
Intercompany interest and royalty fees	9	6	17	15
Intercompany management fees	(4,596)	(4,490)	(8,887)	(8,732)
Equity in earnings (losses) of unconsolidated subsidiaries	13	9	23	24
Interest income				1
Interest expense	(1,072)	(1,313)	(2,150)	(2,661)
Income before income taxes	6,740	6,690	11,479	14,862
Income tax expense (benefit)	58	11	276	279
Net income	6,682	6,679	11,203	14,583
Less: Net income attributable to non-controlling interests	1,644	1,938	2,674	3,653
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	5,038	4,741	8,529	10,930
Select Medical Corporation | Eliminations
Other income and expense:
Equity in earnings of subsidiaries	(59,593)	(30,261)	(105,749)	(77,733)
Net income	(59,593)	(30,261)	(105,749)	(77,733)
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	$ (59,593)	$ (30,261)	$ (105,749)	$ (77,733)

XML

Restructuring Reserves (Details) (USD $) In Thousands, unless otherwise specified			6 Months Ended
	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2012 Lease Termination Costs	Dec. 31, 2007 Outpatient rehabilitation division of HealthSouth Corporation Workforce reductions and lease termination costs	Dec. 31, 2010 Regency Lease Termination Costs
Changes in restructuring activity
Balance at the beginning of the period	$ 3,038	$ 5,027	$ 5,027	$ 18,700	$ 4,300
Amounts paid in 2012			(845)
Accretion expense			157
Revision of estimate			(1,301)
Balance at the end of the period	$ 3,038	$ 5,027	$ 3,038	$ 18,700	$ 4,300

XML

Intangible Assets

6 Months Ended

Jun. 30, 2012

Intangible Assets

Intangible Assets

3.  Intangible Assets

The Company’s intangible assets consist of the following:

	As of June 30, 2012
	Gross Carrying Amount		Accumulated Amortization
	(in thousands)
Amortized intangible assets:
Non-compete agreements	$	25,909	$	(25,909	)
Indefinite-lived intangible assets:
Goodwill	$	1,631,461
Trademarks	57,709
Certificates of need	11,914
Accreditations	2,160
Total	$	1,703,244

The Company’s accreditations and trademarks have renewal terms. The costs to renew these intangibles are expensed as incurred. At June 30, 2012, the accreditations and trademarks have a weighted average time until next renewal of approximately 1.5 years and 8.0 years, respectively.

Amortization expense for the Company’s intangible assets with finite lives follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2012		2011		2012
	(in thousands)				(in thousands)
Amortization expense	$	327	$	85	$	653	$	340

Amortization expense for the Company’s intangible assets primarily relates to the amortization of the value associated with the non-compete agreement entered into in connection with the acquisition of the outpatient rehabilitation division of HealthSouth Corporation. The useful life of the outpatient rehabilitation division of HealthSouth Corporation’s non-compete was five years.

The changes in the carrying amount of goodwill for the Company’s reportable segments for the six months ended June 30, 2012 are as follows:

	Specialty Hospitals			Outpatient Rehabilitation		Total
	(in thousands)
Balance as of December 31, 2011	$	1,333,553		$	298,163	$	1,631,716
Other	(333		)	—		(333		)
Goodwill acquired during the period	—			78		78
Balance as of June 30, 2012	$	1,333,220		$	298,241	$	1,631,461

XML

Income per Common Share (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Numerator:
Net income attributable to Select Medical Holdings Corporation	$ 43,172	$ 11,719	$ 84,714	$ 45,391
Less: Earnings allocated to unvested restricted stockholders	707	125	1,338	486
Net income available to common stockholders	$ 42,465	$ 11,594	$ 83,376	$ 44,905
Denominator:
Weighted average shares - basic	138,456	152,603	139,941	152,720
Effect of dilutive securities: Stock options (in shares)	229	278	221	231
Weighted average shares - diluted	138,685	152,881	140,162	152,951
Income per common share
Basic income per common share (in dollars per share)	$ 0.31	$ 0.08	$ 0.60	$ 0.29
Diluted income per common share (in dollars per share)	$ 0.31	$ 0.08	$ 0.59	$ 0.29
Anti-dilutive securities excluded from computation of earnings per share
Stock options (in shares)	1,684	1,691	1,699	2,400

XML

Segment Information (Details 2) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Segment Information
Adjusted EBITDA	$ 110,279	$ 99,925	$ 219,343	$ 205,659
Depreciation and amortization	(15,428)	(17,999)	(31,627)	(35,221)
Income (loss) from operations	93,513	81,026	185,117	168,658
Loss on early retirement of debt		(31,018)		(31,018)
Equity in losses of unconsolidated subsidiaries	2,752	(251)	5,217	(324)
Income before income taxes	72,467	24,572	142,614	86,523
Select Medical Corporation
Segment Information
Depreciation and amortization	(15,428)	(17,999)	(31,627)	(35,221)
Income (loss) from operations	93,513	81,026	185,117	168,658
Loss on early retirement of debt		(20,385)		(20,385)
Equity in losses of unconsolidated subsidiaries	2,752	(251)	5,217	(324)
Interest expense, net	(20,957)	(19,583)	(42,207)	(38,189)
Income before income taxes	75,308	40,807	148,127	109,760
Select Medical Holdings Corporation
Segment Information
Income (loss) from operations	93,513	81,026	185,117	168,658
Loss on early retirement of debt		(31,018)		(31,018)
Equity in losses of unconsolidated subsidiaries	2,752	(251)	5,217	(324)
Interest expense, net	(23,798)	(25,185)	(47,720)	(50,793)
Income before income taxes	72,467	24,572	142,614	86,523
Specialty Hospitals
Segment Information
Adjusted EBITDA	102,166	91,081	202,120	191,434
Depreciation and amortization	(11,479)	(13,047)	(23,322)	(25,093)
Income (loss) from operations	90,687	78,034	178,798	166,341
Outpatient Rehabilitation
Segment Information
Adjusted EBITDA	25,837	24,467	48,315	45,873
Depreciation and amortization	(3,232)	(4,227)	(6,882)	(8,686)
Income (loss) from operations	22,605	20,240	41,433	37,187
All Other
Segment Information
Adjusted EBITDA	(17,724)	(15,623)	(31,092)	(31,648)
Depreciation and amortization	(717)	(725)	(1,423)	(1,442)
Stock compensation expense	(1,338)	(900)	(2,599)	(1,780)
Income (loss) from operations	$ (19,779)	$ (17,248)	$ (35,114)	$ (34,870)

XML

Commitments and Contingencies (Details) (USD $) In Millions, unless otherwise specified		1 Months Ended		6 Months Ended
	Jun. 30, 2012	May 31, 2012 Probable cause affidavit Minimum item	Apr. 30, 2012 SSH-Evansville Subpoena received from the Office of Attorney General in the State of Indiana item	Jun. 30, 2012 Professional liability claims	Jun. 30, 2012 General liability claims
Commitments and Contingencies
Liability insurance per medical incident or per occurrence				$ 2.0	$ 2.0
Number of subpoenas received from the Office of Attorney General in the State of Indiana			2
Number of identified persons and entities included in request for information or assistance			7
Number of patient deaths		2
Construction Commitments
Outstanding commitments under construction contracts	$ 9.3

XML

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 7 5/8% Senior Subordinated Notes (Details) (7 5/8% senior subordinated notes, Select)	Jun. 30, 2012	Dec. 31, 2011
7 5/8% senior subordinated notes | Select
Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 7 5/8% Senior Subordinated Notes
Interest rate of debt (as a percent)	7.625%	7.625%

XML

Accounting Policies

6 Months Ended

Jun. 30, 2012

Accounting Policies

Accounting Policies

2.Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Recent Accounting Pronouncements

In June 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2011-05, “Comprehensive Income (Topic 220) — Presentation of Comprehensive Income” (“Update 2011-05”) that improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income by eliminating the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. Update 2011-05 requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under either method, adjustments must be displayed for items that are reclassified from other comprehensive income (“OCI”) to net income, in both net income and OCI. Update 2011-05 does not change the current option for presenting components of OCI gross or net of the effect of income taxes, provided that such tax effects are presented in the statement in which OCI is presented or disclosed in the notes to the financial statements. Additionally, Update 2011-05 does not affect the calculation or reporting of earnings per share. Update 2011-05 was effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and is to be applied retrospectively. The Company adopted Update 2011-05 on January 1, 2012.  Update 2011-05 had no effect on the Company’s presentation of other comprehensive income for the three and six months ended June 30, 2011 and 2012 because the Company did not have any items of other comprehensive income during these periods.

XML

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 7 5/8% Senior Subordinated Notes (Details 2) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2011	Dec. 31, 2010
Current Assets:
Cash and cash equivalents	$ 21,520	$ 12,043	$ 13,584	$ 4,365
Accounts receivable, net	423,859	413,743
Current deferred tax asset	15,533	18,305
Prepaid income taxes	4,061	9,497
Other current assets	31,383	29,822
Total Current Assets	496,356	483,410
Property and equipment, net	492,781	510,028
Goodwill	1,631,461	1,631,716
Other identifiable intangibles	71,783	72,123
Assets held for sale	2,742	2,742
Other assets	84,514	72,128
Total Assets	2,779,637	2,772,147
Current Liabilities:
Bank overdrafts	20,348	16,609
Current portion of long-term debt and notes payable	11,785	10,848
Accounts payable	90,132	95,618
Accrued payroll	73,712	82,888
Accrued vacation	56,208	51,250
Accrued interest	26,945	15,096
Accrued restructuring	3,038	5,027
Accrued other	99,583	101,076
Due to third party payors	7,264	5,526
Total Current Liabilities	389,015	383,938
Long-term debt, net of current portion	1,342,134	1,385,950
Non-current deferred tax liability	82,911	82,028
Other non-current liabilities	68,649	64,905
Total Liabilities	1,882,709	1,916,821
Stockholders' Equity:
Common stock	140	145
Capital in excess of par	469,410	493,828
Retained earnings	393,961	328,882
Total Stockholders' Equity	863,511	822,855
Non-controlling interest	33,417	32,471
Total Equity	896,928	855,326
Total Liabilities and Equity	2,779,637	2,772,147
Select Medical Corporation
Current Assets:
Cash and cash equivalents	21,520	12,043	13,584	4,365
Accounts receivable, net	423,859	413,743
Current deferred tax asset	15,533	18,305
Prepaid income taxes	4,061	9,497
Other current assets	31,383	29,822
Total Current Assets	496,356	483,410
Property and equipment, net	492,781	510,028
Goodwill	1,631,461	1,631,716
Other identifiable intangibles	71,783	72,123
Assets held for sale	2,742	2,742
Other assets	83,291	70,719
Total Assets	2,778,414	2,770,738	2,786,433
Current Liabilities:
Bank overdrafts	20,348	16,609
Current portion of long-term debt and notes payable	11,785	10,848
Accounts payable	90,132	95,618
Accrued payroll	73,712	82,888
Accrued vacation	56,208	51,250
Accrued interest	23,746	11,980
Accrued restructuring	3,038	5,027
Accrued other	104,823	106,316
Due to third party payors	7,264	5,526
Total Current Liabilities	391,056	386,062
Long-term debt, net of current portion	1,174,834	1,218,650
Non-current deferred tax liability	82,911	82,028
Other non-current liabilities	68,649	64,905
Total Liabilities	1,717,450	1,751,645
Stockholders' Equity:
Common stock	0	0
Capital in excess of par	853,506	848,844
Retained earnings	174,041	137,778
Total Stockholders' Equity	1,027,547	986,622
Non-controlling interest	33,417	32,471
Total Equity	1,060,964	1,019,093
Total Liabilities and Equity	2,778,414	2,770,738
Select Medical Corporation | Select Medical Corporation (Parent Company Only)
Current Assets:
Cash and cash equivalents	18,100	11,427	10,135	149
Current deferred tax asset	8,774	11,415
Prepaid income taxes	4,061	9,497
Other current assets	7,654	6,340
Total Current Assets	38,589	38,679
Property and equipment, net	14,754	14,641
Investment in affiliates	2,861,419	2,751,776
Assets held for sale	2,742	2,742
Other assets	24,335	28,386
Total Assets	2,941,839	2,836,224
Current Liabilities:
Bank overdrafts	20,348	16,609
Current portion of long-term debt and notes payable	10,236	8,853
Accounts payable	6,679	7,353
Intercompany accounts	1,036,057	975,809
Accrued payroll	13	229
Accrued vacation	4,319	3,703
Accrued interest	22,920	11,843
Accrued other	45,069	47,829
Total Current Liabilities	1,145,641	1,072,228
Long-term debt, net of current portion	723,251	733,328
Non-current deferred tax liability	(3,960)	(2,509)
Other non-current liabilities	49,360	46,555
Total Liabilities	1,914,292	1,849,602
Stockholders' Equity:
Common stock	0	0
Capital in excess of par	853,506	848,844
Retained earnings	174,041	137,778
Total Stockholders' Equity	1,027,547	986,622
Total Equity	1,027,547	986,622
Total Liabilities and Equity	2,941,839	2,836,224
Select Medical Corporation | Subsidiary Guarantors
Current Assets:
Cash and cash equivalents	2,798		2,936	3,567
Accounts receivable, net	367,585	369,321
Current deferred tax asset	3,262	3,221
Other current assets	20,339	19,407
Total Current Assets	393,984	391,949
Property and equipment, net	422,031	440,736
Investment in affiliates	78,736	83,772
Goodwill	1,631,461	1,631,716
Other identifiable intangibles	71,783	72,123
Other assets	58,224	41,480
Total Assets	2,656,219	2,661,776
Current Liabilities:
Current portion of long-term debt and notes payable	370	390
Accounts payable	72,709	76,207
Intercompany accounts	(944,178)	(880,537)
Accrued payroll	73,528	82,518
Accrued vacation	44,964	41,305
Accrued interest	826	137
Accrued restructuring	3,038	5,027
Accrued other	52,856	51,086
Due to third party payors	4,106	13,633
Total Current Liabilities	(691,781)	(610,234)
Long-term debt, net of current portion	392,423	425,315
Non-current deferred tax liability	78,164	75,750
Other non-current liabilities	18,909	17,970
Total Liabilities	(202,285)	(91,199)
Stockholders' Equity:
Retained earnings	724,340	627,120
Subsidiary investment	2,134,164	2,125,855
Total Stockholders' Equity	2,858,504	2,752,975
Total Equity	2,858,504	2,752,975
Total Liabilities and Equity	2,656,219	2,661,776
Select Medical Corporation | Non-Guarantor Subsidiaries
Current Assets:
Cash and cash equivalents	622	616	513	649
Accounts receivable, net	56,274	44,422
Current deferred tax asset	3,497	3,669
Other current assets	3,390	4,075
Total Current Assets	63,783	52,782
Property and equipment, net	55,996	54,651
Other assets	732	853
Total Assets	120,511	108,286
Current Liabilities:
Current portion of long-term debt and notes payable	1,179	1,605
Accounts payable	10,744	12,058
Intercompany accounts	(91,879)	(95,272)
Accrued payroll	171	141
Accrued vacation	6,925	6,242
Accrued other	6,898	7,401
Due to third party payors	3,158	(8,107)
Total Current Liabilities	(62,804)	(75,932)
Long-term debt, net of current portion	59,160	60,007
Non-current deferred tax liability	8,707	8,787
Other non-current liabilities	380	380
Total Liabilities	5,443	(6,758)
Stockholders' Equity:
Retained earnings	22,366	23,154
Subsidiary investment	59,285	59,419
Total Stockholders' Equity	81,651	82,573
Non-controlling interest	33,417	32,471
Total Equity	115,068	115,044
Total Liabilities and Equity	120,511	108,286
Select Medical Corporation | Eliminations
Current Assets:
Investment in affiliates	(2,940,155)	(2,835,548)
Total Assets	(2,940,155)	(2,835,548)
Stockholders' Equity:
Retained earnings	(746,706)	(650,274)
Subsidiary investment	(2,193,449)	(2,185,274)
Total Stockholders' Equity	(2,940,155)	(2,835,548)
Total Equity	(2,940,155)	(2,835,548)
Total Liabilities and Equity	$ (2,940,155)	$ (2,835,548)

XML

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2011	Dec. 31, 2010
Current Assets:
Cash and cash equivalents	$ 21,520	$ 12,043	$ 13,584	$ 4,365
Accounts receivable, net of allowance for doubtful accounts of $47,469 and $44,783 in 2011 and 2012, respectively	423,859	413,743
Current deferred tax asset	15,533	18,305
Prepaid income taxes	4,061	9,497
Other current assets	31,383	29,822
Total Current Assets	496,356	483,410
Property and equipment, net	492,781	510,028
Goodwill	1,631,461	1,631,716
Other identifiable intangibles	71,783	72,123
Assets held for sale	2,742	2,742
Other assets	84,514	72,128
Total Assets	2,779,637	2,772,147
Current Liabilities:
Bank overdrafts	20,348	16,609
Current portion of long-term debt and notes payable	11,785	10,848
Accounts payable	90,132	95,618
Accrued payroll	73,712	82,888
Accrued vacation	56,208	51,250
Accrued interest	26,945	15,096
Accrued restructuring	3,038	5,027
Accrued other	99,583	101,076
Due to third party payors	7,264	5,526
Total Current Liabilities	389,015	383,938
Long-term debt, net of current portion	1,342,134	1,385,950
Non-current deferred tax liability	82,911	82,028
Other non-current liabilities	68,649	64,905
Total Liabilities	1,882,709	1,916,821
Stockholders' Equity:
Common stock	140	145
Capital in excess of par	469,410	493,828
Retained earnings	393,961	328,882
Total Stockholders' Equity	863,511	822,855
Non-controlling interest	33,417	32,471
Total Equity	896,928	855,326
Total Liabilities and Equity	2,779,637	2,772,147
Select
Current Assets:
Cash and cash equivalents	21,520	12,043	13,584	4,365
Accounts receivable, net of allowance for doubtful accounts of $47,469 and $44,783 in 2011 and 2012, respectively	423,859	413,743
Current deferred tax asset	15,533	18,305
Prepaid income taxes	4,061	9,497
Other current assets	31,383	29,822
Total Current Assets	496,356	483,410
Property and equipment, net	492,781	510,028
Goodwill	1,631,461	1,631,716
Other identifiable intangibles	71,783	72,123
Assets held for sale	2,742	2,742
Other assets	83,291	70,719
Total Assets	2,778,414	2,770,738	2,786,433
Current Liabilities:
Bank overdrafts	20,348	16,609
Current portion of long-term debt and notes payable	11,785	10,848
Accounts payable	90,132	95,618
Accrued payroll	73,712	82,888
Accrued vacation	56,208	51,250
Accrued interest	23,746	11,980
Accrued restructuring	3,038	5,027
Accrued other	104,823	106,316
Due to third party payors	7,264	5,526
Total Current Liabilities	391,056	386,062
Long-term debt, net of current portion	1,174,834	1,218,650
Non-current deferred tax liability	82,911	82,028
Other non-current liabilities	68,649	64,905
Total Liabilities	1,717,450	1,751,645
Stockholders' Equity:
Common stock	0	0
Capital in excess of par	853,506	848,844
Retained earnings	174,041	137,778
Total Stockholders' Equity	1,027,547	986,622
Non-controlling interest	33,417	32,471
Total Equity	1,060,964	1,019,093
Total Liabilities and Equity	$ 2,778,414	$ 2,770,738

XML

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Operating activities
Net income	$ 87,388	$ 49,044
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	31,627	35,221
Provision for bad debts	20,404	28,293
Loss on early retirement of debt		31,018
Gain from disposal or sale of assets	(3,604)	(5,201)
Non-cash stock compensation expense	2,599	1,780
Amortization of debt discount	622	962
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Accounts receivable	(30,520)	(81,240)
Other current assets	(1,612)	(1,511)
Other assets	(653)	2,724
Accounts payable	(5,486)	8,107
Due to third-party payors	1,738	(464)
Accrued expenses	6,423	6,775
Income and deferred taxes	9,879	8,019
Net cash provided by operating activities	118,805	83,527
Investing activities
Purchases of property and equipment	(27,934)	(23,696)
Proceeds from sale of assets	16,511	7,879
Investment in business	(10,014)	(13,514)
Acquisition of businesses, net of cash acquired	(206)	1,921
Net cash used in investing activities	(21,643)	(27,410)
Financing activities
Borrowings on revolving credit facilities	340,000	435,000
Payments on revolving credit facilities	(380,000)	(395,000)
Borrowings on 2011 credit facility term loan, net of discount		841,500
Payments on 2011 credit facility term loan	(4,250)
Payments on 2005 credit facility term loans, net of call premium		(484,633)
Repurchase of 10% senior subordinated notes		(150,000)
Repurchase of 7 5/8% senior subordinated notes, net of tender premium		(273,941)
Borrowings of other debt	5,835	5,496
Principal payments on other debt	(5,085)	(3,480)
Debt issuance costs		(18,556)
Repurchase of common stock	(46,790)	(3,285)
Proceeds from issuance of common stock	547	169
Proceeds from bank overdrafts	3,739	2,102
Distributions to non-controlling interests	(1,681)	(2,270)
Net cash used in financing activities	(87,685)	(46,898)
Net increase in cash and cash equivalents	9,477	9,219
Cash and cash equivalents at beginning of period	12,043	4,365
Cash and cash equivalents at end of period	21,520	13,584
Supplemental Cash Flow Information
Cash paid for interest	32,378	59,289
Cash paid for taxes	45,344	29,435
Select
Operating activities
Net income	90,971	64,149
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	31,627	35,221
Provision for bad debts	20,404	28,293
Loss on early retirement of debt		20,385
Gain from disposal or sale of assets	(3,604)	(5,201)
Non-cash stock compensation expense	2,599	1,780
Amortization of debt discount	622	103
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Accounts receivable	(30,520)	(81,240)
Other current assets	(1,612)	(1,511)
Other assets	(839)	2,469
Accounts payable	(5,486)	8,107
Due to third-party payors	1,738	(464)
Accrued expenses	6,340	13,008
Income and deferred taxes	11,809	16,151
Net cash provided by operating activities	124,049	101,250
Investing activities
Purchases of property and equipment	(27,934)	(23,696)
Proceeds from sale of assets	16,511	7,879
Investment in business	(10,014)	(13,514)
Acquisition of businesses, net of cash acquired	(206)	1,921
Net cash used in investing activities	(21,643)	(27,410)
Financing activities
Borrowings on revolving credit facilities	340,000	435,000
Payments on revolving credit facilities	(380,000)	(395,000)
Borrowings on 2011 credit facility term loan, net of discount		841,500
Payments on 2011 credit facility term loan	(4,250)
Payments on 2005 credit facility term loans, net of call premium		(484,633)
Repurchase of 10% senior subordinated notes	0	0
Repurchase of 7 5/8% senior subordinated notes, net of tender premium		(273,941)
Borrowings of other debt	5,835	5,496
Principal payments on other debt	(5,085)	(3,480)
Debt issuance costs		(18,556)
Dividends paid to Holdings	(52,034)	(171,008)
Repurchase of common stock	0	0
Proceeds from issuance of common stock	0	0
Equity investment by Holdings	547	169
Proceeds from bank overdrafts	3,739	2,102
Distributions to non-controlling interests	(1,681)	(2,270)
Net cash used in financing activities	(92,929)	(64,621)
Net increase in cash and cash equivalents	9,477	9,219
Cash and cash equivalents at beginning of period	12,043	4,365
Cash and cash equivalents at end of period	21,520	13,584
Supplemental Cash Flow Information
Cash paid for interest	27,136	41,572
Cash paid for taxes	$ 45,344	$ 29,435

XML

Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified			6 Months Ended		6 Months Ended
	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2012 Trademarks	Jun. 30, 2012 Certificates of need	Jun. 30, 2012 Accreditations	Jun. 30, 2012 Non-compete agreements
Amortized intangible assets:
Gross Carrying Amount						$ 25,909
Accumulated Amortization						(25,909)
Indefinite-lived intangible assets:
Gross Carrying Amount of Goodwill	1,631,461	1,631,716
Gross Carrying Amount	$ 1,703,244		$ 57,709	$ 11,914	$ 2,160
Weighted average time until next renewal			8 years		1 year 6 months

XML

Intangible Assets (Details 3) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012
Goodwill
Balance at the beginning of the period	$ 1,631,716
Other	(333)
Goodwill acquired during the period	78
Balance at the end of the period	1,631,461
Specialty Hospitals
Goodwill
Balance at the beginning of the period	1,333,553
Other	(333)
Balance at the end of the period	1,333,220
Outpatient Rehabilitation
Goodwill
Balance at the beginning of the period	298,163
Goodwill acquired during the period	78
Balance at the end of the period	$ 298,241

XML

Basis of Presentation

6 Months Ended

Jun. 30, 2012

Basis of Presentation

Basis of Presentation

1.Basis of Presentation

Select Medical Corporation (“Select”) was formed in December 1996 and commenced operations during February 1997 upon the completion of its first acquisition. Select Medical Holdings Corporation (“Holdings”) was formed in October 2004 for the purpose of affecting a leveraged buyout of Select, which was a publicly traded entity.  On February 24, 2005, Select merged with a subsidiary of Holdings, which resulted in Select becoming a wholly-owned subsidiary of Holdings (the “Merger”). On September 30, 2009 Holdings completed its initial public offering of common stock.  Generally accepted accounting principles (“GAAP”) require that any amounts recorded or incurred (such as goodwill and compensation expense) by the parent as a result of the Merger or for the benefit of the subsidiary be “pushed down” and recorded in Select’s consolidated financial statements. Holdings and Select and their subsidiaries are collectively referred to as the “Company.” The consolidated financial statements of Holdings include the accounts of its wholly-owned subsidiary Select. Holdings conducts substantially all of its business through Select and its subsidiaries.

The unaudited condensed consolidated financial statements of the Company as of June 30, 2012 and for the three and six month periods ended June 30, 2011 and 2012 have been prepared in accordance with GAAP.  In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods.  All significant intercompany transactions and balances have been eliminated.  The results of operations for the three and six months ended June 30, 2012 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2012.

Certain information and disclosures normally included in the notes to consolidated financial statements have been condensed or omitted consistent with the rules and regulations of the Securities and Exchange Commission (the “SEC”), although the Company believes the disclosure is adequate to make the information presented not misleading.  The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2011 contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 2, 2012.

XML

Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011
Accounts receivable, allowance for doubtful accounts (in dollars)	$ 44,783	$ 47,469
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	700,000,000	700,000,000
Common stock, shares issued	139,863,119	145,268,190
Common stock, shares outstanding	139,863,119	145,268,190
Select
Accounts receivable, allowance for doubtful accounts (in dollars)	$ 44,783	$ 47,469
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares issued	100	100
Common stock, shares outstanding	100	100

XML

Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2012

Intangible Assets

Schedule of intangible assets

	As of June 30, 2012
	Gross Carrying Amount		Accumulated Amortization
	(in thousands)
Amortized intangible assets:
Non-compete agreements	$	25,909	$	(25,909	)
Indefinite-lived intangible assets:
Goodwill	$	1,631,461
Trademarks	57,709
Certificates of need	11,914
Accreditations	2,160
Total	$	1,703,244

Schedule of amortization expenses for the Company's intangible assets with finite lives

	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2012		2011		2012
	(in thousands)				(in thousands)
Amortization expense	$	327	$	85	$	653	$	340

Schedule of changes in the carrying amount of goodwill for the company's reportable segments

	Specialty Hospitals			Outpatient Rehabilitation		Total
	(in thousands)
Balance as of December 31, 2011	$	1,333,553		$	298,163	$	1,631,716
Other	(333		)	—		(333		)
Goodwill acquired during the period	—			78		78
Balance as of June 30, 2012	$	1,333,220		$	298,241	$	1,631,461

XML

Document and Entity Information	6 Months Ended
	Jun. 30, 2012	Jul. 31, 2012
Document and Entity Information
Entity Registrant Name	SELECT MEDICAL HOLDINGS CORP
Entity Central Index Key	0001320414
Document Type	10-Q
Document Period End Date	Jun. 30, 2012
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		139,866,719
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q2

XML

Restructuring Reserves (Tables)

6 Months Ended

Jun. 30, 2012

Restructuring Reserves

Schedule of Company's restructuring activity

	Lease Termination Costs
	(in thousands)
Balance as of December 31, 2011	$	5,027
Amounts paid in 2012	(845		)
Accretion expense	157
Revision of estimate	(1,301		)
Balance as of June 30, 2012	$	3,038

XML

Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net operating revenues	$ 750,193	$ 698,749	$ 1,494,214	$ 1,391,935
Costs and expenses:
Cost of services	612,669	569,666	1,224,288	1,127,082
General and administrative	18,554	16,115	32,778	32,681
Bad debt expense	10,029	13,943	20,404	28,293
Depreciation and amortization	15,428	17,999	31,627	35,221
Total costs and expenses	656,680	617,723	1,309,097	1,223,277
Income from operations	93,513	81,026	185,117	168,658
Other income and expense:
Loss on early retirement of debt		(31,018)		(31,018)
Equity in earnings (losses) of unconsolidated subsidiaries	2,752	(251)	5,217	(324)
Interest income		111		167
Interest expense	(23,798)	(25,296)	(47,720)	(50,960)
Income before income taxes	72,467	24,572	142,614	86,523
Income tax expense	27,651	10,915	55,226	37,479
Net income	44,816	13,657	87,388	49,044
Less: Net income attributable to non-controlling interests	1,644	1,938	2,674	3,653
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	43,172	11,719	84,714	45,391
Income per common share:
Basic (in dollars per share)	$ 0.31	$ 0.08	$ 0.60	$ 0.29
Diluted (in dollars per share)	$ 0.31	$ 0.08	$ 0.59	$ 0.29
Select
Net operating revenues	750,193	698,749	1,494,214	1,391,935
Costs and expenses:
Cost of services	612,669	569,666	1,224,288	1,127,082
General and administrative	18,554	16,115	32,778	32,681
Bad debt expense	10,029	13,943	20,404	28,293
Depreciation and amortization	15,428	17,999	31,627	35,221
Total costs and expenses	656,680	617,723	1,309,097	1,223,277
Income from operations	93,513	81,026	185,117	168,658
Other income and expense:
Loss on early retirement of debt		(20,385)		(20,385)
Equity in earnings (losses) of unconsolidated subsidiaries	2,752	(251)	5,217	(324)
Interest income		111		167
Interest expense	(20,957)	(19,694)	(42,207)	(38,356)
Income before income taxes	75,308	40,807	148,127	109,760
Income tax expense	28,646	16,597	57,156	45,611
Net income	46,662	24,210	90,971	64,149
Less: Net income attributable to non-controlling interests	1,644	1,938	2,674	3,653
Net income attributable to Select Medical Holdings Corporation and Select Medical Corporation	$ 45,018	$ 22,272	$ 88,297	$ 60,496

XML

Segment Information

6 Months Ended

Jun. 30, 2012

Segment Information

Segment Information

6.  Segment Information

The Company’s reportable segments consist of (i) specialty hospitals and (ii) outpatient rehabilitation. All other represents amounts associated with corporate activities and non-healthcare related services. The outpatient rehabilitation reportable segment has two operating segments: outpatient rehabilitation clinics and contract therapy. These operating segments are aggregated for reporting purposes as they have common economic characteristics and provide a similar service to a similar patient base. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. The Company evaluates performance of the segments based on Adjusted EBITDA. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, equity in earnings (losses) of unconsolidated subsidiaries and other income (expense).

The following tables summarize selected financial data for the Company’s reportable segments for the three and six months ended June 30, 2011 and 2012.  The segment results of Holdings are identical to those of Select with the exception of total assets:

	Three Months Ended June 30, 2011
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	520,261	$	178,473	$	15		$	698,749
Adjusted EBITDA	91,081		24,467		(15,623		)	99,925
Total assets:
Select Medical Corporation	2,202,994		471,175		112,264			2,786,433
Select Medical Holdings Corporation	2,202,994		471,175		113,853			2,788,022
Capital expenditures	6,130		2,801		1,845			10,776
	Three Months Ended June 30, 2012
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	557,130	$	193,050	$	13		$	750,193
Adjusted EBITDA	102,166		25,837		(17,724		)	110,279
Total assets:
Select Medical Corporation	2,184,743		437,591		156,080			2,778,414
Select Medical Holdings Corporation	2,184,743		437,591		157,303			2,779,637
Capital expenditures	12,631		2,922		630			16,183

	Six Months Ended June 30, 2011
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	1,040,185	$	351,664	$	86		$	1,391,935
Adjusted EBITDA	191,434		45,873		(31,648		)	205,659
Total assets:
Select Medical Corporation	2,202,994		471,175		112,264			2,786,433
Select Medical Holdings Corporation	2,202,994		471,175		113,853			2,788,022
Capital expenditures	16,617		4,982		2,097			23,696

	Six Months Ended June 30, 2012
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	1,110,168	$	383,949	$	97		$	1,494,214
Adjusted EBITDA	202,120		48,315		(31,092		)	219,343
Total assets:
Select Medical Corporation	2,184,743		437,591		156,080			2,778,414
Select Medical Holdings Corporation	2,184,743		437,591		157,303			2,779,637
Capital expenditures	19,682		6,713		1,539			27,934

A reconciliation of Adjusted EBITDA to income before income taxes is as follows:

	Three Months Ended June 30, 2011
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	91,081			$	24,467			$		(15,623	)
Depreciation and amortization	(13,047			)	(4,227			)	(725			)
Stock compensation expense	—				—				(900			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		78,034		$		20,240		$	(17,248		)	$	81,026		$	81,026
Loss on early retirement of debt													(31,018		)	(20,385		)
Equity in losses of unconsolidated subsidiaries													(251		)	(251		)
Interest expense, net													(25,185		)	(19,583		)
Income before income taxes													$	24,572		$	40,807

	Three Months Ended June 30, 2012
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	102,166			$	25,837			$		(17,724	)
Depreciation and amortization	(11,479			)	(3,232			)	(717			)
Stock compensation expense	—				—				(1,338			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		90,687		$		22,605		$	(19,779		)	$	93,513		$	93,513
Equity in earnings of unconsolidated subsidiaries													2,752			2,752
Interest expense, net													(23,798		)	(20,957		)
Income before income taxes													$	72,467		$	75,308

	Six Months Ended June 30, 2011
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	191,434			$	45,873			$		(31,648	)
Depreciation and amortization	(25,093			)	(8,686			)	(1,442			)
Stock compensation expense	—				—				(1,780			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		166,341		$		37,187		$	(34,870		)	$	168,658		$	168,658
Loss on early retirement of debt													(31,018		)	(20,385		)
Equity in losses of unconsolidated subsidiaries													(324		)	(324		)
Interest expense, net													(50,793		)	(38,189		)
Income before income taxes													$	86,523		$	109,760

	Six Months Ended June 30, 2012
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	202,120			$	48,315			$		(31,092	)
Depreciation and amortization	(23,322			)	(6,882			)	(1,423			)
Stock compensation expense	—				—				(2,599			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		178,798		$		41,433		$	(35,114		)	$	185,117		$	185,117
Equity in earnings of unconsolidated subsidiaries													5,217			5,217
Interest expense, net													(47,720		)	(42,207		)
Income before income taxes													$	142,614		$	148,127

XML

Fair Value

6 Months Ended

Jun. 30, 2012

Fair Value

Fair Value

5.  Fair Value

Financial instruments include cash and cash equivalents, notes payable and long-term debt.  The carrying amount of cash and cash equivalents approximates fair value because of the short-term maturity of these instruments.

The carrying value of Select’s senior secured credit facility was $878.0 million and $834.3 million at December 31, 2011 and June 30, 2012, respectively.  The fair value of Select’s senior secured credit facility was $823.3 million and $815.6 million at December 31, 2011 and June 30, 2012, respectively.  The fair value of Select’s senior secured credit facility was based on quoted market prices for this debt in the syndicated loan market.

The carrying value of Select’s 7 5/8% senior subordinated notes was $345.0 million at both December 31, 2011 and June 30, 2012.  The fair value of Select’s 7 5/8% senior subordinated notes was $326.4 million and $346.3 million at December 31, 2011 and June 30, 2012, respectively.  The fair value of this registered debt was based on quoted market prices.

The carrying value of Holdings’ senior floating rate notes was $167.3 million at both December 31, 2011 and June 30, 2012.  The fair value of Holdings’ senior floating rate notes was $143.9 million and $160.6 million at December 31, 2011 and June 30, 2012, respectively.  The fair value of this registered debt was based on quoted market prices.

The Company considers the inputs in the valuation process of its debt instruments to be Level 2 in the fair value hierarchy.  Level 2 in the fair value hierarchy is defined as inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly.  These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

XML

Intangible Assets (Details 2) (Non-compete agreements, Outpatient rehabilitation division of HealthSouth Corporation, USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Non-compete agreements | Outpatient rehabilitation division of HealthSouth Corporation
Finite-lived intangible assets
Amortization expense	$ 85	$ 327	$ 340	$ 653
Useful life			5 years

XML

Segment Information (Tables)

6 Months Ended

Jun. 30, 2012

Segment Information

Schedule of selected financial data for the Company's reportable segments

	Three Months Ended June 30, 2011
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	520,261	$	178,473	$	15		$	698,749
Adjusted EBITDA	91,081		24,467		(15,623		)	99,925
Total assets:
Select Medical Corporation	2,202,994		471,175		112,264			2,786,433
Select Medical Holdings Corporation	2,202,994		471,175		113,853			2,788,022
Capital expenditures	6,130		2,801		1,845			10,776
	Three Months Ended June 30, 2012
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	557,130	$	193,050	$	13		$	750,193
Adjusted EBITDA	102,166		25,837		(17,724		)	110,279
Total assets:
Select Medical Corporation	2,184,743		437,591		156,080			2,778,414
Select Medical Holdings Corporation	2,184,743		437,591		157,303			2,779,637
Capital expenditures	12,631		2,922		630			16,183

	Six Months Ended June 30, 2011
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	1,040,185	$	351,664	$	86		$	1,391,935
Adjusted EBITDA	191,434		45,873		(31,648		)	205,659
Total assets:
Select Medical Corporation	2,202,994		471,175		112,264			2,786,433
Select Medical Holdings Corporation	2,202,994		471,175		113,853			2,788,022
Capital expenditures	16,617		4,982		2,097			23,696

	Six Months Ended June 30, 2012
	Specialty Hospitals		Outpatient Rehabilitation		All Other			Total
	(in thousands)
Net operating revenue	$	1,110,168	$	383,949	$	97		$	1,494,214
Adjusted EBITDA	202,120		48,315		(31,092		)	219,343
Total assets:
Select Medical Corporation	2,184,743		437,591		156,080			2,778,414
Select Medical Holdings Corporation	2,184,743		437,591		157,303			2,779,637
Capital expenditures	19,682		6,713		1,539			27,934

Schedule of reconciliation of Adjusted EBITDA to income before income taxes

	Three Months Ended June 30, 2011
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	91,081			$	24,467			$		(15,623	)
Depreciation and amortization	(13,047			)	(4,227			)	(725			)
Stock compensation expense	—				—				(900			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		78,034		$		20,240		$	(17,248		)	$	81,026		$	81,026
Loss on early retirement of debt													(31,018		)	(20,385		)
Equity in losses of unconsolidated subsidiaries													(251		)	(251		)
Interest expense, net													(25,185		)	(19,583		)
Income before income taxes													$	24,572		$	40,807

	Three Months Ended June 30, 2012
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	102,166			$	25,837			$		(17,724	)
Depreciation and amortization	(11,479			)	(3,232			)	(717			)
Stock compensation expense	—				—				(1,338			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		90,687		$		22,605		$	(19,779		)	$	93,513		$	93,513
Equity in earnings of unconsolidated subsidiaries													2,752			2,752
Interest expense, net													(23,798		)	(20,957		)
Income before income taxes													$	72,467		$	75,308

	Six Months Ended June 30, 2011
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	191,434			$	45,873			$		(31,648	)
Depreciation and amortization	(25,093			)	(8,686			)	(1,442			)
Stock compensation expense	—				—				(1,780			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		166,341		$		37,187		$	(34,870		)	$	168,658		$	168,658
Loss on early retirement of debt													(31,018		)	(20,385		)
Equity in losses of unconsolidated subsidiaries													(324		)	(324		)
Interest expense, net													(50,793		)	(38,189		)
Income before income taxes													$	86,523		$	109,760

	Six Months Ended June 30, 2012
	(in thousands)
	Specialty Hospitals				Outpatient Rehabilitation				All Other
Adjusted EBITDA	$	202,120			$	48,315			$		(31,092	)
Depreciation and amortization	(23,322			)	(6,882			)	(1,423			)
Stock compensation expense	—				—				(2,599			)
													Select Medical Holdings Corporation			Select Medical Corporation
Income (loss) from operations	$		178,798		$		41,433		$	(35,114		)	$	185,117		$	185,117
Equity in earnings of unconsolidated subsidiaries													5,217			5,217
Interest expense, net													(47,720		)	(42,207		)
Income before income taxes													$	142,614		$	148,127

XML

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 7 5/8% Senior Subordinated Notes

6 Months Ended

Jun. 30, 2012

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 7 5/8% Senior Subordinated Notes

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 7 5/8% Senior Subordinated Notes

9.Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select’s 7 5/8% Senior Subordinated Notes

Select’s 7 5/8% senior subordinated notes are fully and unconditionally guaranteed, except for customary limitations, on a senior subordinated basis by all of Select’s wholly-owned subsidiaries (the “Subsidiary Guarantors”). Certain of Select’s subsidiaries did not guarantee the 7 5/8% senior subordinated notes (the “Non-Guarantor Subsidiaries”).

Select conducts a significant portion of its business through its subsidiaries. Presented below is condensed consolidating financial information for Select, the Subsidiary Guarantors and the Non-Guarantor Subsidiaries at December 31, 2011 and June 30, 2012 and for the three and six months ended June 30, 2011 and 2012.

The equity method has been used by Select with respect to investments in subsidiaries. The equity method has been used by Subsidiary Guarantors with respect to investments in Non-Guarantor Subsidiaries. Separate financial statements for Subsidiary Guarantors are not presented.

	Select Medical Corporation
	Condensed Consolidating Balance Sheet
	June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Assets
Current Assets:
Cash and cash equivalents	$	18,100		$	2,798		$	622		$	—		$	21,520
Accounts receivable, net	—			367,585			56,274			—			423,859
Current deferred tax asset	8,774			3,262			3,497			—			15,533
Prepaid income taxes	4,061			—			—			—			4,061
Other current assets	7,654			20,339			3,390			—			31,383
Total Current Assets	38,589			393,984			63,783			—			496,356
Property and equipment, net	14,754			422,031			55,996			—			492,781
Investment in affiliates	2,861,419			78,736			—			(2,940,155		)(a)(b)	—
Goodwill	—			1,631,461			—			—			1,631,461
Other identifiable intangibles	—			71,783			—			—			71,783
Assets held for sale	2,742			—			—			—			2,742
Other assets	24,335			58,224			732			—			83,291
Total Assets	$	2,941,839		$	2,656,219		$	120,511		$	(2,940,155	)	$	2,778,414
Liabilities and Equity
Current Liabilities:
Bank overdrafts	$	20,348		$	—		$	—		$	—		$	20,348
Current portion of long-term debt and notes payable	10,236			370			1,179			—			11,785
Accounts payable	6,679			72,709			10,744			—			90,132
Intercompany accounts	1,036,057			(944,178		)	(91,879		)	—			—
Accrued payroll	13			73,528			171			—			73,712
Accrued vacation	4,319			44,964			6,925			—			56,208
Accrued interest	22,920			826			—			—			23,746
Accrued restructuring	—			3,038			—			—			3,038
Accrued other	45,069			52,856			6,898			—			104,823
Due to third party payors	—			4,106			3,158			—			7,264
Total Current Liabilities	1,145,641			(691,781		)	(62,804		)	—			391,056
Long-term debt, net of current portion	723,251			392,423			59,160			—			1,174,834
Non-current deferred tax liability	(3,960		)	78,164			8,707			—			82,911
Other non-current liabilities	49,360			18,909			380			—			68,649
Total Liabilities	1,914,292			(202,285		)	5,443			—			1,717,450
Stockholder’s Equity:
Common stock	0			—			—			—			0
Capital in excess of par	853,506			—			—			—			853,506
Retained earnings	174,041			724,340			22,366			(746,706		)(b)	174,041
Subsidiary investment	—			2,134,164			59,285			(2,193,449		)(a)	—
Total Select Medical Corporation Stockholder’s Equity	1,027,547			2,858,504			81,651			(2,940,155		)	1,027,547
Non-controlling interest	—			—			33,417			—			33,417
Total Equity	1,027,547			2,858,504			115,068			(2,940,155		)	1,060,964
Total Liabilities and Equity	$	2,941,839		$	2,656,219		$	120,511		$	(2,940,155	)	$	2,778,414

(a)  Elimination of investments in consolidated subsidiaries.

(b)  Elimination of investments in consolidated subsidiaries’ earnings.

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Three Months Ended June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	13		$	649,628		$	100,552		$	—		$	750,193
Costs and expenses:
Cost of services	521			527,479			84,669			—			612,669
General and administrative	19,345			(791		)	—			—			18,554
Bad debt expense	—			8,832			1,197			—			10,029
Depreciation and amortization	718			12,410			2,300			—			15,428
Total costs and expenses	20,584			547,930			88,166			—			656,680
Income (loss) from operations	(20,571		)	101,698			12,386			—			93,513
Other income and expense:
Intercompany interest and royalty fees	(763		)	754			9			—			—
Intercompany management fees	27,755			(23,159		)	(4,596		)	—			—
Equity in earnings of unconsolidated subsidiaries	—			2,739			13			—			2,752
Interest expense	(13,173		)	(6,712		)	(1,072		)	—			(20,957		)
Income (loss) from operations before income taxes	(6,752		)	75,320			6,740			—			75,308
Income tax expense	2,211			26,377			58			—			28,646
Equity in earnings of subsidiaries	53,981			5,612			—			(59,593		)(a)	—
Net income	45,018			54,555			6,682			(59,593		)	46,662
Less: Net income attributable to non-controlling interests	—			—			1,644			—			1,644
Net income attributable to Select Medical Corporation	$	45,018		$	54,555		$	5,038		$	(59,593	)	$	45,018

(a) Elimination of equity in earnings of subsidiaries.

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Six Months Ended June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	97		$	1,293,953		$	200,164		$	—		$	1,494,214
Costs and expenses:
Cost of services	1,010			1,052,944			170,334			—			1,224,288
General and administrative	33,455			(677		)	—			—			32,778
Bad debt expense	—			17,674			2,730			—			20,404
Depreciation and amortization	1,423			25,580			4,624			—			31,627
Total costs and expenses	35,888			1,095,521			177,688			—			1,309,097
Income (loss) from operations	(35,791		)	198,432			22,476			—			185,117
Other income and expense:
Intercompany interest and royalty fees	(1,556		)	1,539			17			—			—
Intercompany management fees	57,129			(48,242		)	(8,887		)	—			—
Equity in earnings of unconsolidated subsidiaries	—			5,194			23			—			5,217
Interest expense	(26,147		)	(13,910		)	(2,150		)	—			(42,207		)
Income (loss) from operations before income taxes	(6,365		)	143,013			11,479			—			148,127
Income tax expense	1,976			54,904			276			—			57,156
Equity in earnings of subsidiaries	96,638			9,111			—			(105,749		)(a)	—
Net income	88,297			97,220			11,203			(105,749		)	90,971
Less: Net income attributable to non-controlling interests	—			—			2,674			—			2,674
Net income attributable to Select Medical Corporation	$	88,297		$	97,220		$	8,529		$	(105,749	)	$	88,297

(a) Elimination of equity in earnings of subsidiaries.

	Select Medical Corporation
	Condensed Consolidating Statement of Cash Flows
	For the Six Months Ended June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Operating activities
Net income	$	88,297		$	97,220		$	11,203		$	(105,749	)(a)	$	90,971
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,423			25,580			4,624			—			31,627
Provision for bad debts	—			17,674			2,730			—			20,404
Loss (gain) from disposal of assets	—			(3,606		)	2			—			(3,604		)
Non-cash stock compensation expense	2,599			—			—			—			2,599
Amortization of debt discount	622			—			—			—			622
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries	(96,638		)	(9,111		)	—			105,749		(a)	—
Intercompany	46,380			(40,086		)	(6,294		)	—			—
Accounts receivable	—			(15,938		)	(14,582		)	—			(30,520		)
Other current assets	(1,314		)	(983		)	685			—			(1,612		)
Other assets	4,051			(5,011		)	121			—			(839		)
Accounts payable	(674		)	(3,498		)	(1,314		)	—			(5,486		)
Due to third-party payors	—			(9,527		)	11,265			—			1,738
Accrued expenses	8,717			(2,587		)	210			—			6,340
Income and deferred taxes	11,809			—			—			—			11,809
Net cash provided by operating activities	65,272			50,127			8,650			—			124,049
Investing activities
Purchases of property and equipment	(1,536		)	(20,684		)	(5,714		)	—			(27,934		)
Proceeds from sale of assets	—			16,511			—			—			16,511
Investment in businesses	—			(10,014		)	—			—			(10,014		)
Acquisition of businesses, net of cash acquired	—			(206		)	—			—			(206		)
Net cash used in investing activities	(1,536		)	(14,393		)	(5,714		)	—			(21,643		)
Financing activities
Borrowings on revolving credit facility	340,000			—			—			—			340,000
Payments on revolving credit facility	(380,000		)	—			—			—			(380,000		)
Payments on 2011 credit facility term loan	(4,250		)	—			—			—			(4,250		)
Borrowings of other debt	5,557			—			278			—			5,835
Principal payments on other debt	(4,179		)	(220		)	(686		)	—			(5,085		)
Dividends paid to Holdings	(52,034		)	—			—			—			(52,034		)
Equity investment by Holdings	547			—			—			—			547
Proceeds from bank overdrafts	3,739			—			—			—			3,739
Intercompany debt reallocation	33,557			(32,716		)	(841		)	—			—
Distributions to non-controlling interests	—			—			(1,681		)	—			(1,681		)
Net cash used in financing activities	(57,063		)	(32,936		)	(2,930		)	—			(92,929		)
Net increase in cash and cash equivalents	6,673			2,798			6			—			9,477
Cash and cash equivalents at beginning of period	11,427			—			616			—			12,043
Cash and cash equivalents at end of period	$	18,100		$	2,798		$	622		$	—		$	21,520

(a)  Elimination of equity in earnings of consolidated subsidiaries.

	Select Medical Corporation
	Condensed Consolidating Balance Sheet
	December 31, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Assets
Current Assets:
Cash and cash equivalents	$	11,427		$	—		$	616		$	—		$	12,043
Accounts receivable, net	—			369,321			44,422			—			413,743
Current deferred tax asset	11,415			3,221			3,669			—			18,305
Prepaid income taxes	9,497			—			—			—			9,497
Other current assets	6,340			19,407			4,075			—			29,822
Total Current Assets	38,679			391,949			52,782			—			483,410
Property and equipment, net	14,641			440,736			54,651			—			510,028
Investment in affiliates	2,751,776			83,772			—			(2,835,548		)(a)(b)	—
Goodwill	—			1,631,716			—			—			1,631,716
Other identifiable intangibles	—			72,123			—			—			72,123
Assets held for sale	2,742			—			—			—			2,742
Other assets	28,386			41,480			853			—			70,719
Total Assets	$	2,836,224		$	2,661,776		$	108,286		$	(2,835,548	)	$	2,770,738
Liabilities and Equity
Current Liabilities:
Bank overdrafts	$	16,609		$	—		$	—		$	—		$	16,609
Current portion of long-term debt and notes payable	8,853			390			1,605			—			10,848
Accounts payable	7,353			76,207			12,058			—			95,618
Intercompany accounts	975,809			(880,537		)	(95,272		)	—			—
Accrued payroll	229			82,518			141			—			82,888
Accrued vacation	3,703			41,305			6,242			—			51,250
Accrued interest	11,843			137			—			—			11,980
Accrued restructuring	—			5,027			—			—			5,027
Accrued other	47,829			51,086			7,401			—			106,316
Due to third party payors	—			13,633			(8,107		)	—			5,526
Total Current Liabilities	1,072,228			(610,234		)	(75,932		)	—			386,062
Long-term debt, net of current portion	733,328			425,315			60,007			—			1,218,650
Non-current deferred tax liability	(2,509		)	75,750			8,787			—			82,028
Other non-current liabilities	46,555			17,970			380			—			64,905
Total Liabilities	1,849,602			(91,199		)	(6,758		)	—			1,751,645
Stockholder’s Equity:
Common stock	0			—			—			—			0
Capital in excess of par	848,844			—			—			—			848,844
Retained earnings	137,778			627,120			23,154			(650,274		)(b)	137,778
Subsidiary investment	—			2,125,855			59,419			(2,185,274		)(a)	—
Total Select Medical Corporation Stockholder’s Equity	986,622			2,752,975			82,573			(2,835,548		)	986,622
Non-controlling interest	—			—			32,471			—			32,471
Total Equity	986,622			2,752,975			115,044			(2,835,548		)	1,019,093
Total Liabilities and Equity	$	2,836,224		$	2,661,776		$	108,286		$	(2,835,548	)	$	2,770,738

(a)  Elimination of investments in consolidated subsidiaries.

(b)  Elimination of investments in consolidated subsidiaries’ earnings.

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Three Months Ended June 30, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	15		$	605,562		$	93,172		$	—		$	698,749
Costs and expenses:
Cost of services	194			493,059			76,413			—			569,666
General and administrative	16,039			76			—			—			16,115
Bad debt expense	—			11,908			2,035			—			13,943
Depreciation and amortization	654			15,099			2,246			—			17,999
Total costs and expenses	16,887			520,142			80,694			—			617,723
Income (loss) from operations	(16,872		)	85,420			12,478			—			81,026
Other income and expense:
Intercompany interest and royalty fees	(1,000		)	994			6			—			—
Intercompany management fees	44,391			(39,901		)	(4,490		)	—			—
Loss on early retirement of debt	(20,385		)	—			—			—			(20,385		)
Equity in earnings (losses) of unconsolidated subsidiaries	—			(260		)	9			—			(251		)
Interest income	34			77			—			—			111
Interest expense	(9,011		)	(9,370		)	(1,313		)	—			(19,694		)
Income (loss) from operations before income taxes	(2,843		)	36,960			6,690			—			40,807
Income tax expense	362			16,224			11			—			16,597
Equity in earnings of subsidiaries	25,477			4,784			—			(30,261		)(a)	—
Net income	22,272			25,520			6,679			(30,261		)	24,210
Less: Net income attributable to non-controlling interests	—			—			1,938			—			1,938
Net income attributable to Select Medical Corporation	$	22,272		$	25,520		$	4,741		$	(30,261	)	$	22,272

(a) Elimination of equity in earnings of subsidiaries.

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Six Months Ended June 30, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	86		$	1,205,815		$	186,034		$	—		$	1,391,935
Costs and expenses:
Cost of services	832			974,281			151,969			—			1,127,082
General and administrative	32,494			187			—			—			32,681
Bad debt expense	—			24,909			3,384			—			28,293
Depreciation and amortization	1,300			29,455			4,466			—			35,221
Total costs and expenses	34,626			1,028,832			159,819			—			1,223,277
Income (loss) from operations	(34,540		)	176,983			26,215			—			168,658
Other income and expense:
Intercompany interest and royalty fees	(1,995		)	1,980			15			—			—
Intercompany management fees	67,863			(59,131		)	(8,732		)	—			—
Loss on early retirement of debt	(20,385		)	—			—			—			(20,385		)
Equity in earnings (losses) of unconsolidated subsidiaries	—			(348		)	24			—			(324		)
Interest income	65			101			1			—			167
Interest expense	(16,376		)	(19,319		)	(2,661		)	—			(38,356		)
Income (loss) from operations before income taxes	(5,368		)	100,266			14,862			—			109,760
Income tax expense	1,288			44,044			279			—			45,611
Equity in earnings of subsidiaries	67,152			10,581			—			(77,733		)(a)	—
Net income	60,496			66,803			14,583			(77,733		)	64,149
Less: Net income attributable to non-controlling interests	—			—			3,653			—			3,653
Net income attributable to Select Medical Corporation	$	60,496		$	66,803		$	10,930		$	(77,733	)	$	60,496

(a) Elimination of equity in earnings of subsidiaries.

	Select Medical Corporation
	Condensed Consolidating Statement of Cash Flows
	For the Six Months Ended June 30, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Operating activities
Net income	$	60,496		$	66,803		$	14,583		$	(77,733	)(a)	$	64,149
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,300			29,455			4,466			—			35,221
Provision for bad debts	—			24,909			3,384			—			28,293
Loss on early retirement of debt	20,385			—			—			—			20,385
Loss (gain) from disposal of assets	10			(5,225		)	14			—			(5,201		)
Non-cash stock compensation expense	1,780			—			—			—			1,780
Amortization of debt discount	103			—			—			—			103
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries	(67,152		)	(10,581		)	—			77,733		(a)	—
Intercompany	53,735			(46,683		)	(7,052		)	—			—
Accounts receivable	—			(73,715		)	(7,525		)	—			(81,240		)
Other current assets	(2,096		)	245			340			—			(1,511		)
Other assets	(4,203		)	6,564			108			—			2,469
Accounts payable	2,758			4,531			818			—			8,107
Due to third-party payors	—			6,599			(7,063		)	—			(464		)
Accrued expenses	9,410			4,606			(1,008		)	—			13,008
Income and deferred taxes	16,151			—			—			—			16,151
Net cash provided by operating activities	92,677			7,508			1,065			—			101,250
Investing activities
Purchases of property and equipment	(1,178		)	(18,898		)	(3,620		)	—			(23,696		)
Investment in business	—			(13,514		)	—			—			(13,514		)
Acquisition of businesses, net of cash acquired	—			1,921			—			—			1,921
Proceeds from sale of assets	—			7,879			—			—			7,879
Net cash used in investing activities	(1,178		)	(22,612		)	(3,620		)	—			(27,410		)
Financing activities
Borrowings on revolving credit facilities	435,000			—			—			—			435,000
Payments on revolving credit facilities	(395,000		)	—			—			—			(395,000		)
Borrowings on 2011 credit facility term loan, net of discount	841,500			—			—			—			841,500
Payments on 2005 credit facility term loans, net of call premium	(484,633		)	—			—			—			(484,633		)
Repurchase of 7 5/8% senior subordinated notes, net of tender premium	(273,941		)	—			—			—			(273,941		)
Borrowings of other debt	5,496			—			—			—			5,496
Principal payments on other debt	(2,581		)	(899		)	—			—			(3,480		)
Debt issuance costs	(18,556		)	—			—			—			(18,556		)
Proceeds from bank overdrafts	2,102			—			—			—			2,102
Equity investment by Holdings	169			—			—			—			169
Dividends paid to Holdings	(171,008		)	—			—			—			(171,008		)
Intercompany debt reallocation	(20,061		)	15,372			4,689			—			—
Distributions to non-controlling interests	—			—			(2,270		)	—			(2,270		)
Net cash provided by (used in) financing activities	(81,513		)	14,473			2,419			—			(64,621		)
Net increase (decrease) in cash and cash equivalents	9,986			(631		)	(136		)	—			9,219
Cash and cash equivalents at beginning of period	149			3,567			649			—			4,365
Cash and cash equivalents at end of period	$	10,135		$	2,936		$	513		$	—		$	13,584

(a)  Elimination of equity in earnings of consolidated subsidiaries.

XML

Income per Common Share

6 Months Ended

Jun. 30, 2012

Income per Common Share

Income per Common Share

7.  Income per Common Share

The Company applies the two-class method for calculating and presenting income per common share. The two-class method is an earnings allocation formula that determines earnings per share for each class of stock participation rights in undistributed earnings. Effective January 1, 2009 the Financial Accounting Standards Board (“FASB”) clarified that share based payment awards that have not yet vested meet the definition of a participating security provided the right to receive the dividend is non-forfeitable and non-contingent. Participating securities are defined as securities that participate in dividends with common stock according to a predetermined formula. These participating securities should be included in the computation of basic earnings per share under the two class method. Based upon the clarification made by FASB, the Company concluded that its non-vested restricted stock awards meet the definition of a participating security and should be included in the Company’s computation of basic earnings per share.

The following table sets forth for the periods indicated the calculation of net income per share in the Company’s consolidated statement of operations and the differences between basic weighted average shares outstanding and diluted weighted average shares outstanding used to compute basic and diluted earnings per share, respectively:

	For the Three Months				For the Six Months
	Ended June 30,				Ended June, 30
	2011		2012		2011		2012
	(in thousands, except per share data)
Numerator:
Net income attributable to Select Medical Holdings Corporation	$	11,719	$	43,172	$	45,391	$	84,714
Less: Earnings allocated to unvested restricted stockholders	125		707		486		1,338
Net income available to common stockholders	$	11,594	$	42,465	$	44,905	$	83,376
Denominator:
Weighted average shares – basic	152,603		138,456		152,720		139,941
Effect of dilutive securities:
Stock options	278		229		231		221
Weighted average shares – diluted	152,881		138,685		152,951		140,162
Basic income per common share	$	0.08	$	0.31	$	0.29	$	0.60
Diluted income per common share	$	0.08	$	0.31	$	0.29	$	0.59

The following share amounts are shown here for informational and comparative purposes only since their inclusion would be anti-dilutive:

	For the Three Months Ended June 30,		For the Six Months Ended June 30,
	2011	2012	2011	2012
	(in thousands)
Stock options	1,691	1,684	2,400	1,699

XML

Commitments and Contingencies

6 Months Ended

Jun. 30, 2012

Commitments and Contingencies

Commitments and Contingencies

8. Commitments and Contingencies

Litigation

The Company is a party to various legal actions, proceedings and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of its business. The Company cannot predict the ultimate outcome of pending litigation, proceedings and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines and other penalties. The Department of Justice, Centers for Medicare & Medicaid Services (“CMS”) or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company’s businesses in the future that may, either individually or in the aggregate, have a material adverse effect on the Company’s business, financial position, results of operations and liquidity.

To address claims arising out of the operations of the Company’s specialty hospitals and outpatient rehabilitation facilities, the Company maintains professional malpractice liability insurance and general liability insurance, subject to self-insured retention of $2.0 million per medical incident for professional liability claims and $2.0 million per occurrence for general liability claims. The Company also maintains umbrella liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the Company’s other insurance policies. These insurance policies also do not generally cover punitive damages and are subject to various deductibles and policy limits. Significant legal actions, as well as the cost and possible lack of available insurance, could subject the Company to substantial uninsured liabilities. In the Company’s opinion, the outcome of these actions, individually or in the aggregate, will not have a material adverse effect on its financial position, results of operations, or cash flows.

Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act. Qui tam lawsuits typically remain under seal (hence, usually unknown to the defendant) for some time while the government decides whether or not to intervene on behalf of a private qui tam plaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the suits. The Company has been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.

During April 2012, the Company’s long term acute care hospital in Evansville, Indiana (“SSH - Evansville”) received two subpoenas from the Office of Attorney General for the State of Indiana. One subpoena demanded certain patient medical records of SSH - Evansville. The second subpoena demanded reports and documents related to SSH - Evansville for various periods beginning in 2006, including certain financial, statistical, billing and quality reports; certain policies and procedures, joint venture board meeting minutes, and documents related to certain complaints and internal investigations. SSH — Evansville subsequently received a Request for Information or Assistance from the Office of Inspector General of the U.S. Department of Health and Human Services (Indianapolis, Indiana Field Office) covering the period beginning in 2007 seeking substantially the same records demanded by the Indiana Attorney General’s Office, additional patient medical records of SSH - Evansville and additional documents and information of SSH - Evansville, including documents concerning SSH - Evansville’s relationships with its joint venture partner and seven other identified persons and entities. During May 2012, the Evansville (Indiana) Police Department executed a search warrant at SSH - Evansville purporting to seek evidence pertaining to the crime of theft. At the Company’s request, the Vanderburgh (Indiana) Superior Court ordered the release of the probable cause affidavit supporting that search warrant. According to the affidavit, confidential informants, some of whom are purportedly current or former employees of SSH-Evansville, alleged, among other things, that a physician on the medical staff at SSH-Evansville improperly manipulated patient diagnoses to raise the diagnosis related group (DRG) and lengths-of-stay to enhance reimbursement and, on one occasion, discontinued treatments to a patient based on financial motivation and without regard to the patient’s end of life instructions resulting in the patient’s death, and that a second physician on the medical staff at SSH-Evansville performed bronchoscopes that were medically unnecessary and resulted in at least two patient deaths. The affidavit also makes allegations that imply that the Company may not have provided complete or accurate documents called for in the Indiana Attorney General’s Office subpoenas which were received during April 2012. In August 2012, the Company received a subpoena from the Office of Inspector General of the U.S. Department of Health and Human Services (Chicago Regional Office) demanding additional documents covering the period beginning in March 2007 relating to the Company and SSH - Evansville, including contracts with SSH - Evansville’s joint venture partner, contracts and other documents relating to financial relationships with physicians practicing at SSH - Evansville, records of payments to and hours worked by physicians practicing at SSH - Evansville, documents relating to actual or expected physician referrals and admissions to SSH - Evansville, documents relating to billing for services furnished by the Company’s long term acute care hospitals (“LTCHs”), such as government program guidance and staff training materials, information relating to case manager duties and responsibilities at the Company’s LTCHs, reports on patient admissions, discharges, DRG, length-of-stay and transfers at SSH - Evansville, and documents relating to criteria used by the Company or SSH - Evansville for patient admissions, discharges and eligibility for service.  The Company has produced and will continue to produce documents in response to, and intends to fully cooperate with, these governmental investigations. At this time, the Company is unable to predict the timing and outcome of this matter.

Construction Commitments

At June 30, 2012, the Company had outstanding commitments under construction contracts related to new construction, improvements and renovations at the Company’s long term acute care properties and inpatient rehabilitation facilities totaling approximately $9.3 million.

XML

Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2012

Accounting Policies

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In June 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2011-05, “Comprehensive Income (Topic 220) — Presentation of Comprehensive Income” (“Update 2011-05”) that improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income by eliminating the option to present components of other comprehensive income as part of the statement of changes in stockholders’ equity. Update 2011-05 requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Under either method, adjustments must be displayed for items that are reclassified from other comprehensive income (“OCI”) to net income, in both net income and OCI. Update 2011-05 does not change the current option for presenting components of OCI gross or net of the effect of income taxes, provided that such tax effects are presented in the statement in which OCI is presented or disclosed in the notes to the financial statements. Additionally, Update 2011-05 does not affect the calculation or reporting of earnings per share. Update 2011-05 was effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 and is to be applied retrospectively. The Company adopted Update 2011-05 on January 1, 2012.  Update 2011-05 had no effect on the Company’s presentation of other comprehensive income for the three and six months ended June 30, 2011 and 2012 because the Company did not have any items of other comprehensive income during these periods.

XML

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 7 5/8% Senior Subordinated Notes (Details 4) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended				3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012 Select Medical Corporation	Jun. 30, 2011 Select Medical Corporation	Jun. 30, 2012 Select Medical Corporation	Jun. 30, 2011 Select Medical Corporation	Jun. 30, 2012 Select Medical Corporation 7 5/8% senior subordinated notes	Dec. 31, 2011 Select Medical Corporation 7 5/8% senior subordinated notes	Jun. 30, 2012 Select Medical Corporation Select Medical Corporation (Parent Company Only)	Jun. 30, 2011 Select Medical Corporation Select Medical Corporation (Parent Company Only)	Jun. 30, 2012 Select Medical Corporation Select Medical Corporation (Parent Company Only)	Jun. 30, 2011 Select Medical Corporation Select Medical Corporation (Parent Company Only)	Jun. 30, 2012 Select Medical Corporation Subsidiary Guarantors	Jun. 30, 2011 Select Medical Corporation Subsidiary Guarantors	Jun. 30, 2012 Select Medical Corporation Subsidiary Guarantors	Jun. 30, 2011 Select Medical Corporation Subsidiary Guarantors	Jun. 30, 2012 Select Medical Corporation Non-Guarantor Subsidiaries	Jun. 30, 2011 Select Medical Corporation Non-Guarantor Subsidiaries	Jun. 30, 2012 Select Medical Corporation Non-Guarantor Subsidiaries	Jun. 30, 2011 Select Medical Corporation Non-Guarantor Subsidiaries	Jun. 30, 2012 Select Medical Corporation Eliminations	Jun. 30, 2011 Select Medical Corporation Eliminations	Jun. 30, 2012 Select Medical Corporation Eliminations	Jun. 30, 2011 Select Medical Corporation Eliminations
Operating activities
Net income	$ 44,816	$ 13,657	$ 87,388	$ 49,044	$ 46,662	$ 24,210	$ 90,971	$ 64,149			$ 45,018	$ 22,272	$ 88,297	$ 60,496	$ 54,555	$ 25,520	$ 97,220	$ 66,803	$ 6,682	$ 6,679	$ 11,203	$ 14,583	$ (59,593)	$ (30,261)	$ (105,749)	$ (77,733)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,428	17,999	31,627	35,221	15,428	17,999	31,627	35,221			718	654	1,423	1,300	12,410	15,099	25,580	29,455	2,300	2,246	4,624	4,466
Provision for bad debts	10,029	13,943	20,404	28,293	10,029	13,943	20,404	28,293							8,832	11,908	17,674	24,909	1,197	2,035	2,730	3,384
Loss on early retirement of debt		31,018		31,018		20,385		20,385				20,385		20,385
Loss (gain) from disposal of assets			(3,604)	(5,201)			(3,604)	(5,201)						10			(3,606)	(5,225)			2	14
Non-cash stock compensation expense			2,599	1,780			2,599	1,780					2,599	1,780
Amortization of debt discount			622	962			622	103					622	103
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries											(53,981)	(25,477)	(96,638)	(67,152)	(5,612)	(4,784)	(9,111)	(10,581)					59,593	30,261	105,749	77,733
Intercompany													46,380	53,735			(40,086)	(46,683)			(6,294)	(7,052)
Accounts receivable			(30,520)	(81,240)			(30,520)	(81,240)									(15,938)	(73,715)			(14,582)	(7,525)
Other current assets			(1,612)	(1,511)			(1,612)	(1,511)					(1,314)	(2,096)			(983)	245			685	340
Other assets			(653)	2,724			(839)	2,469					4,051	(4,203)			(5,011)	6,564			121	108
Accounts payable			(5,486)	8,107			(5,486)	8,107					(674)	2,758			(3,498)	4,531			(1,314)	818
Due to third-party payors			1,738	(464)			1,738	(464)									(9,527)	6,599			11,265	(7,063)
Accrued expenses			6,423	6,775			6,340	13,008					8,717	9,410			(2,587)	4,606			210	(1,008)
Income and deferred taxes			9,879	8,019			11,809	16,151					11,809	16,151
Net cash provided by operating activities			118,805	83,527			124,049	101,250					65,272	92,677			50,127	7,508			8,650	1,065
Investing activities
Purchases of property and equipment	(16,183)	(10,776)	(27,934)	(23,696)			(27,934)	(23,696)					(1,536)	(1,178)			(20,684)	(18,898)			(5,714)	(3,620)
Investment in businesses			(10,014)	(13,514)			(10,014)	(13,514)									(10,014)	(13,514)
Acquisition of businesses, net of cash acquired			(206)	1,921			(206)	1,921									(206)	1,921
Proceeds from sale of assets			16,511	7,879			16,511	7,879									16,511	7,879
Net cash used in investing activities			(21,643)	(27,410)			(21,643)	(27,410)					(1,536)	(1,178)			(14,393)	(22,612)			(5,714)	(3,620)
Financing activities
Borrowings on revolving credit facilities			340,000	435,000			340,000	435,000					340,000	435,000
Payments on revolving credit facilities			(380,000)	(395,000)			(380,000)	(395,000)					(380,000)	(395,000)
Borrowings on 2011 credit facility term loan, net of discount				841,500				841,500						841,500
Payments on 2011 credit facility term loan			(4,250)				(4,250)						(4,250)
Payments on 2005 credit facility term loans, net of call premium				(484,633)				(484,633)						(484,633)
Repurchase of 7 5/8% senior subordinated notes, net of tender premium				(273,941)				(273,941)						(273,941)
Interest rate of debt (as a percent)									7.625%	7.625%
Borrowings of other debt			5,835	5,496			5,835	5,496					5,557	5,496							278
Principal payments on other debt			(5,085)	(3,480)			(5,085)	(3,480)					(4,179)	(2,581)			(220)	(899)			(686)
Debt issuance costs				(18,556)				(18,556)						(18,556)
Proceeds from bank overdrafts			3,739	2,102			3,739	2,102					3,739	2,102
Equity investment by Holdings							547	169					547	169
Dividends paid to Holdings							(52,034)	(171,008)					(52,034)	(171,008)
Intercompany debt reallocation													33,557	(20,061)			(32,716)	15,372			(841)	4,689
Distributions to non-controlling interests			(1,681)	(2,270)			(1,681)	(2,270)													(1,681)	(2,270)
Net cash used in financing activities			(87,685)	(46,898)			(92,929)	(64,621)					(57,063)	(81,513)			(32,936)	14,473			(2,930)	2,419
Net increase in cash and cash equivalents			9,477	9,219			9,477	9,219					6,673	9,986			2,798	(631)			6	(136)
Cash and cash equivalents at beginning of period			12,043	4,365			12,043	4,365					11,427	149				3,567			616	649
Cash and cash equivalents at end of period	$ 21,520	$ 13,584	$ 21,520	$ 13,584	$ 21,520	$ 13,584	$ 21,520	$ 13,584			$ 18,100	$ 10,135	$ 18,100	$ 10,135	$ 2,798	$ 2,936	$ 2,798	$ 2,936	$ 622	$ 513	$ 622	$ 513

XML

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 7 5/8% Senior Subordinated Notes (Tables)

6 Months Ended

Jun. 30, 2012

Financial Information for Subsidiary Guarantors and Non-Guarantor Subsidiaries under Select's 7 5/8% Senior Subordinated Notes

Schedule of Condensed Consolidating Balance Sheet

	Select Medical Corporation
	Condensed Consolidating Balance Sheet
	June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Assets
Current Assets:
Cash and cash equivalents	$	18,100		$	2,798		$	622		$	—		$	21,520
Accounts receivable, net	—			367,585			56,274			—			423,859
Current deferred tax asset	8,774			3,262			3,497			—			15,533
Prepaid income taxes	4,061			—			—			—			4,061
Other current assets	7,654			20,339			3,390			—			31,383
Total Current Assets	38,589			393,984			63,783			—			496,356
Property and equipment, net	14,754			422,031			55,996			—			492,781
Investment in affiliates	2,861,419			78,736			—			(2,940,155		)(a)(b)	—
Goodwill	—			1,631,461			—			—			1,631,461
Other identifiable intangibles	—			71,783			—			—			71,783
Assets held for sale	2,742			—			—			—			2,742
Other assets	24,335			58,224			732			—			83,291
Total Assets	$	2,941,839		$	2,656,219		$	120,511		$	(2,940,155	)	$	2,778,414
Liabilities and Equity
Current Liabilities:
Bank overdrafts	$	20,348		$	—		$	—		$	—		$	20,348
Current portion of long-term debt and notes payable	10,236			370			1,179			—			11,785
Accounts payable	6,679			72,709			10,744			—			90,132
Intercompany accounts	1,036,057			(944,178		)	(91,879		)	—			—
Accrued payroll	13			73,528			171			—			73,712
Accrued vacation	4,319			44,964			6,925			—			56,208
Accrued interest	22,920			826			—			—			23,746
Accrued restructuring	—			3,038			—			—			3,038
Accrued other	45,069			52,856			6,898			—			104,823
Due to third party payors	—			4,106			3,158			—			7,264
Total Current Liabilities	1,145,641			(691,781		)	(62,804		)	—			391,056
Long-term debt, net of current portion	723,251			392,423			59,160			—			1,174,834
Non-current deferred tax liability	(3,960		)	78,164			8,707			—			82,911
Other non-current liabilities	49,360			18,909			380			—			68,649
Total Liabilities	1,914,292			(202,285		)	5,443			—			1,717,450
Stockholder’s Equity:
Common stock	0			—			—			—			0
Capital in excess of par	853,506			—			—			—			853,506
Retained earnings	174,041			724,340			22,366			(746,706		)(b)	174,041
Subsidiary investment	—			2,134,164			59,285			(2,193,449		)(a)	—
Total Select Medical Corporation Stockholder’s Equity	1,027,547			2,858,504			81,651			(2,940,155		)	1,027,547
Non-controlling interest	—			—			33,417			—			33,417
Total Equity	1,027,547			2,858,504			115,068			(2,940,155		)	1,060,964
Total Liabilities and Equity	$	2,941,839		$	2,656,219		$	120,511		$	(2,940,155	)	$	2,778,414

(a)  Elimination of investments in consolidated subsidiaries.

(b)  Elimination of investments in consolidated subsidiaries’ earnings.

	Select Medical Corporation
	Condensed Consolidating Balance Sheet
	December 31, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Assets
Current Assets:
Cash and cash equivalents	$	11,427		$	—		$	616		$	—		$	12,043
Accounts receivable, net	—			369,321			44,422			—			413,743
Current deferred tax asset	11,415			3,221			3,669			—			18,305
Prepaid income taxes	9,497			—			—			—			9,497
Other current assets	6,340			19,407			4,075			—			29,822
Total Current Assets	38,679			391,949			52,782			—			483,410
Property and equipment, net	14,641			440,736			54,651			—			510,028
Investment in affiliates	2,751,776			83,772			—			(2,835,548		)(a)(b)	—
Goodwill	—			1,631,716			—			—			1,631,716
Other identifiable intangibles	—			72,123			—			—			72,123
Assets held for sale	2,742			—			—			—			2,742
Other assets	28,386			41,480			853			—			70,719
Total Assets	$	2,836,224		$	2,661,776		$	108,286		$	(2,835,548	)	$	2,770,738
Liabilities and Equity
Current Liabilities:
Bank overdrafts	$	16,609		$	—		$	—		$	—		$	16,609
Current portion of long-term debt and notes payable	8,853			390			1,605			—			10,848
Accounts payable	7,353			76,207			12,058			—			95,618
Intercompany accounts	975,809			(880,537		)	(95,272		)	—			—
Accrued payroll	229			82,518			141			—			82,888
Accrued vacation	3,703			41,305			6,242			—			51,250
Accrued interest	11,843			137			—			—			11,980
Accrued restructuring	—			5,027			—			—			5,027
Accrued other	47,829			51,086			7,401			—			106,316
Due to third party payors	—			13,633			(8,107		)	—			5,526
Total Current Liabilities	1,072,228			(610,234		)	(75,932		)	—			386,062
Long-term debt, net of current portion	733,328			425,315			60,007			—			1,218,650
Non-current deferred tax liability	(2,509		)	75,750			8,787			—			82,028
Other non-current liabilities	46,555			17,970			380			—			64,905
Total Liabilities	1,849,602			(91,199		)	(6,758		)	—			1,751,645
Stockholder’s Equity:
Common stock	0			—			—			—			0
Capital in excess of par	848,844			—			—			—			848,844
Retained earnings	137,778			627,120			23,154			(650,274		)(b)	137,778
Subsidiary investment	—			2,125,855			59,419			(2,185,274		)(a)	—
Total Select Medical Corporation Stockholder’s Equity	986,622			2,752,975			82,573			(2,835,548		)	986,622
Non-controlling interest	—			—			32,471			—			32,471
Total Equity	986,622			2,752,975			115,044			(2,835,548		)	1,019,093
Total Liabilities and Equity	$	2,836,224		$	2,661,776		$	108,286		$	(2,835,548	)	$	2,770,738

(a)  Elimination of investments in consolidated subsidiaries.

(b)  Elimination of investments in consolidated subsidiaries’ earnings.

Schedule of Condensed Consolidating Statement of Operations

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Three Months Ended June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	13		$	649,628		$	100,552		$	—		$	750,193
Costs and expenses:
Cost of services	521			527,479			84,669			—			612,669
General and administrative	19,345			(791		)	—			—			18,554
Bad debt expense	—			8,832			1,197			—			10,029
Depreciation and amortization	718			12,410			2,300			—			15,428
Total costs and expenses	20,584			547,930			88,166			—			656,680
Income (loss) from operations	(20,571		)	101,698			12,386			—			93,513
Other income and expense:
Intercompany interest and royalty fees	(763		)	754			9			—			—
Intercompany management fees	27,755			(23,159		)	(4,596		)	—			—
Equity in earnings of unconsolidated subsidiaries	—			2,739			13			—			2,752
Interest expense	(13,173		)	(6,712		)	(1,072		)	—			(20,957		)
Income (loss) from operations before income taxes	(6,752		)	75,320			6,740			—			75,308
Income tax expense	2,211			26,377			58			—			28,646
Equity in earnings of subsidiaries	53,981			5,612			—			(59,593		)(a)	—
Net income	45,018			54,555			6,682			(59,593		)	46,662
Less: Net income attributable to non-controlling interests	—			—			1,644			—			1,644
Net income attributable to Select Medical Corporation	$	45,018		$	54,555		$	5,038		$	(59,593	)	$	45,018

(a) Elimination of equity in earnings of subsidiaries.

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Six Months Ended June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	97		$	1,293,953		$	200,164		$	—		$	1,494,214
Costs and expenses:
Cost of services	1,010			1,052,944			170,334			—			1,224,288
General and administrative	33,455			(677		)	—			—			32,778
Bad debt expense	—			17,674			2,730			—			20,404
Depreciation and amortization	1,423			25,580			4,624			—			31,627
Total costs and expenses	35,888			1,095,521			177,688			—			1,309,097
Income (loss) from operations	(35,791		)	198,432			22,476			—			185,117
Other income and expense:
Intercompany interest and royalty fees	(1,556		)	1,539			17			—			—
Intercompany management fees	57,129			(48,242		)	(8,887		)	—			—
Equity in earnings of unconsolidated subsidiaries	—			5,194			23			—			5,217
Interest expense	(26,147		)	(13,910		)	(2,150		)	—			(42,207		)
Income (loss) from operations before income taxes	(6,365		)	143,013			11,479			—			148,127
Income tax expense	1,976			54,904			276			—			57,156
Equity in earnings of subsidiaries	96,638			9,111			—			(105,749		)(a)	—
Net income	88,297			97,220			11,203			(105,749		)	90,971
Less: Net income attributable to non-controlling interests	—			—			2,674			—			2,674
Net income attributable to Select Medical Corporation	$	88,297		$	97,220		$	8,529		$	(105,749	)	$	88,297

(a) Elimination of equity in earnings of subsidiaries.

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Three Months Ended June 30, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	15		$	605,562		$	93,172		$	—		$	698,749
Costs and expenses:
Cost of services	194			493,059			76,413			—			569,666
General and administrative	16,039			76			—			—			16,115
Bad debt expense	—			11,908			2,035			—			13,943
Depreciation and amortization	654			15,099			2,246			—			17,999
Total costs and expenses	16,887			520,142			80,694			—			617,723
Income (loss) from operations	(16,872		)	85,420			12,478			—			81,026
Other income and expense:
Intercompany interest and royalty fees	(1,000		)	994			6			—			—
Intercompany management fees	44,391			(39,901		)	(4,490		)	—			—
Loss on early retirement of debt	(20,385		)	—			—			—			(20,385		)
Equity in earnings (losses) of unconsolidated subsidiaries	—			(260		)	9			—			(251		)
Interest income	34			77			—			—			111
Interest expense	(9,011		)	(9,370		)	(1,313		)	—			(19,694		)
Income (loss) from operations before income taxes	(2,843		)	36,960			6,690			—			40,807
Income tax expense	362			16,224			11			—			16,597
Equity in earnings of subsidiaries	25,477			4,784			—			(30,261		)(a)	—
Net income	22,272			25,520			6,679			(30,261		)	24,210
Less: Net income attributable to non-controlling interests	—			—			1,938			—			1,938
Net income attributable to Select Medical Corporation	$	22,272		$	25,520		$	4,741		$	(30,261	)	$	22,272

(a) Elimination of equity in earnings of subsidiaries.

	Select Medical Corporation
	Condensed Consolidating Statement of Operations
	For the Six Months Ended June 30, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Net operating revenues	$	86		$	1,205,815		$	186,034		$	—		$	1,391,935
Costs and expenses:
Cost of services	832			974,281			151,969			—			1,127,082
General and administrative	32,494			187			—			—			32,681
Bad debt expense	—			24,909			3,384			—			28,293
Depreciation and amortization	1,300			29,455			4,466			—			35,221
Total costs and expenses	34,626			1,028,832			159,819			—			1,223,277
Income (loss) from operations	(34,540		)	176,983			26,215			—			168,658
Other income and expense:
Intercompany interest and royalty fees	(1,995		)	1,980			15			—			—
Intercompany management fees	67,863			(59,131		)	(8,732		)	—			—
Loss on early retirement of debt	(20,385		)	—			—			—			(20,385		)
Equity in earnings (losses) of unconsolidated subsidiaries	—			(348		)	24			—			(324		)
Interest income	65			101			1			—			167
Interest expense	(16,376		)	(19,319		)	(2,661		)	—			(38,356		)
Income (loss) from operations before income taxes	(5,368		)	100,266			14,862			—			109,760
Income tax expense	1,288			44,044			279			—			45,611
Equity in earnings of subsidiaries	67,152			10,581			—			(77,733		)(a)	—
Net income	60,496			66,803			14,583			(77,733		)	64,149
Less: Net income attributable to non-controlling interests	—			—			3,653			—			3,653
Net income attributable to Select Medical Corporation	$	60,496		$	66,803		$	10,930		$	(77,733	)	$	60,496

(a) Elimination of equity in earnings of subsidiaries.

Schedule of Condensed Consolidating Statement of Cash Flows

	Select Medical Corporation
	Condensed Consolidating Statement of Cash Flows
	For the Six Months Ended June 30, 2012
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Operating activities
Net income	$	88,297		$	97,220		$	11,203		$	(105,749	)(a)	$	90,971
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,423			25,580			4,624			—			31,627
Provision for bad debts	—			17,674			2,730			—			20,404
Loss (gain) from disposal of assets	—			(3,606		)	2			—			(3,604		)
Non-cash stock compensation expense	2,599			—			—			—			2,599
Amortization of debt discount	622			—			—			—			622
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries	(96,638		)	(9,111		)	—			105,749		(a)	—
Intercompany	46,380			(40,086		)	(6,294		)	—			—
Accounts receivable	—			(15,938		)	(14,582		)	—			(30,520		)
Other current assets	(1,314		)	(983		)	685			—			(1,612		)
Other assets	4,051			(5,011		)	121			—			(839		)
Accounts payable	(674		)	(3,498		)	(1,314		)	—			(5,486		)
Due to third-party payors	—			(9,527		)	11,265			—			1,738
Accrued expenses	8,717			(2,587		)	210			—			6,340
Income and deferred taxes	11,809			—			—			—			11,809
Net cash provided by operating activities	65,272			50,127			8,650			—			124,049
Investing activities
Purchases of property and equipment	(1,536		)	(20,684		)	(5,714		)	—			(27,934		)
Proceeds from sale of assets	—			16,511			—			—			16,511
Investment in businesses	—			(10,014		)	—			—			(10,014		)
Acquisition of businesses, net of cash acquired	—			(206		)	—			—			(206		)
Net cash used in investing activities	(1,536		)	(14,393		)	(5,714		)	—			(21,643		)
Financing activities
Borrowings on revolving credit facility	340,000			—			—			—			340,000
Payments on revolving credit facility	(380,000		)	—			—			—			(380,000		)
Payments on 2011 credit facility term loan	(4,250		)	—			—			—			(4,250		)
Borrowings of other debt	5,557			—			278			—			5,835
Principal payments on other debt	(4,179		)	(220		)	(686		)	—			(5,085		)
Dividends paid to Holdings	(52,034		)	—			—			—			(52,034		)
Equity investment by Holdings	547			—			—			—			547
Proceeds from bank overdrafts	3,739			—			—			—			3,739
Intercompany debt reallocation	33,557			(32,716		)	(841		)	—			—
Distributions to non-controlling interests	—			—			(1,681		)	—			(1,681		)
Net cash used in financing activities	(57,063		)	(32,936		)	(2,930		)	—			(92,929		)
Net increase in cash and cash equivalents	6,673			2,798			6			—			9,477
Cash and cash equivalents at beginning of period	11,427			—			616			—			12,043
Cash and cash equivalents at end of period	$	18,100		$	2,798		$	622		$	—		$	21,520

(a)  Elimination of equity in earnings of consolidated subsidiaries.

	Select Medical Corporation
	Condensed Consolidating Statement of Cash Flows
	For the Six Months Ended June 30, 2011
	(unaudited)
	Select Medical Corporation (Parent Company Only)			Subsidiary Guarantors			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(in thousands)
Operating activities
Net income	$	60,496		$	66,803		$	14,583		$	(77,733	)(a)	$	64,149
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,300			29,455			4,466			—			35,221
Provision for bad debts	—			24,909			3,384			—			28,293
Loss on early retirement of debt	20,385			—			—			—			20,385
Loss (gain) from disposal of assets	10			(5,225		)	14			—			(5,201		)
Non-cash stock compensation expense	1,780			—			—			—			1,780
Amortization of debt discount	103			—			—			—			103
Changes in operating assets and liabilities, net of effects from acquisition of businesses:
Equity in earnings of subsidiaries	(67,152		)	(10,581		)	—			77,733		(a)	—
Intercompany	53,735			(46,683		)	(7,052		)	—			—
Accounts receivable	—			(73,715		)	(7,525		)	—			(81,240		)
Other current assets	(2,096		)	245			340			—			(1,511		)
Other assets	(4,203		)	6,564			108			—			2,469
Accounts payable	2,758			4,531			818			—			8,107
Due to third-party payors	—			6,599			(7,063		)	—			(464		)
Accrued expenses	9,410			4,606			(1,008		)	—			13,008
Income and deferred taxes	16,151			—			—			—			16,151
Net cash provided by operating activities	92,677			7,508			1,065			—			101,250
Investing activities
Purchases of property and equipment	(1,178		)	(18,898		)	(3,620		)	—			(23,696		)
Investment in business	—			(13,514		)	—			—			(13,514		)
Acquisition of businesses, net of cash acquired	—			1,921			—			—			1,921
Proceeds from sale of assets	—			7,879			—			—			7,879
Net cash used in investing activities	(1,178		)	(22,612		)	(3,620		)	—			(27,410		)
Financing activities
Borrowings on revolving credit facilities	435,000			—			—			—			435,000
Payments on revolving credit facilities	(395,000		)	—			—			—			(395,000		)
Borrowings on 2011 credit facility term loan, net of discount	841,500			—			—			—			841,500
Payments on 2005 credit facility term loans, net of call premium	(484,633		)	—			—			—			(484,633		)
Repurchase of 7 5/8% senior subordinated notes, net of tender premium	(273,941		)	—			—			—			(273,941		)
Borrowings of other debt	5,496			—			—			—			5,496
Principal payments on other debt	(2,581		)	(899		)	—			—			(3,480		)
Debt issuance costs	(18,556		)	—			—			—			(18,556		)
Proceeds from bank overdrafts	2,102			—			—			—			2,102
Equity investment by Holdings	169			—			—			—			169
Dividends paid to Holdings	(171,008		)	—			—			—			(171,008		)
Intercompany debt reallocation	(20,061		)	15,372			4,689			—			—
Distributions to non-controlling interests	—			—			(2,270		)	—			(2,270		)
Net cash provided by (used in) financing activities	(81,513		)	14,473			2,419			—			(64,621		)
Net increase (decrease) in cash and cash equivalents	9,986			(631		)	(136		)	—			9,219
Cash and cash equivalents at beginning of period	149			3,567			649			—			4,365
Cash and cash equivalents at end of period	$	10,135		$	2,936		$	513		$	—		$	13,584

(a)  Elimination of equity in earnings of consolidated subsidiaries.

XML

Fair Value (Details) (USD $) In Millions, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011
Senior secured credit facility | Select
Fair Value
Carrying value	$ 834.3	$ 878.0
Fair value	815.6	823.3
7 5/8% senior subordinated notes | Select
Fair Value
Carrying value	345.0	345.0
Fair value	346.3	326.4
Interest rate of debt (as a percent)	7.625%	7.625%
Senior floating rate notes | Holdings
Fair Value
Carrying value	167.3	167.3
Fair value	$ 160.6	$ 143.9

XML

Consolidated Statement of Changes in Equity and Income (USD $) In Thousands, unless otherwise specified	Total	Common Stock	Capital in Excess of Par	Retained Earnings	Non-controlling Interests	Select	Select Common Stock	Select Capital in Excess of Par	Select Retained Earnings	Select Non-controlling Interests
Balance at Dec. 31, 2011	$ 855,326	$ 145	$ 493,828	$ 328,882	$ 32,471	$ 1,019,093	$ 0	$ 848,844	$ 137,778	$ 32,471
Balance (in shares) at Dec. 31, 2011		145,268					0
Increase (Decrease) in Stockholders' Equity
Net income	87,388			84,714	2,674	90,971			88,297	2,674
Issuance and vesting of restricted stock	1,998	0	1,998
Issuance and vesting of restricted stock (in shares)		194
Exercise of stock options	547	0	547
Exercise of stock options (in shares)		127
Stock option expense	601		601
Repurchase of common shares	(46,790)	(5)	(27,150)	(19,635)
Repurchase of common shares (in shares)		(5,726)
Federal tax benefit of losses contributed by Holdings						1,930		1,930
Additional investment by Holdings						547		547
Dividends declared and paid to Holdings						(52,034)			(52,034)
Distributions to non-controlling interests	(1,681)				(1,681)	(1,681)				(1,681)
Other	(461)		(414)		(47)	(461)		(414)		(47)
Contribution related to restricted stock awards and stock option issuances by Holdings						2,599		2,599
Balance at Jun. 30, 2012	896,928	140	469,410	393,961	33,417	1,060,964	0	853,506	174,041	33,417
Balance (in shares) at Jun. 30, 2012		139,863					0
Balance at Mar. 31, 2012
Increase (Decrease) in Stockholders' Equity
Net income	44,816					46,662
Balance at Jun. 30, 2012	$ 896,928					$ 1,060,964	$ 0
Balance (in shares) at Jun. 30, 2012							0

XML

Restructuring Reserves

6 Months Ended

Jun. 30, 2012

Restructuring Reserves

Restructuring Reserves

4.  Restructuring Reserves

In connection with the acquisition of substantially all of the outpatient rehabilitation division of HealthSouth Corporation, the Company recorded an estimated liability of $18.7 million in 2007 for business restructuring which was accounted for as additional purchase price. This reserve primarily included costs associated with workforce reductions and lease termination costs in accordance with the Company’s restructuring plan.

In connection with the acquisition of all the issued and outstanding equity securities of Regency Hospital Company, L.L.C. (“Regency”), an operator of long term acute care hospitals, the Company recorded an estimated liability of $4.3 million in 2010 for business restructuring related to lease termination costs.

The following summarizes the Company’s restructuring activity:

	Lease Termination Costs
	(in thousands)
Balance as of December 31, 2011	$	5,027
Amounts paid in 2012	(845		)
Accretion expense	157
Revision of estimate	(1,301		)
Balance as of June 30, 2012	$	3,038

The Company expects to pay out the remaining lease termination costs through 2014 for the acquisition of the outpatient rehabilitation division of HealthSouth Corporation and through 2015 for the Regency acquisition.

XML

Segment Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Dec. 31, 2011
Segment Information
Net operating revenue	$ 750,193	$ 698,749	$ 1,494,214	$ 1,391,935
Adjusted EBITDA	110,279	99,925	219,343	205,659
Total assets:	2,779,637		2,779,637		2,772,147
Capital expenditures	16,183	10,776	27,934	23,696
Select Medical Corporation
Segment Information
Net operating revenue	750,193	698,749	1,494,214	1,391,935
Total assets:	2,778,414	2,786,433	2,778,414	2,786,433	2,770,738
Capital expenditures			27,934	23,696
Select Medical Holdings Corporation
Segment Information
Total assets:	2,779,637	2,788,022	2,779,637	2,788,022
Specialty Hospitals
Segment Information
Net operating revenue	557,130	520,261	1,110,168	1,040,185
Adjusted EBITDA	102,166	91,081	202,120	191,434
Capital expenditures	12,631	6,130	19,682	16,617
Specialty Hospitals | Select Medical Corporation
Segment Information
Total assets:	2,184,743	2,202,994	2,184,743	2,202,994
Specialty Hospitals | Select Medical Holdings Corporation
Segment Information
Total assets:	2,184,743	2,202,994	2,184,743	2,202,994
Outpatient Rehabilitation
Segment Information
Number of operating segments			2
Net operating revenue	193,050	178,473	383,949	351,664
Adjusted EBITDA	25,837	24,467	48,315	45,873
Capital expenditures	2,922	2,801	6,713	4,982
Outpatient Rehabilitation | Select Medical Corporation
Segment Information
Total assets:	437,591	471,175	437,591	471,175
Outpatient Rehabilitation | Select Medical Holdings Corporation
Segment Information
Total assets:	437,591	471,175	437,591	471,175
All Other
Segment Information
Net operating revenue	13	15	97	86
Adjusted EBITDA	(17,724)	(15,623)	(31,092)	(31,648)
Capital expenditures	630	1,845	1,539	2,097
All Other | Select Medical Corporation
Segment Information
Total assets:	156,080	112,264	156,080	112,264
All Other | Select Medical Holdings Corporation
Segment Information
Total assets:	$ 157,303	$ 113,853	$ 157,303	$ 113,853

XML

Income per Common Share (Tables)

6 Months Ended

Jun. 30, 2012

Income per Common Share

Schedule of calculation of net income per share

	For the Three Months				For the Six Months
	Ended June 30,				Ended June, 30
	2011		2012		2011		2012
	(in thousands, except per share data)
Numerator:
Net income attributable to Select Medical Holdings Corporation	$	11,719	$	43,172	$	45,391	$	84,714
Less: Earnings allocated to unvested restricted stockholders	125		707		486		1,338
Net income available to common stockholders	$	11,594	$	42,465	$	44,905	$	83,376
Denominator:
Weighted average shares – basic	152,603		138,456		152,720		139,941
Effect of dilutive securities:
Stock options	278		229		231		221
Weighted average shares – diluted	152,881		138,685		152,951		140,162
Basic income per common share	$	0.08	$	0.31	$	0.29	$	0.60
Diluted income per common share	$	0.08	$	0.31	$	0.29	$	0.59

Schedule of anti-dilutive shares excluded from computation

	For the Three Months Ended June 30,		For the Six Months Ended June 30,
	2011	2012	2011	2012
	(in thousands)
Stock options	1,691	1,684	2,400	1,699